Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2012

Myelin Gene Expression: Implications for Alcohol Abuse and
Dependence
Sean Farris
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Medical Pharmacology Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/322

This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars
Compass. For more information, please contact libcompass@vcu.edu.

! Sean P. Farris

2012

All Rights Reserved

Myelin Gene Expression: Implications for Alcohol Abuse and Dependence

A thesis submitted in partial fulfillment of the requirement for the degree of Doctor of
Philosophy in Pharmacology and Toxicology at Virginia Commonwealth University.

By

Sean Patrick Farris
Bachelor of Science in Forensic Science from Eastern Kentucky University 2005

Directed by: Michael F. Miles, M.D., Ph.D.,
Professor of Pharmacology and Toxicology

Virginia Commonwealth University
Richmond, Virginia
March 2012

i

ACKNOWLEDGMENTS

I would like to sincerely thank several people for their contributions to my
academic research endeavors as well as growth as a scientist and an individual. First, I
would like to thank my family for all of their support and patience. Secondly, I would like
to thank my friends and fellow members of the Sigma Chi Fraternity that have given me
a wealth of advice, encouragement, and laughter. Kassy and Michael Pelzel have given
me a place of refuge over the past few years and have been a constant reminder of
some the best things in my own life. I would also like to thank Jonathan Potts and Guy
Frye for always shining a positive light on any situation no matter how grim.
Professionally, I would like to thank Dr. Dorit Ron from the University of California
San Francisco for her helpful thoughts on this project and support of my predoctoral
fellowship from the National Institute of Alcohol Abuse and Alcoholism. This particular
project has also been helped through the advice of several collaborators; a special
thanks to Drs. John Crabbe, Susan Bergeson, and Rob Williams for their contributions.
I would like to express my sincere gratitude to all of the members of Dr. Michael
Miles’ laboratory for technical contributions to my dissertation work, especially Nathanial
Bruce, Jennifer Wolstenholme, Aaron Wolen, and JoLynne Harenza. An immense
amount of gratitude goes to Dr. Michael F. Miles for his intellectual contributions, his
constant encouragement, and unwavering support in my development as an
independent scientist. I would like to thank the Department of Pharmacology and
Toxicology for accepting me into the program; a decision that has greatly impacted my
life and future. I would also like to thank the Department of Pharmacology and

ii

Toxicology, the National Institute of Drug Abuse, and the National Institute of Alcohol
Abuse and Alcoholism for all of the financial support I have received during my tenure
with Virginia Commonwealth University and the Medical College of Virginia. Lastly, I
would like to thank my new mentor, Dr. Adron Harris, for accepting me into his
laboratory and notable advice: “The PhD is the beginning, not the end of your
education, the only constant is change and we must continually reinvent ourselves.”

iii

Table of Contents

Acknowledgements……………………………………………………………………………..ii
List of Tables…………………………………………………………………………………....vi
List of Figures…………………………………………………………………………………..vii
Abstract…………………………………………………………………………………………xiii
Chapter
1

Introduction……………………………………………………………….............…...1

2

Background and Significance……………………………………………………….7
Genetic Contributions to Alcoholism and Ethanol-Related Behaviors in Humans.9
Model Organisms for the Genetic and Genomic Analysis of Complex Traits…...12
Mapping Quantitative Traits in Model Organisms for Disease……………………17
Neuropharmacology of Acute and Chronic Alcohol Exposure……………………23
Neurobiology of Myelin and Animal Models of Demyelination……………………34
Application of DNA Microarrays on Ethanol and Ethanol-related Phenotypes….50
Bioinformatics and Network Analysis of Gene Expression………………………..62
Concluding Remarks……………………………………………………………….....68

3

Gene Networks of Chronic Alcohol Administration Across Species
Introduction……………………………………………………………………………..72
Materials and Methods………………………………………………………………..76
Results………………………………………………………………………………….87
Discussion…………………………………………………………………………….136

iv

4

Alcohol-related Behavioral Phenotypes and Variation of Myelin Gene
Expression in Prefrontal Cortex
Introduction……………………………………………………………………………142
Materials and Methods………………………………………………………………145
Results………………………………………………………………………………...150
Discussion…………………………………………………………………………….166

5

Fyn-Dependent Gene Networks in Acute Alcohol Sensitivity
Introduction……………………………………………………………………………171
Materials and Methods………………………………………………………………173
Results………………………………………………………………………………...179
Discussion…………………………………………………………………………….203

6

Myelin Gene Expression and The Loss of Righting Reflex Behavior
Introduction……………………………………………………………………………207
Materials and Methods………………………………………………………………210
Results………………………………………………………………………………...221
Discussion…………………………………………………………………………….247

7

General Discussion and Future Perspectives…..………………………...…..254

Literature Cited………………………………………………………………………..……...269
Vita……………………………………………………………………………………………..329

v

List of Tables
Table 1. Functional over-representation for brain-region differences in female
cynomolgus macaques………………………..………………….……………90
Table 2. Functional over-representation for overlapping expression profiles between
PFC, HPC, NAC, and AMY in female cynomolgus macaques…….………91
Table 3. Functional over-representation for alcohol-responsive genes in
different brain regions of female cynomolgus macaques……..……95
Table 4. Functional over-representation for rhesus macaque PFC modules
associated with alcohol drinking behavior………………………………….118
Table 5. Functional over-representation of microRNAs associated with alcohol
drinking networks…………...…………………………………………………122
Table 6. Alcohol behavioral phenotypes associated with myelin gene expression in
PFC……………………………………………………………………………..163
Table 7. Functional over-representation for Fyn knockout mice basal gene
expression……………………………………………………………………...183
Table 8. Functional over-representation for Fyn kncockout mice basal dependent
gene network…………………………………………………………………..197
Table 9. Functional over-representation for Fyn kncockout mice alcohol dependent
gene network…………………………………………………………………..200

vi

List of Figures
Figure 1. Diagram of multiple potential subcomponent vectors contributing to the
observed behavioral phenomenon of alcohol dependence…………….......8
Figure 2. Schematic of BXD recombinant inbred mice……………………..…………19
Figure 3. Pictorial of myelinated axon……………………………………………….…..36
Figure 4. Myelin Basic Protein (Mbp) and Proteolipid Protein (Plp1) mRNA
expression in mouse brain……………………………………………..……..38
Figure 5. Myelin-associated pathogenic loop…………………………………….…….43
Figure 6. Microarray analysis of acute ethanol-responsive gene expression in B6
and D2 mice……………………………………………………..………...…...57
Figure 7. Decrease myelin-associated gene expression from human PFC…………58
Figure 8. Systems genetics approach towards behavioral endophenotypes
associated with alcohol abuse and dependence……………………....…..71
Figure 9. Correlation of blood ethanol concentration (BEC) with ethanol selfadministration in cynomolgus macaques……….…………………………..78
Figure 10. Basal gene expression differences among different brain regions in
female cynomolgus macaques…………….………………………………...88

vii

Figure 11. Microarray analysis of alcohol-responsive gene expression for female
cynomolgus macaques ...……………………….……………......................92
Figure 12. Literature association networks using Ingenuity Pathway Analysis for
alcohol-responsive gene expression in female cynomolgus macaques...96
Figure 13. Alcohol-responsive gene expression in male cynomolgus macaque
prefrontal cortex…………………………………………………..………….102
Figure 14. Venn diagram for alcohol-responsive gene expression in female and male
cynomolgus macaques PFC…………………………………...…………..103
Figure 15. Literature association analysis of male & female cynomolgus macaque
PFC overlapping with genes correlating to alcohol intake in mouse PFC
……………….……………………………………………………………..…106
Figure 16. Male and female cynomolgus macaque PFC differential expression and
gene ontology analysis……………………..………………………………107
Figure 17. Analysis of NADH4L gene expression and sequencing for female
cynomolgus macaques PFC……………………………………………….109
Figure 18. Sequencing confirmation of genetic differences between controls and
alcohol-drinking cynomolgus macaques…………………………….……111
Figure 19. Pairwise comparison of male cynomolgus macaque and rhesus macaque
PFC microarrays…………………………………………….………………112

viii

Figure 20. Drinking histogram frequencies for each of the three monkey cohorts
………………………………………………………………………………...113
Figure 21. Weighted gene co-expression network analysis (WGCNA) for rhesus
macaque PFC……………………………………….…......………………..115
Figure 22. S-scored modules significantly correlated to alcohol drinking behavior in
male rhesus macaque PFC…………………………………….…………..116
Figure 23. S-scored modules significantly correlated to alcohol drinking behavior in
male rhesus macaque PFC…………………………………………..…….117
Figure 24. Male rhesus macaque PFC module eigengene correlations to alcohol
intake………………………………………………………………………....119
Figure 25. MicroRNA network for rhesus macaque PFC associated alcohol-drinking
modules………………………………………………………...…………….121
Figure 26. Module membership correlation for rhesus macaque PFC associated
alcohol-drinking modules……………………………….…….....………....124
Figure 27. RMA modules significantly correlated to alcohol drinking behavior in male
rhesus macaque PFC……………………………………………………….126
Figure 28. Comparison of methods for collapsing probes to genes across mice and
rhesus macaques…………………………………………….……….…….128
Figure 29. Ranked gene expression for maximum mean expression……...………129

ix

Figure 30. Cross-species weighted gene co-expression PFC dendrograms……...130
Figure 31. Module eigengene expression for collapsed rhesus macaque PFC
dataset ………………………………………….………………………...….131
Figure 32. Overlap of weighted gene co-expression modules across species …...133
Figure 33. Phylogenetic display of myelin conservation between species….……..134
Figure 34. Association of myelin gene expression with alcohol drinking behavior
………………………………………………………………………………...135
Figure 35. Cross-species myelin gene expression network…………………………137
Figure 36. Model for genotype to phenotype relationship……………………………152
Figure 37. Time-course of myelin-associated gene expression from DBA/2J mice
………………………………………….………………………….………….154
Figure 38. Subset of alcohol behavioral phenotypes for C57BL/6J and DBA/2J mice
……………………….……………………………….……………………….155
Figure 39. Myelin gene expression variation between C57BL/6J and DBA/2J, and
BXD RI mice……….…………………………...……………………………156
Figure 40. Weighted gene co-expression network analysis of LXS and BXD PFC
………………………………………………………………………………...158

x

Figure 41. Functional over-representation analysis of LXS and BXD PFC modules
………………………………………………………………………..……….159
Figure 42. Brain-region specific differences in the myelin-associated gene network
………………………………………………………………………………...161
Figure 43. Pilot study on genome wide-association of myelin genes for
endophenotypes of alcohol dependence…………………………..……..165
Figure 44. Literature association analysis of myelin gene expression……….…….180
Figure 45. Basal and alcohol-responsive gene expression differences between Fyn
knockout mice and controls……………………………….………….…….182
Figure 46. Over Representation Analysis (ORA) of Myelin-Associated Gene
Expression…………………………………………………….……….….....187
Figure 47. Alcohol-Responsive Fyn Gene Network Differences……………………190
Figure 48. Fyn-LORR Correlation Network within PFC…………….………………..194
Figure 49. In silico correlation analysis of Fyn and LORR behavior……………….196
Figure 50. Independent assessment of Fyn kinase correlation networks….….......202
Figure 51. Behavioral genomics of ILS, ISS, L.5S, S.5L…….……………………....222
Figure 52. Genetic analysis of Lore5 genotype ………………………………...……224

xi

Figure 53. PFC basal Ndrg1 expression and LORR behavior………………..........228
Figure 54. Ndrg1 and associated gene expression………………………….............231
Figure 55. Validation of cuprizone model for myelin-associated gene expression
……………………………………………………………………………......235
Figure 56. Validation of cuprizone model for decreased CNS white matter……….236
Figure 57. Cuprizone effect on anxiety-like behavior…………………….………......238
Figure 58. Cuprizone effect on locomotor behavior……………………….……........240
Figure 59. Cuprizone effect on additional motor-oriented behaviors…………........242
Figure 60. Cuprizone effect on gaiting behavior….………………………………......244
Figure 61. Cuprizone effect on handling induced convulsion (HiC) behavior …….246
Figure 62. Cuprizone effect on LORR behavior and alcohol metabolism …....……248
Figure 63. Myelin and Alcoholism ………………………….……………………….....268

xii

ABSTRACT

Myelin Gene Expression: Implications for Alcohol Abuse and Dependence
By: Sean P. Farris
A Dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University

Virginia Commonwealth University 2012

Major Director: Michael F. Miles, M.D., Ph.D.
Professor, Departments of Pharmacology and Toxicology, and Neurology

Acute behavioral responses to ethanol have predictive value for determining an
individual's risk of long-term drinking behavior. Although the neurobiology of alcohol
abuse is complex, prior studies from our laboratory demonstrated differential myelinassociated gene expression (MAGE) in medial prefrontal cortex (PFC) as one potential
mechanism influencing acute ethanol behaviors between C57BL/6J (B6) and DBA/2J
(D2) mice. Our laboratory and others have also shown MAGE is reduced in PFC of
alcoholics. Herein, I have extended these findings through expression profiling of PFC
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into chronic models of ethanol self-administration from non-human primates and mice.
Together, these results suggest that regulation of MAGE may be relevant to behavioral
phenotypes witnessed in alcoholism. The pathogenesis of alcoholism progresses
through multiple stages of drug exposure and withdrawal, however, genetic
predisposition is also a major contributing factor for this disease. Therefore, I tested the
hypothesis that not only does ethanol have direct effects on MAGE, but also variation in
basal MAGE within the PFC is a molecular endophenotype underlying ethanol
behavioral sensitivity. Bioinformatics of basal MAGE across the BXD recombinant
inbred panel (n=29), derived from B6 and D2 mice, revealed a densely correlated
myelin gene network associated with several ethanol behavioral phenotypes. Literature
association tools identified Fyn kinase as potential regulator of MAGE. Fyn knockout
mice are known to be more sensitive to the sedative-hypnotic properties of ethanol in
the loss of righting reflex (LORR) paradigm. Microarray analysis of Fyn knockout mice
revealed a significant decrease in MAGE, suggesting MAGE may be an underlying
factor for LORR. In support of this premise, microarray analysis of genetic variance in
LORR across Inbred Long Sleep and Inbred Short Sleep mice, as well as congenics for
the Lore5 quantitative trait locus, also demonstrated an inverse relationship between
MAGE and duration of LORR. The hypothesis was further investigated using cuprizone
to model demyelination in B6 mice and test them in a battery of acute ethanol
behaviors. Cuprizone-treated mice had a significantly greater duration in LORR (p <
0.01), demonstrating that myelin is an important contributor to the genetic variance in
LORR. Thus, through genetic, genomic, and pharmacological tools I have ‘molecularly
triangulated’ a myelin gene network as a contributing factor influencing acute ethanol
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behavioral sensitivity. The ability of myelin to alter acute ethanol sensitivity may warrant
a prospective study of myelin in humans as a predictive molecular phenotype for an
individual’s risk of developing alcohol dependence. Additionally, further genomic
dissection of MAGE architecture and associated networks may aid in developing novel
pharmacotherapies for an alcohol use disorder. Supported by NIAAA grants F31
AA018615 to SPF.
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CHAPTER 1: INTRODUCTION

Alcohol abuse and alcohol dependence, collectively referred to as an alcohol use
disorder, is a serious debilitating disorder with long-standing implications on society and
the global disease burden. An epidemiological survey of the United States determined
approximately 9% of the population, 17.6 million adult Americans, suffer from an alcohol
use disorder (Grant et al., 2004). Perhaps even more staggering, a report by the World
Health Organization estimates more than 140 million individuals around the world suffer
from alcoholism; however, this number may be woefully underestimated due to the
variation in screening, diagnostic criterion, and absence of adequate data from
developing countries. Alcohol abuse is defined by the 4th edition of the Diagnostic and
Statistical Manual of Mental Disorders as a maladaptive pattern of alcohol usage in
spite of reoccurring adverse consequences such as failure to fulfill major obligations,
physically hazardous situations, alcohol-related legal issues, and recurrent social or
interpersonal problems. In addition to the symptoms of alcohol abuse, the manifestation
of alcohol dependence is more extensively characterized by the development of
tolerance, withdrawal, loss of control, preoccupation of use, and increased habitual
drinking patterns leading to the presence of physical dependence (2000).
The socioeconomic impact of alcohol abuse and dependence in the United
States is estimated to account for roughly 220 billion dollars per year (University, 2006);
with an estimated economic cost worldwide ranging between one and six percent of a
country’s gross domestic product (Organization, 2004). The dollar amount associated
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with alcohol or substance abuse; however, pales in comparison to the tremendous
personal costs arising from the physiological and psychological consequences in
afflicted individuals, as well as their surrounding friends and family. The average
lifespan of an individual enduring an alcohol use disorder is cut short 10 to 15 years,
with the lifetime risk of occurrence among developed countries being greater than 20%
for men and 8 to 10% for women (Schuckit, 2009a). In spite of these dramatic personal,
societal, and financial expenditures there is no medicinal cure for an alcohol use
disorder, and few effective pharmacotherapies exist to date for treatment regimens.
Medication is often paired with cognitive-behavioral studies, but often show minimal
success rates for preventing alcoholic recidivism (Mariani and Levin, 2004).
Similar to other medical conditions such as heart disease and obesity, there is no
singular cause of alcoholism. The underlying molecular biology regulating the risk for
developing this disorder has remained elusive despite numerous years of scientific
innovations and inquiry. Family and twin-based adoption studies suggest that 40-60% of
the risk of developing an alcohol use disorder is inherited through an individuals’ genetic
background with the remainder associated with gene-environment interactions (Prescott
and Kendler, 1999, Schuckit et al., 2001). Genetic variation (i.e. polymorphisms) in the
metabolizing enzymes guiding the breakdown of alcohol into acetaldehyde has been
identified in Asian populations as being protective against dependence, but the entire
complement of genetic variants guarding against or predisposing the risk of
dependence remains undefined. Further complicating the identification of causal
variants is interpreting how such DNA polymorphisms contribute to the range of
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endophenotypes, which subsequently interact with the environment, and lead to
alcoholism.
Additional risk factors for alcohol dependence such as age of onset (Chou and
Pickering, 1992, Grant and Dawson, 1997) and impulsivity (Dick et al., 2010), among
many others, have been repeatedly. As many as 80% of men and 60% of women
experiment with alcohol consumption at some point throughout their lifetime (Teesson et
al., 2006). In the United States nearly 50% of all individuals surveyed report having
consumed an alcoholic beverage within the past 30 days (Administration 2005).
However, only 20% of the population consumes over 80% of all the alcohol sold
(Dawson, 2000), and not everyone exposed to alcohol or genetically predisposed for the
condition will go on to develop an alcohol use disorder. Furthermore, risk factors are not
predictive of treatment outcomes (Vaillant, 2003). Thus, a complex interaction of abuse
liability, acute experiences, and habitual drinking behavior contributes to physiological
and psychological dependence on alcohol.
Preclinical in vitro and in vivo models have accelerated our insights into the
molecular targets involved with the varying stages of addiction (Koob, 2006). Such
preclinical models are not without limitation. The low molecular weight, low potency,
relatively poor reactivity, and distribution into total-body water complicate characterizing
the precise pharmacological profile of ethanol. Changes in the expression or function of
cell signaling mechanisms typically are of small effect size with changes of only 30% not
uncommon (Lovinger and Crabbe, 2005). Overcoming these hurdles has been met with
significant rigor by the scientific community through the creation of numerous molecular
assays, behavioral models, and genetically engineered mouse models. Although animal
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models do not perfectly mimic the human condition as a whole, lacking the operative
psychopathology and diagnostic criteria, they do model varying specific aspects of the
disease (Bennett et al., 2006).
Studies directly addressing the consilience between human and animal models
for understanding the molecular basis of endophenotypes in alcohol use disorders has
been sparse (Crabbe et al., 2010a) but are not beyond our grasp. For example,
quantitative trait loci (QTL) mapping studies have identified syntenic regions within the
mouse and human genome for alcohol-related phenotypes suggesting the existence of
evolutionary conserved genetic factors influencing the behavioral response to alcohol
(Ehlers et al., 2010). Combining QTL mapping with expression profiling studies, now
commonly referred to as genetical-genomics, has been suggested to further facilitate
the identification of genes underlying complex traits (Jansen and Nap, 2001). Compared
to other scientific fields of inquiry the neuroscience community has been slow to adopt
the use of functional genomics, certain genetic methodologies, and large-scale
databases or web-based resources (Geschwind and Konopka, 2009); however, these
methods have shown promise in the discovery of novel quantitative trait genes (QTGs)
shaping the phenotypic variance of disease (Schadt et al., 2003, Schadt et al., 2005).
Single gene approaches utilizing genetic strategies within the central nervous
system have received considerable attention in regards to the effect of these genes on
ethanol behavioral phenotypes (Crabbe et al., 2006b, Crabbe et al., 2010a). None of
these studies have produced the proverbial silver bullet in alcohol abuse or
dependence, with many of these studies showing only modest effect. An alternative and
more inclusive approach are to examine the phenotypic variance of several
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endophenotypes alongside the accompanying genotypic variance. By using genetic
linkage to anchor both gene expression networks and behavioral sub-phenotypes, the
actual goal of defining an “alcoholism gene” or quantitative trait gene becomes less
important, shifting the focus from a single gene to a series of genes or gene networks.
The underlying premise for this approach is that gene expression per se can be treated
as a quantitative trait just as with behavioral phenotypes, and that genetically driven
alterations in gene expression might underlie much of the genetic contribution to
complex traits (Farris et al., 2010, Farris and Miles, 2011). Changes in gene expression
following acute and repeated drug administration are proposed as critical molecular
adaptations in promoting substance dependence (Nestler and Aghajanian, 1997).
Additional variation in the baseline abundance of gene networks may also functionally
contribute to predisposition for abuse and long-term maintenance of drinking behavior.
Given the complex role of pleotropic and polygenic effects of genes on the expression
of behavior, gene networks may offer improved mechanistic insight into the underlying
neuropathology and risks for developing an alcohol use disorder.
Herein, this dissertation will discuss and show evidence to test the hypothesis for
the role of a myelin-associated gene expression network in acute ethanol sensitivity and
long-term drinking behavior across mouse, monkey, and human model systems. Studies
within the medial prefrontal cortex utilizing molecular triangulation through the
combination of genetic, genomic, and pharmacological approaches has produced
support for the role of a myelin-associated network underlying acute ethanol sensitivity
as measured by the loss of righting reflex behavior and in phenotypic variance of
ethanol drinking behavior. In part, these studies provide confirmation of a network
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approach to unraveling specific endophenotypes associated with ethanol. Furthermore,
this body of work may warrant a prospective study of CNS myelin within human
populations as an inherent risk factor for the development of alcoholism. Lastly, future
genomic dissection of myelin-associated gene expression and associated networks may
aid in the development of novel pharmacotherapies for treatment and prevention of
alcoholism.
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CHAPTER 2: BACKGROUND AND SIGNIFICANCE

The overall framework leading to the onset of alcohol dependence involves the
progression from initial acute exposure toward compulsive drug use with frequent
intermixed reoccurring bouts of tolerance and withdrawal (Koob and Volkow, 2010). The
disease involves reward seeking, formation of compulsive and habitual behavior,
aversive stimuli (e.g. withdrawal) and multiple other behavioral facets. There is likely no
single causative factor in alcoholism, and thus each facet of this disorder may provide
an important area of scientific inquiry. For example, interpreting the gene network
structure of an organism undergoing withdrawal may impart novel mechanistic
information contributing to the neuroadaptations driving relapse behavior. The overall
phenotype of alcoholism could thus be considered a “behavioral vector” that is made up
of multiple component vectors sub serving endophenotypes as mentioned above
(Figure 1). Vectors of interacting neuronal/glial networks across multiple brain regions,
in turn, likely control each of these endophenotype vectors. Drilling down yet further,
these neural networks are ultimately controlled by the regulation and function of multiple
gene networks expressed within individual neurons or glial cells. As depicted in Figure
1, this hierarchy of nested response vectors, extending from the molecular to the
behavioral, likely explains the tremendous difficulty encountered in studying
mechanisms of diverse complex traits such as alcoholism. This degree of complexity
also explains why efforts to correlate function/expression of single genes to a complex
disease are exceedingly difficult. When considered in reference to this framework, it
becomes apparent that progress in studying the mechanisms of complex disease
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Figure 1. Diagram of multiple potential subcomponent vectors contributing to the
observed behavioral phenomenon of alcohol dependence. The figure illustrates the
premise that observed behavioral phenotypes studied in humans or animal models are
actually made up of multiple behavioral subcomponents (e.g. endophenotypes) that are
in turn controlled by neural networks. The gene networks derived by genomic studies
are a syncytium of gene regulation events occurring within multiple cells comprising a
given neural network.
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requires a combined distillation of traits into endophenotypes and the amalgamation of
brain regional gene function/expression into networks relevant to the trait vectors. Once
the network structure of these varying endophenotypes is successfully mapped, we may
be able to identify major genetic hubs for developing more rational pharmacotherapies
in the treatment of alcoholism.

Genetic Contribution to Alcoholism and Ethanol-Related Behaviors in Humans
Alcohol abuse and dependence has been documented throughout history, dating
back to Biblical time-periods and early Egyptian culture. The term ‘alcoholism’ is thought
to be initially coined by Dr. Magnus Huss describing a chronic relapsing physiological
condition attributed to the repeated ingestion of alcohol (Marcet, 1860). However, formal
recognition of alcoholism as a disease is often attributed to Dr. Elvin Morton Jellinek in
his published work The Disease Concept of Alcoholism (Jellinek, 1960). Recognition of
alcoholism as a disease, rather than dismissed as problematic behavior or moral
weakness, contributed to a need for the medicinal community to determine the
underlying cause, and prompt pharmacological and psychological intervention.
The underlying factors causing alcoholism are unknown, but human research
suggests 40-60% of the risks for the development of this condition are genetic in origin
with the remaining factors due to environmental influences (Schuckit and Smith, 2006,
Timberlake et al., 2007). Familial inheritance is a well-recognized factor in the risk of
alcoholism (Cotton, 1979, Lieb et al., 2002), with early evidence suggestive of an 82%
chance of disease co-occurrence within family members (Lucero et al., 1971).
Distinguishing whether the trait was biologically inherited or a consequence of being
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exposed to a shared hazardous environment is problematic when interpreting familial
risk studies. Complementary studies in monozygotic and dizygotic twins; however, have
also established a genetic component for alcoholism. Identical twins have higher rates
of alcohol abuse and dependence compared with fraternal twins (Pickens et al., 1991).
This is not due entirely to a shared environment as cross fostering studies of adopted
identical siblings from an alcoholic parent into an the household of non-biological
relative without substance abuse remain at a significantly increased risk of developing
alcoholism (Cloninger et al., 1981). Collectively family, twin, and adoption-based studies
suggest a sizable genetic component contributes to predisposition for the disease.

Discovering which genes are responsible or causal for an alcohol use disorder
has been an area of intensive inquiry. One complication in the elucidation of risk alleles
is the presence of comorbid mental health diseases; 37% of individuals with alcohol
related issues also suffer from mental disorders such as schizophrenia and antisocial
personality disorder (Regier et al., 1990). The common disease-common variant
hypothesis has proposed the genetic risk of common diseases is due to the relatively
increased frequency of common disease causing alleles (Lander, 1996). Heritability of
alcoholism and related psychiatric conditions may thus be due in part to a collection of
individual genetic variants of small effect size that have an additive effect in driving
susceptibility of disease. For example, variants in the corticotropin-releasing factor
system (CRHR1 and CRHBP) are predictive of comorbid alcohol use disorder in
schizophrenic patients (Ribbe et al., 2011). It is possible that no single or set of common
characteristics may be necessary or sufficient in complex diseases across all
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populations, and concerns have been raised regarding the ‘common disease-common
variant’ model (Becker, 2004, Dickson et al., 2010). Although no single study can prove
or refute common-disease-common variant disease model, large- and small-scale
initiatives do jointly add to our knowledge base for unraveling the genetic architecture of
multifaceted diseases including alcoholism.
The Collaborative Study on the Genetics of Alcoholism (COGA) was one of the
first large-scale initiatives from treatment centers across the United States aimed at the
identification of genes contributing to alcohol dependence. Linkage and genome-wide
association studies from this collaborative and others have made progress in detecting
common genetic variants conferring vulnerability or protective effects for an alcohol use
disorder. These recognized variants are involved in multiple physiological systems:
alcohol metabolism (i.e. alcohol dehydrogenase and aldehyde dehydrogenase
enzymes), dopamine system, GABAergic system, glutamatergic system, opioid system,
cholinergic system, serotonin system, and Neuropeptide Y signaling processes (Michael
D. Kohnke 2008). Genetic loci related to alcoholism are spread out across the genome
with evidence on chromosomes 1, 2, 6, 7, 10, 12, 14, 16 and 17 (Hill et al., 2004).
Although several candidates have been identified some subsequent studies have failed
replication. For example, Blum et al. initially reported allelic variation associated with
alcoholism for the dopamine receptor DRD2, a key component of the mesocorticolimbic
‘reward’ pathway (Blum et al., 1990). But, further investigation into the DRD2 gene has
been controversial with regard to mixed results and phenotypic outcome measures
(Kidd, 1993, Noble, 1998). Additionally, the DRD2 is in strong linkage disequilibrium with
ANKK1 (ankyrin repeat and kinase domain containing 1), which is involved in numerous
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signal transduction pathways. The close physical association of DRD2 and ANKK1 may
thus make it difficult to discern which gene is responsible for driving the observable
phenotype (Neville et al., 2004). Discovery and disentanglement of all the geneticfactors, including the relationship between DRD2 and ANKK1, involved in an alcohol
use disorder may further hinge on the investigation of genotype-environment
interactions(Young-Wolff et al., 2011).
In spite of significant advancement in the areas of genetics and genomics it is a
sobering reality that there is a clear lack in effective long-term pharmacotherapies for
addiction (Goldman et al., 2005). Arguably expensive genomic inquiries concerning drug
and alcohol abuse may be of low priority relative to other inherited diseases due to an
individual’s choice for continued consumption and heterogeneous etiology (Merikangas
and Risch, 2003). Improvement in the identification of candidate genes and defining the
causal mechanisms of action underlying disease progression may come from the
integration across scientific disciplines. Animal studies offer a suitable extension for
scientific inquiry into the underlying biology of substance abuse, offering a more
homogenous genetic background, better-controlled environmental variables, and allow
studies that are not necessarily ethical or amenable to human research.

Model Organisms for the Genetic and Genomic Analysis of Complex Traits
Model organisms offer an extraordinary window into the physiological and
pathological processes governing complex traits. Animal models may not necessarily
reflect the exact disposition shaping disease as whole, but certainly can model
distinctive characteristics (or endophenotypes) underlying disease. Alcohol abuse and
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dependence are human delineations of a psychiatric diagnosis. Model organisms lack
the functional criteria for psychiatric diagnosis, but are able to mimic human conditions
with two overall goals: (i) testing of mechanistic hypothesis and (ii) test and validate
drug treatments (Bennett et al., 2006, Crawley, 2007).
The laboratory mouse, or Mus musculus, is one of the most important model
organisms and an indispensable tool in medicinal research (Boguski, 2002). Completion
of the human genome project (Lander et al., 2001, Venter et al., 2001) was swiftly
followed with an initial draft of the mouse genome, based on the C57BL/6J strain that
was developed in the 1920s, in order to connect clinical and basic research scientists
through comparative genomics (Waterston et al., 2002). This initial sequencing has
been complimented through the determination of subspecific origin, haplotype diversity,
and identical by descent maps for 198 samples (including 100 classical strains) across
three different subspecies of Mus musculus (Yang et al., 2011). Additionally, at the time
of this dissertation, there are now at least seventeen different inbred strains of mice that
have been fully sequenced, which are representative of the most commonly used
laboratory strains (Keane et al., 2011). Such a tremendous amount of genetic diversity
can help dissect phenotypic variation of complex traits within multiple homogeneous
reference populations and controlled environmental contexts.
Mus musculus are an excellent genetic tool for the analysis of complex traits in
medicinal research sharing nearly 99% of their genes with humans, which account for
approximately 30,000 protein-coding genes (Waterston et al., 2002). Additionally, mice
are a mammalian organism that have a comparable physiological profile to humans and
share common inherited diseases such as diabetes and several neurological disorders
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(Peters et al., 2007). Spontaneous mutations, chemical mutagenesis, or targeted
deletion through homologous recombination, for the loss of function of specific genes
within the mouse genome has provided significant insight into the function of individual
genes and some of the underlying biological processes governing disease states
(Paigen, 2003b, a). For example, single gene mutations in mice for the hormone leptin
has uncovered some of the pathophysiological aspects managing body weight that are
related to obesity (Zhang et al., 1994, Friedman and Halaas, 1998). Such experimental
evidence continues to provide credence to the fact that there are genetic pathways
perturbed by various diseases, which are biological in nature and beyond the naïve or
misguided perspective of a lack in willpower or moral control.
Although genetically engineered mice have certainly provided discernible clues
into the underlying biology of complex traits, approximately only 10% of all the genes
within the mouse genome have been utilized in generating knockout mice (Austin et al.,
2004). The lack of null alleles for a large portion of the mouse genome serves as an
untapped resource that has lead to the founding of ‘The Knockout Mouse Project;’ an
ongoing high-throughput international effort to systematically construct knockout alleles
for all mouse genes and place them into the public domain with accompanying
phenotypic information (Austin et al., 2004). Certain null mutations can however result in
embryonic-lethality or have deleterious effects on development and metabolism, but
molecular techniques are continually being refined to incorporate temporal and spatial
control over gene targeting strategies allowing for unprecedented precision in
characterizing a variety of phenotypes, including mammalian brain function
(Lewandoski, 2001). Deciphering the down-stream effects of null and conditional-allele
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approaches, not to mention the amount of time and financial contribution required for
such a task are well beyond the resources of any single collective or research group,
requiring collaborative efforts on global scale (Grimm, 2006). The International Knockout
Mouse Consortium was established to meet the growing needs of the research
community in the post-genome era for genetic analysis of all protein-coding genes
within the mouse genome and following phenotyping efforts (Skarnes et al., 2011). The
availability of knockout mouse resources continues to expand through international
collaboration and is poised to uncover the phenotypic impact of every gene within the
mammalian genome (Guan et al., 2010). Ascertaining the shared relationship between
the genome and phenome may very well promise to be next the hurdle to overcome
(Houle et al., 2010).
Interpretation of the phenotypes, especially those related to behavioral research,
which emerge due to single genetic null mutations should be examined with caution as
phenotypic outcome measures may vary due to the background genotype (Sibilia and
Wagner, 1995, Gerlai, 1996, 2001), compensatory mechanisms (Gerlai, 2001), and
laboratory environment (Crabbe et al., 1999, Wahlsten et al., 2003). Careful evaluation
of relevant individual endophenotypes in animal models concerning neuropsychiatric
diseases including alcoholism are particularly challenging given the unknown etiology of
psychiatric diseases and potential impact of multiple genes and environmental factors
(Takao et al., 2007). Genetic variance among differing inbred strains is however
markedly robust for several behavioral phenotypes (Crabbe et al., 1999) and can
establish a baseline level of performance prior to any mutagenesis assays (Tarantino et
al., 2000). Single gene mediated responses may be of small effect size and possibly be
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obscured by background genotype if there is strong intra-strain variability for a particular
response. Therefore, it is important to carefully consider which endophenotype and
mouse strain is most appropriate for testing any hypothesis. Certainly no result can
stand entirely on it’s own and consensus among different laboratories for behavioral
results among mice carrying a specific null mutation is essential before concluding the
impact of any single gene on a distinct behavioral domain (Crabbe et al., 1999,
Tarantino and Bucan, 2000).
Complex traits such as neuropsychiatric disorders are multifaceted
ailments of complex origin involving non-Mendelian modes of inheritance. The mouse
has emerged as the preeminent model system for the dissection of complex traits
(Rosenthal and Brown, 2007). Significant advances in the manipulation of the mouse
genome and derivation of accompanying phenotypes have spurred large-scale
collaborations for a systemic assault of every gene-phenotype relationship throughout
the mammalian genome. The Mouse Phenome Database and EuroPhenome are just
two examples of collaborative open-source repositories for helping capture some of the
genetic-genomic complexities underlying complex traits using mouse models (Grubb et
al., 2009, Morgan et al., 2010). Integrating findings from mouse models with human
data as well as additional model organisms will assist in defining causal mechanisms of
gene action. Model organisms allow investigators to circumvent some of the challenges
faced in human studies such as uncontrolled environmental variables or the influence of
genetic heterogeneity, and put disease-associated genes within a biological context
(Aitman et al., 2011). Model organisms also offer the ability to discover novel intrinsic
factors regulating genes and the potential manifestation of disease. For example,
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microRNAs are short ribonucleic acids initially discovered in Caenorhabditis elegans
that modulate gene regulation through complementary binding of a target genes
messenger RNA (Lee et al., 1993). Following this discovery it is now known that
hundreds of conserved and non-conserved microRNAs exist across species (Bentwich
et al., 2005) and are involved in behavioral processes relevant to complex traits such as
substance abuse (Kocerha et al., 2009, Hollander et al., 2010).
The genetic underpinnings of complex traits are amenable to functional
evaluation and novel discovery through the use of model organisms. Environmental
pressures and epistatic interactions may initially complicate the interpretation of genetic
associations with varying endophenotypes; however, they are also fertile areas for basic
science and translational research. It may not only be essential to consider the impact
of individual gene effects on complex traits, but also the entire complement of genes
throughout the genome across multiple different genetic backgrounds and experimental
conditions (Chadman et al., 2009, Doetschman, 2009). Human and model systems are
complementary approaches needed for effectively defining causal genetic associations
with disease. Even in the post-genomic era uncovering and prioritizing candidate genes
in the analysis of complex traits will require a plethora of genetically homogeneous and
heterogeneous stocks, available mutants for suspected variants, and precise definition
of reproducible quantitative traits (i.e. endophenotypes), which accurately model
differing aspects of human disease (Bucan and Abel, 2002).

Mapping Quantitative Traits in Model Organisms for Disease
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Physically mapping the human and mouse genomes has provided the necessary
platform in comparative cross-species functional and genetics studies for understanding
complex traits (Gregory et al., 2002, Keane et al., 2011). Although the identification of
sequence variants driving quantitative traits has shown limited success, genetic
mapping studies have demonstrated favorable agreement in the genetic architecture of
complex traits between humans and model organisms (Flint and Mackay, 2009). A
quantitative trait is a measurable difference in a continuous phenotypic distribution
within a population that stems from variation in genetic and/or environmental influences
(Abiola et al., 2003). Genetic variation may arise from several sources, including
spontaneous mutations, chemical or genetic mutagenesis, and selective breeding
strategies of inbred mice (Peters et al., 2007). Advantages and disadvantages exist for
the separate approaches, but working in concert with one another provide exquisite
insight into complex traits associated with human diseases (Belknap et al., 2001).
The chromosomal regions harboring genetic variants responsible for phenotypic
variation are referred to as quantitative trait loci (QTL) (Geldermann, 1975, Lander and
Botstein, 1989). Mapping quantitative trait loci begins with selectively mating two
parental strains (usually demonstrating contrasting phenotypes of interest) to produce
F1 offspring, followed by F2 progeny, and subsequent intercrosses of brother-sister
matings for 20+ generations to establish a mosaic of recombinant inbred strains with a
distinctive complement of the parental genomes (Figure 2) (Peters et al., 2007, Wu et
al., 2010). Leveraging the genetic variation derived from selective breeding for a panel
of recombinant inbred mice against resulting phenotypic variation can discern a
chromosomal region containing the genetic variant associated with the defined trait
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Figure 2. Schematic of BXD recombinant inbred mice. Illustration of the breeding
strategy used to create BXD RI strains of mice. Two genetically distinct strains of mice
(i.e. C57BL/6J and DBA/2J) are mated to create an isogenic F1 generation, consisting
of 50% of each progenitor. F1 mice are then used to generate a heterogeneous F2
population, then selectively inbred for 20+ generations to create a mosaic of individual
BXD lines carrying a unique genomic combination of the two progenitor strains.
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(Darvasi, 1998). Distinguishing a significant QTL amid competing genetic and
environmental factors relies on the statistical association of sufficiently divergent trait
data and genetic marker information (Tanksley, 1993, Belknap and Atkins, 2001,
Doerge, 2002, Henderson et al., 2004). Scale of the experiment and the density of DNA
markers determine the size of the genomic region beneath a defined QTL interval,
which can span hundreds of genes depending on the number of recombination events
previously occurring in a defined region (Mackay, 2001). Multiple interacting genetic loci
may be involved in complex traits, complicating the associating between the
polymorphic alleles and phenotypic variation (Glazier et al., 2002, Ehrenreich et al.,
2010). Behavioral traits in particular, may be influenced by multiple genetic variants of
small effect size, and not always attributed to an individual quantitative trait locus
(Plomin, 1990). However, QTLs can be replicated across independent studies for
behavioral traits (Belknap and Atkins, 2001, Henderson et al., 2004). In the absence of
potential epistatic interaction, improved phenotypic resolution for a single QTL may be
obtained through the use of reciprocal interval-specific congenics, which are genetically
identical to their respective progenitor strain except at the suspected QTL interval
(Flaherty, 1981, Bennett, 2000). Narrowing the implicated QTL region to a quantitative
trait gene (QTG) posses a significant challenge for further characterizing phenotypic
differences at the molecular level (Flint et al., 2005). Integrating conventional QTL
strategies with differential gene expression and directed sequencing may assist in the
identification of QTGs (Wayne and McIntyre, 2002, Hitzemann et al., 2003). Following
candidate gene identification molecular signatures (i.e. QTGs) of phenotypic variance
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can be further dissected using null mutations or transgenic animal models, as well as
pharmacological interventions (Hoffman and Tabakoff, 2005).
Candidate genes or candidate loci derived from model organisms furthers the
identification of genetic variants in human diseases. Human and mouse genomes have
genes ordered in a syntenic fashion, occurring in the same order in the differing species
(Pennacchio, 2003, Peters et al., 2007). Less than 1% of the genes within the mouse
and human genome lack a clear homologue between the two species (Okazaki et al.,
2002, Waterston et al., 2002). The BXD recombinant inbred mouse lines, derived from
C57BL/6 and DBA/2 mice, and the LXS recombinant inbred mouse lines, derived from
Inbred Long Sleep (ILS) and Inbred Short Sleep (ISS) mice, have been widely used as
reference populations to identify QTLs associated with alcohol behavioral phenotypes
(Johnson et al., 1992). Additional QTL evidence for alcohol-related behavioral traits has
been garnered through a multiple cross-mapping strategy from a panel of inbred strains
(Hitzemann et al., 2002, Malmanger et al., 2006). Mouse QTL information can be
viewed alongside human linkage data for alcohol related endophenotypes to interrogate
consilience across species and further the identification of putative QTGs (Uhl et al.,
2008, Ehlers et al., 2010). Syntenic mapping of mouse and human data for alcohol
associated traits has identified two examples of concordance and suggested the
inwardly-rectifying potassium channel subunit Kcnj9 as a high-priority candidate gene
for alcohol-related responses (Ehlers et al., 2010). A null mouse mutant for Kcnj9
exhibits less withdrawal signs from sedative-hypnotic agents, including alcohol,
suggesting it may be a QTG for alcohol withdrawal syndrome (Kozell et al., 2009).
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The multiple PDZ domain protein (Mpdz) has been formally identified as a
quantitative trait gene for alcohol withdrawal severity (Shirley et al., 2004). C57BL/6
(B6) and DBA/2 (D2) mice display contrasting acute ethanol withdrawal behaviors
(Crabbe et al., 1983). Genetic mapping studies using B6 and D2 mice as progenitors
identified four chromosomal loci influencing acute alcohol withdrawal severity, including
on mouse chromosome 4 (Buck et al., 1997). Acute alcohol withdrawal scores within
this genetic population were significantly correlated to a subsequent study on
pentobarbital withdrawal, suggesting common genetic factors underlie these druginduced behavioral phenotypes (Buck et al., 1999). Additional evidence identified a QTL
on chromosome 4 using an F2 intercross between B6 and D2 mice (B6D2F2) for chronic
alcohol withdrawal severity (Buck et al., 2002). Congenic animals fine-mapped the QTL
for withdrawal severity to a < 1-centimorgan interval on chromosome 4, with Mpdz being
recognized as virtually the only gene within this region showing variation in sequence
and/or gene expression (Fehr et al., 2002). Additionally, Mpdz co-segregated with acute
alcohol withdrawal severity in mice selectively bred for this phenotypic difference (Fehr
et al., 2004). The QTL on chromosome 4 was further fine-mapped using six additional
interval-specific congenic strain, leaving Mpdz as the only candidate displaying
genotype-dependent differences in coding sequence and/or expression, also witnessed
at the protein level; confirming Mpdz as a QTG for alcohol withdrawal severity in mice
(Shirley et al., 2004). Although the function of Mpdz in alcohol withdrawal remains to be
elucidated, the phenotype is thought to manifest through the interaction of Mpdz with
serotonin 5-HT2c and gamma-amino butyric acid receptor B (GABAB) (Shirley et al.,
2004, Milner and Buck, 2010).
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Genotyping of two human populations combined with a genetical-genomics
analysis of HXB/BXH recombinant inbred rat strains identified variation GABAergic
pathways for alcohol consumption (Tabakoff et al., 2009). Polymorphisms in MPDZ were
also significantly associated with alcohol intake, which may suggest a signaling pathway
involving MPDZ and GABAergic signaling mechanisms influence alcohol-drinking
behavior (Tabakoff et al., 2009). Sequence variants in MPDZ were also associated with
alcohol dependence in European Americans, but not alcohol withdrawal symptoms
(Karpyak et al., 2009). Convergent evidence from Mus musculus, Rattus norvegicus,
and Homo sapiens suggests genes involved in alcohol associated endophenotypes
within animal models, such as Mpdz, are relevant risk factors for alcoholism in human
populations. Continued insights into the genetic underpinnings of human diseases will
emerge through the integration of existing datasets and genetical genomics approaches
combined with novel genetically diverse reference populations such as the Collaborative
Cross (Churchill et al., 2004). The pleotropic effects of single genetic variants also
necessitates the need for an extensive collection of carefully defined phenotypes (Houle
et al., 2010).

Neuropharmacology of Acute and Chronic Alcohol Exposure
Ethanol readily distributes into total-body water, exhibiting it's pharmacological
properties within multiple biological compartments and organ systems including most
notably the central nervous system. A number of molecular and neurobiological
pathways have been implicated in acute and chronic responses to ethanol. In
comparison with other drugs of abuse, such as cannabinoids and opioids, ethanol does
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not have a clearly defined receptor or binding profile. The biophysical properties of
ethanol result in poor reactivity and low potency preventing many pharmacological
techniques from assessing molecular interactions as putative drug targets for ethanol
(Lovinger and Crabbe, 2005). In vitro and in vivo evidence from model systems has
helped delineate some of the major direct and indirect sites of ethanol action including,
but not limited to, the GABAergic system, glutamatergic system, opioid system, and the
mesocorticolimbic dopaminergic system, as well as a host of intracellular signaling
pathways. Changes within these target systems facilitate the acute reinforcing effects of
ethanol and the molecular adaptations causing tolerance and dependence following
repeated exposure.
The neurobiology of substance abuse has long suspected vulnerability within the
mesocorticolimbic dopaminergic pathway in the development and maintenance of
addiction (Koob and Nestler, 1997, Koob and Volkow, 2010). Exposure of the
dopaminergic system to ethanol and other drugs of abuse reduces the threshold for
electrical stimulation associated with reinforcement (Olds and Milner, 1954, Wise,
1996). The ventral tegmental area (VTA), nucleus accumbens (NAC), and prefrontal
cortex (PFC) constitute the three major brain structures within this reinforcing
dopaminergic neural pathway (Nestler, 2001). In support of premise that ethanol exerts
its effects on the mesocorticolimbic system, it has been shown that acute low-dose
ethanol administration to unanesthetized rats increases the firing rate of dopaminergic
neurons and the release of dopamine within the mesolimbic pathway, whose release is
often associated with rewarding stimuli (Gessa et al., 1985, Di Chiara and Imperato,
1988). Additionally, ethanol is readily self-administered into the ventral tegmental area
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by rats selectively bred for alcohol preference (Waller et al., 1984, Gatto et al., 1994).
Self-administration of ethanol, but not water or total fluid intake, is decreased in rats
following site-specific delivery of the dopaminergic antagonist fluphenazine into the
nucleus accumbens (Rassnick et al., 1992). Similarly, the oral ingestion of ethanol (1 ml/
kg) in humans leads to reduced binding of the dopamine receptor ligand [11C] raclopride
within the ventral striatum (Boileau et al., 2003), which is suggested to correlate with the
euphoric effects of dopamine release (Drevets et al., 2001). The availability of dopamine
receptors within ventral striatum of humans and mammalian models, and other brain
structures such as prefrontal cortex, may therefore regulate the consumption and
subjective effects of ethanol (Hodge et al., 1997, Yoder et al., 2005). Although the
midbrain dopamine system may serve as a point of convergence for multiple drugs of
abuse, activation of this reward circuitry can occur via disparate molecular mechanisms
(Nestler, 2005). Acute ethanol acts as a positive allosteric modulator of GABAA
receptors (Ticku et al., 1986, Allan and Harris, 1987), which may facilitate the loss of
inhibitory control over dopaminergic tone (Mereu and Gessa, 1985, Diana et al., 1993).
GABAA receptors are ligand-gated ion channels composed of multiple subunits classes:
α(1-6), β(1-3), γ(1-3), δ, ε, θ, π, and ρ(1-3) (Olsen and Sieghart, 2008, 2009). The
heteromeric subunit composition of GABAA receptors substantially effects ethanol
sensitivity over a wide range of concentrations, but in general ethanol is capable of
enhancing GABAergic neurotransmission at low to moderate intoxicating concentrations
(3-30 mM) (Lobo and Harris, 2008). Chronic exposure to ethanol differentially alters
GABAA receptor subunit gene expression (Mhatre and Ticku, 1992) and can impair ion
channel function at blood ethanol concentrations associated with withdrawal syndrome
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(Morrow et al., 1988). Alterations in the function and distribution of GABAA receptor
subunits likely underlies the manifestation of tolerance and dependence; however,
assessing the contribution of individual subunits on ethanol-associated behaviors is best
achieved through genetically modified mouse models.
Variation in a cluster on chromosome 4 of GABAA receptor subunits (GABRG1,
GABRA2, GABRA4, and GABRB1) are associated with alcohol dependence and
endophenotypes related to neural excitation; the most prominent and reproducible
association was detected for the GABRA2 subunit (Edenberg et al., 2004). A null
mutation for Gabra2 in mice cause a decrease in the sedative-hypnotic properties of
ethanol, decrease in acute ethanol withdrawal, and decreased ethanol preference
(Boehm et al., 2004c). Knock-in of Gabra2 that retains normal function, but are
insensitive to ethanol-induced potentiation, have altered ethanol-intake and increased
sensitivity to ethanol-induced sedation without affecting ethanol-induced motor
incoordination (Blednov et al., 2011). Ethanol insensitive mutants for Gabra1, the most
abundant alpha subunit (Kralic et al., 2002), do not show any alterations in ethanol
drinking behavior, sedation, locomotor stimulation or cognitive impairment (Werner et
al., 2006). The coordinate action of ethanol on specific behavioral processes is thus
related to different GABAA receptor subunits, as well as non-GABergic targets that may
indirectly influence GABA-mediated responses (Kumar et al., 2009). Although GABAA
receptors are influential targets of ethanol action, the molecular binding site(s) of
ethanol for the different subunits and the specific behavioral responses mediated by
GABAA receptor subunits and non-GABergic targets warrant further investigation
(Crabbe et al., 2006b, Addolorato et al., 2011).
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The neurotransmitter γ-aminobutyric acid (GABA) is synthesized by glutamate
decarboxylase from the precursor glutamate (Walker, 1983). There are both ionotropic
and metabotropic glutamatergic receptors present within the mammalian central
nervous system with more than 20 glutamate receptors having been identified (2011,
Harvey and Shahid, 2011). N-methyl D-aspartate (NMDA) is one of the main ionotropic
glutamate receptors comprised of a heteromeric assembly of genes encoding NR1,
NR2A-NR2D, and NR3A-NR3B subunits (Stephenson et al., 2008). NMDA receptor
function is attenuated in a concentration-dependent manner by physiological relevant
amounts of ethanol (Lovinger et al., 1989). Site-directed mutagenesis assays suggest
ethanol is a non-competitive partial antagonist that may interact within the third
transmembrane domain of the NR1 subunit (Ronald et al., 2001); however, ethanol
most potently inhibits NR2A and NR2B containing receptors (Woodward, 2000,
Smothers et al., 2001). Prolonged exposure to ethanol in cultured neurons and animal
models alters the expression of NR2A-B receptor subunits and ion-channel function,
suggesting neuroadaptive changes in this system that may compensate for the
attenuating effects of ethanol (Snell et al., 1996, Kalluri et al., 1998, Chandler et al.,
1999).
Animals will readily substitute NMDA receptor antagonists for ethanol in
discriminative stimulus paradigms (Shelton and Balster, 1994), which occurs due to the
involvement of NMDA receptors within the nucleus accumbens, and interactions with
other brain structures (Hodge and Cox, 1998). The neural circuitry underlying substance
abuse suggests the dorsal striatum is an important brain region that is associated with
the nucleus accumbens and additional brain regions such as the ventral tegmental area
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(Volkow et al., 2011). Dorsal striatum is involved in goal-directed actions and formation
of habitual behavior, aiding in the progression of addiction (Everitt and Robbins, 2005,
Yin and Knowlton, 2006). Repeated exposure to ethanol leads to a long-lasting increase
in the activity of NR2B containing receptors within dorsomedial striatum, which if
inhibited using the NR2B selective antagonist ifenprodil, causes a significant reduction
in ethanol self-administration and seeking behavior (Wang et al., 2010). Ifenprodil can
also lessen the severity of ethanol withdrawal and the acute sedative-hynotic effects of
ethanol (Malinowska et al., 1999), suggesting NR2B-containing receptors as prominent
sites of ethanol action. These pharmacological studies are partially supported by a
conditional knockout for NR2B in mouse forebrain, where mice carrying the null
mutation are more sensitive to the sedative-hypnotic properties of ethanol without
differing in their pharmacokinetic profile (Badanich et al., 2011). The acute intoxicating
effects of ethanol relative to NMDA receptor inhibition are however subunit specific, as a
null mutation for NR2A does not significantly alter ethanol-induced sleep time (BoyceRustay and Holmes, 2005). The ensuing downstream effects elicited by ethanol
administration may thus act via a complex, yet selective system of ionotropic receptors
normally managed by selective neurotransmitters such as glutamate and γ-aminobutyric
acid under physiological conditions.
In addition to modulating the biochemical and behavioral properties of
neurotransmitter systems, acute and chronic ethanol augments the function of
endogenous neuropeptides, endorphins, and enkephalins. Endogenous opioids, acting
on their corresponding receptors, are one of the mitigating factors associated with
ethanol-induced reward and continuous self-administration (Vengeliene et al., 2008).
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The opioid receptor antagonist naltrexone slows the acquisition of ethanol drinking
behavior (Phillips et al., 1997), reduces ethanol self-administration in rodents (Altshuler
et al., 1980, Middaugh et al., 2000), and is a prescribed pharmacotherapy that
decreases habitual drinking among high-level consuming alcoholics (McCaul et al.,
2000). A genetic variant in the µ-opioid receptor is significantly associated with
naltrexone response among alcohol dependent subjects (Oslin et al., 2003).
Interestingly, µ-opioid receptor mice knockout mice do not readily self-administer
ethanol under multiple different paradigms (Roberts et al., 2000), and the human
equivalent of the µ-opioid receptor variant leads to enhanced ethanol drinking behavior
in non-human primates (Barr et al., 2007).
The κ-opioid and δ-opioid receptors are two additional internal substrates for
endogenous opioids, whose cellular signaling can be affected by acute and chronic
ethanol exposure. Dynorphin is an endogenous opioid peptide that primarily mediates
its psychoactive effects through κ-opioid receptors (Chavkin et al., 1982). Genetic
deletion or pharmacological inhibition of dynorphin show an increased response for
ethanol-induced conditioned place preference, suggesting κ-opioid receptors may
exhibit a negatively regulatory tone for ethanol reward like behavior (Nguyen et al.,
2012). Direct activation of the kappa opioid receptor system using a kappa agonist,
such as endolin or bremazocine, leads to decreased ethanol self-administration in
rodents and rhesus monkeys (Holter et al., 2000, Cosgrove and Carroll, 2002). Ethanoldrinking behavior, however, is increased δ-opioid receptors knockout mice (Roberts et
al., 2001). Selective agonism of δ-opioid receptor subtypes can also augment the
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rewarding properties of ethanol (van Rijn et al., 2011), and attenuate anxiety-like
behavior (van Rijn et al., 2010). Collectively, the opioid receptor system encompassing
µ-, κ-, and δ-opioid receptors plays an extensive role in mediating several ethanol
behavioral phenotypes; especially those phenotypes interconnected with ethanol
drinking behavior (Camarini et al., 2010). Pharmacological intervention targeting the
opioid receptor system may thus be of crucial importance in the armamentarium against
an alcohol use disorder (Hillemacher et al., 2011), with consideration for the opposing
roles of each opioid receptor subtype and any potential interacting druggable targets
(Kroeze and Roth, 2006).
The acute behavioral responses and enduring neuroadaptations occurring in
response to a substance of abuse is initiated by multiple extracellular systems such as
the dopaminergic and opioid system, but is ultimately achieved through a series of
intracellular signaling cascades and transcriptional events (Koob and Nestler, 1997,
Robison and Nestler, 2011). There is substantial heterogeneity in the molecular
transducers required in order to facilitate the psychoactive effects of ethanol and other
drugs of abuse; however, a few key targets have emerged as the principle focus in the
short- and long-term neurobiology of ethanol (Nestler, 2005, Ron and Jurd, 2005, Heilig
et al., 2011). The cyclic adenosine monophosphate response element binding protein
(CREB) is a stimulus-inducible transcription factor that regulates the expression for a
large abundance of genes within the nervous systems (Lonze and Ginty, 2002,
Conkright et al., 2003). Acutely ethanol can lead to increased expression and
phosphorylation of CREB (Yang et al., 1996, Asyyed et al., 2006). Conversely, chronic
ethanol can cause the opposite effects on CREB phosphorylation and downstream
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factors (Yang et al., 1998a, Yang et al., 1998b, Pandey et al., 2001). The opposing roles
of acute and chronic ethanol on CREB activation may suggest the transcription factor is
acting as a molecular switch in the predisposition and development of alcohol
dependence. For example, CREB haplo-insufficient mice display increased anxiety-like
behavior and increased ethanol preference (Pandey et al., 2004). Haplo-insufficiency for
CREB also results in corresponding decreases in the expression of neuropeptide Y
(NPY) and brain-derived neurotrophic factor (BDNF) (Pandey et al., 2004). Reduced
expression of either NPY or BDNF causes increased ethanol consumption (Thiele et al.,
1998, McGough et al., 2004), suggesting CREB activation and subsequent transcription
of select downstream targets may be a pathophysiological mechanism governing
ethanol intake patterns.
Upstream of CREB are multiple protein kinases important in ethanol behavioral
and molecular processes, that promote CREB-mediated transcriptional events (Moonat
et al., 2010). Among several others, cAMP-dependent protein kinase (also known as
PKA) is a prominent regulator of CREB activation through phosphorylation of
serine-133; blockade of which abolishes transcriptional activity (Gonzalez and
Montminy, 1989). In order to initiate PKA signaling events ethanol induces production of
the second messenger cyclic adenosine 3’ 5’-monophosphate (cAMP) through adenyl
cyclases coupled to stimulatory guanine nucleotide binding proteins (Sutherland et al.,
1962, Coles, 1994, Diamond and Gordon, 1997). Nine different isoforms of adenylate
cyclase have been identified in mammalian species (Hanoune and Defer, 2001).
Comparatively, type VII adenylyl cyclase is 2-3 times more sensitive for cAMP
production in response to intoxicating amounts of ethanol (Yoshimura and Tabakoff,
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1995, 1999). Increases in cAMP causes the release of PKA regulatory subunits,
exposing the catalytic subunits that phosphorylate neighboring proteins (Mochly-Rosen,
1995). Activation of PKA also causes translocation of the catalytic subunit into the
nucleus, triggering CREB and nuclear dependent gene expression (Dohrman et al.,
1996). Repression of the cAMP dependent kinase pathway via pharmacological or
genetic inhibition of PKA significantly alters acute ethanol sensitivity and drinking
behavior (Moore et al., 1998, Wand et al., 2001).
The multiple points of convergence between ethanol and the cAMP-PKA-CREB
pathway provides strong evidence it is a major signaling cascade involved in the
molecular and behavioral processes associated with alcoholism (Ron and Jurd, 2005).
However, substantial cross-talk exists among intracellular signaling mechanisms
perturbed by ethanol exposure, which makes it exceedingly difficult to elucidate the
precise machinery and develop targeted pharmacotherapies for substance abuse (Lee
and Messing, 2008). Pharmacotherapies aimed at disrupting protein kinases is active
area of CNS drug development, but lags behind other disease oriented fields such as
cancer (Chico et al., 2009). Therapeutic potential exists for both single- and multitargeted kinases inhibitor, which one day could exploit the entire complement of kinases
throughout the genome (Sebolt-Leopold and English, 2006). Additionally, kinase
inhibitors already approved by the Food and Drug Administration for oncology and other
disorders may provide important information in developing therapies for an alcohol use
disorder. Through inhibition of a serine/threonine kinase known as mTORC1
(mammalian target of rapamycin complex 1) t he immunosuppressent rapamycin, also
known as sirolimus, decreases ethanol seeking behavior, conditioned place preference,
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and consumption in a preclinical animal model (Neasta et al., 2010). Inhibition of this
particular pathway is not associated with altered motivation states (Neasta et al., 2010,
Neasta et al., 2011), and is well tolerated in humans without any cognitive deficits (Lang
et al., 2009).
A horde of extracellular and intracellular targets are responsible for the
physiological and behavioral effects of ethanol (Harris et al., 2008). However, the
pathophysiology underlying alcohol abuse and alcoholism is still largely unknown and
much of the published research has presented a spherical cow of a very complex
psychiatric condition. Understanding how the multitude of receptors and signaling
pathways interact in the neuropharmacology of acute and long-term ethanol exposure
may rest upon a systems biology approach (Spanagel, 2009, Farris et al., 2010).
Systems biology utilizes advancements in molecular biology, mathematical modeling,
and technology in order to simultaneous examine of all the working elements within a
functioning biological system (Ideker et al., 2001). Deciphering the working environment
of cellular systems, including the neurobiological factors perturbed by ethanol, is
possible through the use of high-throughput genomic and proteomic strategies paired
with computational tools and large-scale, systematic scientific efforts (Lockhart and
Winzeler, 2000, Tyers and Mann, 2003). The blending of computational approaches with
modern techniques for both spatial and temporal control of cellular biology will ultimately
shape our comprehension of synaptic plasticity, and neural networks governing
behavior (Kotaleski and Blackwell, 2010). Such blending will also integrate information
from a diverse set of mammalian brain cells (Okaty et al., 2011) and structural
abnormalities intrinsic to individual differences in human behavior (Kanai and Rees,
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2011). Guarded with the existing knowledge across multiple biological systems
translational research will help advance the development of personalized treatments for
alcoholism and other psychiatric disorders (Goldman et al., 2005, Heilig et al., 2011).

Neurobiology of Myelin and Animal Models of Demyelination
The central nervous system is fundamentally wired through the extensive
interconnections of neurons and neuronal synapses; however, glial cells, which occupy
more than half of the volume of a mammalian brain, are essential elements in brain
development, structure, function, and disease (Barres, 2008, Eroglu and Barres, 2010).
Astrocytes, oligodendrocytes, and microglia are the three major glial cell-types within
the central nervous system, each serving specialized responsibilities (Haydon, 2001).
Oligodendrocytes are the myelin-forming glial cells of the CNS that follow a distinct
lineage classified by differences in proliferation, migration capability, morphology, and
the presence of cellular markers (Rowitch and Kriegstein, 2010). A single mature
oligodendrocyte can ensheath as many as 50 separate neuronal axons in a lipid-rich
membrane (Peters and Proskauer, 1969). Lipid-rich membrane ensheathments form the
‘white matter’ of the brain, capable of axo-glial communication and CNS plasticity
(Karadottir et al., 2005, Micu et al., 2006, Fields, 2010). The majority of white matter
(~70-75% of its dry weight) are lipids such as cholesterol, galactosylceramide, and
sulfatide (Gielen et al., 2006); however, hundreds of proteins have been characterized
within myelin fractions of mice and humans that may be important in the pathology of
myelin-related diseases (Ishii et al., 2009).
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Myelin is the most abundant membrane structure in the CNS, which has evolved
in concert with vertebrate physiology (Baumann and Pham-Dinh, 2001). Axondependent signals promote proliferation and survival of mature oligodendrocytes to
match the surface area required for myelination (Barres and Raff, 1999). Following
maturation oligodendrocytes extend processes that tightly spiral around neuronal axons
in 150-200 µm segments (Bunge, 1968), extruding cytoplasm to form compacted multilamellar myelin layers (Bauer et al., 2009). Myelin forms near concentric layers,
characterized by the presence of major and minor dense (also known as intraperiod)
lines, increasing transverse resistance and decreasing capacitance that allows for the
efficient communication of action potentials between neurons along nodes of Ranvier
(Figure 3) (Poliak and Peles, 2003).
Facilitated by myelin the formation of nodes of Ranvier is under strict
developmental control, causing an abundant clustering of Na+/K+ ATPases, NA+/Ca2+
exchangers, and Na+ voltage-gated channels along short regularly spaced axonal
intervals (Waxman and Ritchie, 1993). Although not fully elucidated this axonal-glial
interface is possible through the interaction of several cell-surface adhesion molecules
and the specialized function of multiple individual myelin proteins (Sherman and Brophy,
2005). Myelin-associated glycoprotein (Mag) is a member of the immunoglobulin family
that mediates neuronal-oligo interaction, promoting the formation and maintenance of
myelin in the CNS (Schachner and Bartsch, 2000). Once myelin biogenesis is initiated
precise sorting and trafficking of distinct protein-lipid interactions occur within the
intracellular space of oligodendrocytes (Maier et al., 2008). Myelin basic protein (Mbp)
and proteolipid protein (Plp1) constitute the two most predominant myelin proteins
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Figure 3. Pictorial of myelinated axon. Oligodendrocytes ensheathing a neuronal
axon, permitting the efficient transmission of action potentials along Nodes of Ranvier.
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within the CNS (Jahn et al., 2009), which are spatially and temporally regulated through
different intracellular mechanisms for the proper assembly of myelin sheets (Pfeiffer et
al., 1993). Mbp and Plp1 are ubiquitously expressed throughout the mammalian brain
to facilitate the formation of compact myelin sheaths (Figure 4) (Lein et al., 2007).
Proteolipid protein is the most abundant myelin protein in the CNS, representing
approximately 50% of total CNS myelin protein (Nave et al., 1987). Interspersed
intracellular and extracellular loops for proteolipid protein (Plp1) are involved in the
formation of the intraperiod line through the proper apposition of myelin membrane
extracellular surfaces (Popot et al., 1991). Proteolipid protein is synthesized by
processes associated with the secretory pathway, which coordinates many of the
intracellular events during myelin biogenesis (Lin and Popko, 2009). Pathophysiology
studies have demonstrated mutant forms of proteolipid protein cause retention within
the endoplasmic reticulum, activating the unfolded protein response, and eventually
leading to apoptosis (Dhaunchak and Nave, 2007). Proteolipid protein associates with
galactosylceramide and cholesterol to form proteolipid rafts within the Golgi, which may
be important for intracellular trafficking and formation of the myelin sheath (Simons et
al., 2000). Palmitoylation of the N-terminal region of proteolipid protein may also be
important for stabilizing protein-lipid interactions, and is necessary for transporting
proteolipid protein to the myelin membrane (Schneider et al., 2005).
Myelin basic protein is the second most abundant CNS protein, accounting for
30% of total CNS myelin protein (Kamholz et al., 1986). Although multiple isoforms
exist, the two major MBP isoforms are 18.5 kDa and 14 kDa in size, for humans and
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Figure 4. Myelin Basic Protein (Mbp) and Proteolipid Protein (Plp1) mRNA
expression in mouse brain. (A) In situ hybridization of Mbp in a coronal section of
mouse brain. (B) In situ hybridization of Mbp in a sagittal session of mouse brain. (C) In
situ hybridization of Plp1 in a sagittal session of mouse brain. (D) Relative expression of
Mbp and Plp1 in different brain regions, showing abundant and near uniform myelin
expression throughout the brain (ISO = isocortex, OLF = olfactory areas, HPF =
hippocampal formation, CTXsp = cortical subplate, STR = striatum, PAL = pallidum, CB
= cerebellum, TH = thalamus, HPY = hypothalamus, MB = midbrain, P = pons, MY =
medulla). Data available through http://www.brain-map.org/.
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rodents respectively (Boggs, 2006). Myelin basic protein mRNA, as well as closely
related myelin genes such as myelin oligodendrocyte basic protein (Mobp), are
trafficked to distal cellular processes by heterogenous ribonucleoproteins that bind to
the three-primed untranslated region (3’-UTR) of the myelin mRNA (Raju et al., 2008);
allowing for Mbp to be locally translated into protein at the cell surface. Guiding Mbp
mRNA to the membrane for protein synthesis prevents unfavorable adhesion to nonmyelin intracellular membranes and increases interactions with the negatively charged
polar head groups of lipids at sites of active myelin biogenesis (Barbarese et al., 1999).
Binding of myelin basic protein to lipid-rich moieties enables the compaction of opposing
cytoplasmic membrane surfaces, forming the major dense line within the myelin sheath
(Readhead et al., 1987). Presence of the major dense line is essential for compact
myelin and thus MBP has been referred to as the executive molecule of CNS myelin
(Moscarello, 1997).
Shiverer (shi /shi) mice cary an autosomal recessive mutation for the MBP
gene, that is caused by genomic recombination on chromosome 18 leading to deletion
of a 20-kilobase region within the MBP gene (Molineaux et al., 1986). Behaviorally
shiverer mice are characterized by generalized tremors, abnormal gait, and seizure
activity (Chernoff, 1981). Depending on the genetic background, shiverer mice have a
shortened lifespan between 50 and 100 days (Readhead and Hood, 1990). Mice
bearing this mutation fail to assemble compact myelin and exhibit a CNS
hypomyelination (Rosenbluth, 1980). Similarly, Long Evans shaker rats harbors a
mutation in the MBP causing a dysmyelinating disorder (Carre et al., 2002). Abnormal
molecular and behavioral phenotypes are reversed in transgenic mice expressing a
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single wild-type MBP gene (Readhead et al., 1987, Kimura et al., 1989). Additionally, the
shiverer phenotype can be introduced using an anit-sense MBP transgene (Katsuki et
al., 1988), suggesting a central role for MBP in compact myelin. Deficits in myelin basic
protein do not result in oligodendrocyte degeneration or axonal loss; however, deficits
can lead to aberrant axonal cytoskeletons and impaired conduction velocities (Brady et
al., 1999, Nave, 2010).
Mutations in proteolipid protein can also cause CNS hypomyelination and
adversely affect the physiology of humans and other vertebrates (Duncan, 2005).
Myelin-deficient rats do not express proteolipid protein reduced reduced white matter,
generalized tremors, and eventually premature death (Csiza and de Lahunta, 1979,
Zeller et al., 1989). Mouse models of proteolipid protein abnormalities depict a similar
picture as myelin-deficient rats. The mutant mouse jimpy is hypomyelinated in the CNS
due to alternative splicing and a 74 nucleotide deletion, which alters the the carboxyl
terminus of proteolipid protein (Nave et al., 1986). Conservative amino acid
substitutions in PLP, replacing valine for alanine, can cause a similar phenotype (Gencic
and Hudson, 1990). The rump-shaker mouse mutant for PLP, substituting isoleucine for
threonine, also results in CNS hypomyelination, but unlike jimpy mice have normal
longevity and morphologically normal oligodendrocytes (Schneider et al., 1992).
In addition to genetic mutations, homeostatic control over the expression of
myelin genes is important for CNS myelin formation. Transgenic mice over-expressing
proteolipid protein halts oligodendrocyte maturation and survival, bringing about
dysmyelination (Kagawa et al., 1994). Aberrant myelination arising from transmitting
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extra copies of proteolipid protein may be due to a breakdown in the endoplasmic
reticulum-Golgi apparatus system (Kagawa et al., 1994). The transport of abnormal
PLP is restricted within the endoplasmic reticulum preventing PLP from participating in
myelin formation at the oligodendrocyte processes (Roussel et al., 1987, Gow et al.,
1994). During transport through the secretory pathway proteolipid protein may associate
with lipid rafts containing cholesterol and galactosylceramide (Simons et al., 2000).
However, the lipid composition of CNS myelin in jimpy and shiverer mice is unaltered
(Ganser et al., 1988a, b). This may suggest an organized series of pathways participate
in myelin architecture that depend on specific protein-lipid interactions for compact
myelin ensheathments (Baron and Hoekstra, 2010).
The sphingolipid galactocerebroside and its sulfated derivative sulfatide
constitute the two major lipids expressed within the myelin sheath (Coetzee et al.,
1998). Galactocerebroside, which acts as a marker for oligodendrocytes, is synthesized
by the enzyme uridine diphophate-galactose:ceramide galactosyltransferase (CGT or
UGT) that transfers galactose from uridine diphosphate-galactose to ceramide (Morell
and Radin, 1969, Raff et al., 1978). Mice deficient in CGT assemble myelin with normal
ultrastructure, but exhibit tremors, mild ataxia, and eventually develop hindlimb paralysis
(Coetzee et al., 1996). CGT-deficient mice also display reduced conduction velocities,
comparable to unmyelinated axons (Bosio et al., 1996). Phenotypic abnormalities of
CGT-deficient mice are rescued by over-expression of a CGT transgene under the
control of an oligodendrocyte promoter (Zoller et al., 2005). Due to the expression of
galactosylceramide in neurons and astrocytes, oligodendrocyte specific reintroduction of
CGT indicates a central role of myelinating glial cells in the phenotypes accompanying
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CGT deficiency (Zoller et al., 2005). Additionally, the presence of galactolipids produced
by CGT are important in the formation of nodes and paranodes, demonstrating a
fundamental role for lipids in mediating interactions between the myelin sheath and
neuronal axons (Dupree et al., 1998).
Regardless of the numerous potential proteins and lipids shaping the myelin
sheath, it is evident that white matter ensheathment is necessary for the development
and maintenance of axonal integrity (Poliak and Peles, 2003). Myelin enables the needs
of a complex nervous system existing within a confined space, forcing the transmission
of action potentials along nodes of Ranvier and reducing the metabolic requirements for
neuronal communication (Boron and Boulpaep, 2009). Dysmyelinating and
demyelinating mutations within the CNS cause aberrant axonal conduction and
behavioral phenotypes (Werner et al., 1998). Although myelin in the central and
peripheral nervous system (PNS) serve similar purposes, the CNS and PNS are
morphologically and biochemically distinct (Morell et al., 1999, Quarles et al., 2006). For
example, shiverer mice, lacking MBP and compact CNS myelin, have normal myelin
morphology and periodicity in the PNS (Kirschner and Ganser, 1980). Structural and
mechanistic differences existing between the CNS and PNS may be expected as each
system serves distinct functions (McKinley and O'Loughlin, 2006). White matter
anomalies affecting the CNS are heterogenous in nature, observed in a wide range of
human psychiatric disorders including alcoholism and drug abuse (Fields, 2008). The
context of the relationship between psychiatric illness and CNS myelin is unknown,
however, it most likely affects both white matter and neuronal integrity (Pfefferbaum and
Sullivan, 2005). In essence, dysfunction of white matter creates a pathogenic loop
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Figure 5. Myelin-associated pathogenic loop. Diagram of potential convergence for
psychiatric diseases with alcohol abuse and alcoholism through dysfunction of CNS
myelin. Abnormal CNS myelin feeds back to alter neuronal signaling and influence
cross-talk between neurons and oligodendrocytes leading to vulnerability to disease;
adapted from (Feng, 2008).
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affecting neuronal signaling and psychiatric disorders, including alcohol abuse and
dependence (Figure 5).
Brain atrophy, also commonly referred to as brain shrinkage due to the loss of
both white and grey matter within the CNS, has often been attributed to the excessive
life-long consumption of alcohol (Kril and Halliday, 1999). The total brain weight of
alcoholics is significantly less than non-alcoholics (Harper and Blumbergs, 1982), which
may be associated with the rate and total lifetime consumption of alcohol (Harding et al.,
1996). Moderate alcohol drinking behavior, defined as those individuals having
consumed 15-20 drinks per week on average and no greater than a lifetime
consumption of 170-240 kg, does not adversely affect the size of male or female brains
(de Bruin et al., 2005). Heavy (418.1 g/week), but not moderate (181.2 g/week), social
drinking among non-alcoholics is associated with brain atrophy (Kubota et al., 2001),
suggesting a neurotoxic effect of excessive alcohol drinking behavior. Although precise
definitions of moderate and heavy drinking behavior is not well established and varies
among scientific reports, conclusions generally support the role of recurring patterns of
excessive alcohol intake leading to brain atrophy and cognitive impairment. The
neurobiological alterations found with brain atrophy due to alcoholism, however, may be
multifactorial in origin and target differing areas of the human brain (Neiman, 1998).
Individuals suffering from an alcohol use disorder are at risk for liver cirrhosis and
severe nutritional deficiencies, which may also affect brain structure (Guerrini et al.,
2009, Rehm et al., 2010). Liver dysfunction, in the absence of nutritional deficits, is
significant correlated to a decrease grey matter, white matter, and total brain volume in
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alcohol dependent patients (Chen et al., 2011). Reduction in total brain volume may be
due to alcohol induced dysfunction of the liver-brain axis, causing oxidative stress and
the production of toxic lipids capable of crossing the blood brain barrier (de la Monte et
al., 2009). A preexisting metabolic condition or dietary problems leading to progressive
inflammation may further exacerbate alcohol-related neurodegeneration (de la Monte et
al., 2009). However, morphological analysis of uncomplicated alcoholics, those without
confounding liver or nutritional issues, has shown brain abnormalities and cognitive
deficits (Pfefferbaum et al., 1997).
Wernicke-Korsakoff syndrome, characterized by the presence of Wernicke
encephalopathy and Korsakoff psychosis, is a frequently antemortem under diagnosed
condition associated with alcoholism and malnutrition (Zubaran et al., 1997). Resulting
from thiamine (vitamin B1) deficiency due at least in part to an alcohol use disorder,
Wernicke-Korsakoff syndrome leads to brain atrophy and structural changes in multiple
brain regions that markedly impairs cognitive function (Sullivan and Pfefferbaum, 2009).
Alcoholism induced brain atrophy, and brain structure, is largely due to the loss of CNS
myelin (Harper and Kril, 1985, de la Monte, 1988). The most profound changes being
detected in the prefrontal cortex white matter of alcoholics with Wernicke-Korsakoff
syndrome (Kril et al., 1997); a brain region implicated in higher-order executive
functions, motor control, and substance abuse. Additionally, alcoholism is associated
with a decrease in the volume of the corpus callosum, the major white matter
commissure of the brain that permits the exchange of information between cerebral
hemispheres (Arnone et al., 2006). A rat model of alcohol consumption using
pyrithiamine, a thiamine inhibitor, revealed a compounding effect of alcohol and
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thiamine deficiency on the corpus callosum (He et al., 2007). Importantly, ethanol
induced neurotoxicity can be readily distinguished from nutritional deficiencies
associated with Wernicke-Korsakoffe syndrome and other disorders affecting CNS white
matter, such as Marchiafava-Bignami syndrome (Charness, 1993).
Alcoholics with and without Wernicke encephalopathy differentially affect the
extent and location of corpus callosum damage, suggesting fundamental differences in
neurotoxicity and malnutrition (Lee et al., 2005b). The loss of brain weight in alcohol
dependence has been shown to occur independently from the presence of Wernicke
encephalopathy (Harper and Blumbergs, 1982). Non-malnourished canines chronically
exposed to alcohol experience a similar pathology, with regional loss of white matter in
the neocortex and corpus callosum, resulting in enlargement of the lateral ventricles
(Hansen et al., 1991). Structural magnetic resonance imaging (MRI) and diffusion
tensor imaging (DTI) have shown degradation of white matter microstructure within the
corpus callosum of alcoholics (Pfefferbaum et al., 2006). Neuroimaging has also
identified multiple brain regions susceptible to the neurotoxic effects of ethanol in
uncomplicated alcoholics (Gallucci et al., 1989, Sullivan and Pfefferbaum, 2009).
Selective in vivo monitoring of patients through imaging technologies may help
diagnose and differentiate Wernicke encephalopath, Korsakoff amnesic state, and
alcohol dependence (Victor, 1990). Although some of the neurotoxic effects of ethanol
may be permanent, continued abstinence from alcohol reverses the loss of white matter
in uncomplicated alcoholics (Shear et al., 1994, Pfefferbaum et al., 1995). The recovery
of white matter deficits from chronic alcohol perniciousness is parralled by improved
metabolic function and neuropsychological performance (Bartsch et al., 2007).
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Neurodevelopment proceeds through multiple stages in the maturation to
adulthood. The prefrontal cortex in particular undergoes active development during
early childhood and adolescence (Giedd et al., 1999, Thompson et al., 2000). White
matter within the frontal cortex progressively increases throughout childhood and
adolescence reaching maximum between the second and third decade of life
(Pfefferbaum et al., 1994, Sowell et al., 1999). Similar to adults, adolescents (13-17
years of age) and young adults (18-21 years of age) with an alcohol use disorder have
diminished white matter volume within the prefrontal cortex, which inversely correlates
with alcohol consumption (De Bellis et al., 2005). Deficits in white matter are not due to
comorbid psychiatric or neurological disorders (Medina et al., 2008). Binge-drinking
adolescents without a history of drug or alcohol abuse, exhibit diminished white matter
integrity, suggesting heavy episodic drinking adversely affects neurodevelopment
processes related to CNS myelin (McQueeny et al., 2009).
Alcohol consumption during pregnancy can grievously affect a developing fetus,
leading to the development of fetal alcohol spectrum disorder; the most serious form of
which is diagnosed as fetal alcohol syndrome (Medina, 2011). Prenatal alcohol
exposure adversely impacts multiple biological processes, including the central nervous
system (Sulik, 2005, Davis et al., 2011). Post-mortem studies have shown widespread
brain atrophy and structural anomalies occur in infants prenatally exposed to alcohol
(Jones and Smith, 1973, Clarren et al., 1978). Alterations in brain morphology contribute
to the continuum of neurobehavioral abnormalities associated with prenatal alcohol
exposure (Mattson and Riley, 1998). Overall reductions in brain volume for fetal alcohol
spectrum disorder is due to a greater reduction in white matter than grey matter,
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affecting numerous major white matter fiber tracts throughout the brain (Archibald et al.,
2001, Lebel et al., 2008). The degree of brain damage occurring is influenced by the
amount and pattern of alcohol exposure, as well as developmental timing (Maier et al.,
1996). Although ethanol-induced teratogenesis may transpire throughout the entire
brain, in vivo studies have revealed some brain regions may be more sensitive to the
neurotoxic effects of ethanol than others (Riley et al., 2004).
Corpus callosum, the major white matter fiber tract of the brain, undergoes
significant alterations in cases of fetal alcohol syndrome (Riley and McGee, 2005).
Children with fetal alcohol syndrome show significant thinning of the corpus callosum,
and in some severe cases complete agenesis (Mattson et al., 1992, Clark et al., 2000).
The rate of corpus callosum agenesis is considerably higher than the general
population, 6.8% versus 0.3% (Roebuck et al., 1998). Additionally, the abnormalities
within the frontal cortex are among the most consistent findings from case reports of
prenatal ethanol exposure (Norman et al., 2009). Decreases in white matter and
structural irregularities within the frontal lobe persist long after prenatal alcohol exposure
on the developing brain (Sowell et al., 2002). Persistent defects within the forebrain, due
to prenatal alcohol insult, may underlie concomitant behavioral problems associated
with a lack of inhibition and impaired executive function (Olson et al., 1998, Connor et
al., 2000). Unlike alcoholic adults, the detrimental changes in white matter and structural
integrity for individuals afflicted with fetal alcohol syndrome or spectrum are irreversible
(Kodituwakku et al., 2001, Alfonso-Loeches and Guerri, 2011).
Animal models have accelerated our understanding of the teratogenic properties
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of ethanol on development (Cudd, 2005). Craniofacial and forebrain abnormalities in
mice prenatally exposed to alcohol at specific developmental stages, correspond to
phenotypic abnormalities in children suffering from fetal alcohol syndrome (Webster et
al., 1980, Sulik et al., 1981). The extent of malformation depends on the severity of
alcohol exposure and coincidence with critical developmental windows (Riley and
McGee, 2005). Interestingly, defects in facial development correlate with the severity of
brain deformities and associated behavioral problems (Riley et al., 2011). Alcohol
exposure during periods of rapid CNS growth significantly reduces weight of rat
forebrain (Maier et al., 1997). Decreases in brain weight are due in part to the reduction
in myelin thickness and number of myelinated fibers following alcohol exposure during
rat development (Phillips et al., 1991). Akin to their human counterparts, animals
prenatally exposed to alcohol exhibit thinning and partial agenesis of the corpus
callosum (O'Leary-Moore et al., 2011). Alcohol exposure during critical developmental
periods reduces the number of oligodendrocytes, delays oligodendrocyte maturation,
and reduces the expression of myelin basic protein, without affecting neuronal
expression of neural cell adhesion molecule (Phillips and Krueger, 1992, Ozer et al.,
2000).
Alcohol affects the myelin architecture at all of the stages of human development,
spanning from in utero exposure to adulthood. Although the mechanisms of ethanolinduced neurotoxicity remain to be fully elucidated, the adverse consequences of
excessive alcohol consumption on neurobehavioral abnormalities are well substantiated
in both humans and animal model. The etiology and pathophysiology of psychiatric
diseases and alcoholism may be due in part to imperfections arising from
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oligodendroglia and myelin (Sokolov, 2007). Impairments in myelin expression and
formation likely disrupts axonal integrity, putting individuals at risk for continued or future
substance abuse (Bava et al., 2009, Harper, 2009). Dysfunction of white matter in
discrete brain regions confers control over specific cognitive and motor impairments
(Pfefferbaum et al., 2010). Continued scientific inquiry into the fundamental aspects
governing white matter, brain structure, and behavior will help delineate the genetic risk
factors and neurobiology of alcohol abuse and dependence (Zahr et al., 2011).

Application of DNA Microarrays on Ethanol and Ethanol-related Phenotypes
Through an unbiased, parallel examination of mRNA expression from virtually the
entire genome, DNA microarrays can identify genes or gene expression patterns
associated with a given phenotype (drug response, disease, developmental stage, etc.)
(Lockhart and Winzeler, 2000, Lockhart and Barlow, 2001). Gene expression provided
by such studies can provide novel information regarding the mechanisms underlying
disease. Microarrays provide a complementary approach to genetic mapping for the
non-biased identification of disease-related genes. Since the inception of microarrays a
growing number of studies have applied expression profiling towards the neurobiology
of alcohol abuse and dependence. Although differences exist among the various
platforms, microarrays depend on similar underlying molecular fundamentals.
Fluorescent-labeled probes are generated from RNA isolated from a desired tissue or
cell type. Target molecules may be either RNA or DNA based, depending on the
particular microarray platform. A target gene of interest, through the basic principle of
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complementary base pairing of nucleotides, adheres to small probes attached to a solidphase support such as a glass slide, bead, or nylon membrane. The probes are
generally DNA oligonucleotides 25–70 nucleotides in length. Following hybridization and
washing, fluorescent signals are detected and these correlate directly to specific mRNA
abundance to monitor changes in gene expression (Chee et al., 1996). Monitoring
simultaneous changes in gene expression can identify the function of uncharacterized
genes and the pharmacological mechanisms of action for drugs of unknown function
(Hughes et al., 2000).
Alcoholism is a complex disease influenced by a multitude of potential factors, both
genetic and environmental in origin (Spanagel, 2009). As described previously, the
genetic predisposition for the risk of developing alcoholism has been well documented
through a host of publications on the familial origin of substance abuse (Merikangas et
al., 1998, Hill et al., 2008). Genetic inquiries of human and animal models have to date
only identified a few well-documented genes contributing to the risk for alcoholism or
genetic variation in behavioral responses to ethanol. This difficulty is likely due to the
occurrence of one or more rare polymorphisms of small effect size in a large number of
genes being causal elements in complex traits such as alcoholism. Additionally, the
alteration in mRNA transcript abundance evoked by ethanol or substance abuse are
proposed as mechanisms underlying enduring neuroadaptations leading to abuse and
addiction (Nestler and Aghajanian, 1997). Disrupted homeostatic control of gene
networks is also a possible mechanism underlying CNS toxicity from compulsive
ethanol or drug use. Furthermore, genetic differences in gene expression responses to
ethanol are also thought to be an important mechanism underlying a predisposition to
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alcoholism or other complex traits (Schadt et al., 2003, Chesler et al., 2005).
Differences in ethanol-induced signaling events are a dynamic aspect influencing
the maturation of alcohol dependent behaviors. Divergent sensitivity to an initial acute
exposure to ethanol is correlated with the potential for long-term drinking behavior
(Schuckit, 1994), suggesting divergence in acute ethanol-induced signaling events may
be an important risk factor for developing alcoholism. Alterations in gene expression can
occur at biologically relevant concentrations of ethanol within 4 hours after initial
exposure and persist for extended periods of time (Miles et al., 1991). Expression
profiling of neuroblastoma cells identified some of the major gene targets of ethanol
(Thibault et al., 2000). Genomic profiling pointed to catecholamine metabolism
(dopamine B-hydroxylase), cellular survival and oxidative stress, and cyclic-AMP
(cAMP) signaling mechanisms. The cAMP system is a known factor underlying acute
and chronic ethanol action; however, profiling of neuroblastoma cells also exemplified
that ethanol has unique signaling mechanisms owing to the fact that not all of the same
genes were regulated solely by cAMP (Thibault et al., 2000, Hassan et al., 2003,
Thibault et al., 2005). Characterizing these differences in gene expression both
validated the use of microarrays by uncovering genes known to contribute to ethanol
responses (i.e. cAMP signaling genes), and demonstrated the utility of genomic
approaches to identify novel genes unique to an ethanol-induced response.
Microarray studies on brain tissue for complex traits related to alcohol abuse and
dependence can be subdivided into human versus animal model, acute versus chronic,
basal versus treated, and whole brain versus brain regional. In general, for the animal
model studies, two different experimental approaches have been used. The first entails
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profiling of ‘basal gene expression’ across two or more lines of animals that are known
to have important differences in ethanol drinking or other behavioral responses to
ethanol. The second approach looks at responses to acute or chronic ethanol exposure
or ethanol withdrawal. The two approaches have been merged in a limited number of
studies where ethanol responses across different lines of animals are also studied. As a
general conclusion, all of these approaches have produced statistically significant
results, generating prodigious gene lists under continued evaluation and validation.
Genomic studies on ethanol-naive inbred strains of mice differing in ethanolsensitive behavioral phenotypes have been important for determining genes and
molecular pathways potentially involved in ethanol-related physiological pathways. For
example, whole-brain expression profiling of inbred long sleep (ILS) and inbred short
sleep mice (ISS), specifically bred for their initial sensitivity to a sedative-hypnotic dose
of ethanol, show expression differences for approximately 41 genes (Xu et al., 2001).
Expression differences between ILS and ISS mice suggested the involvement of several
assorted gene ontology categories. One prospective category included glycolysis,
implicated through differential expression of pyruvate dehydrogenase E1-a subunit, a
key enzyme in the conversion of pyruvate to acetyl coenzyme A (acetyl-CoA). Additional
follow-up analysis of ILS and ISS samples suggested potential splice variants for
unknown cDNA clones contributes to variation in the sedative-hypnotic effects of acute
ethanol (Xu et al., 2001).
A meta-analysis of differential gene expression across a panel of alcohol naive
inbred mice strains that are known to differ in voluntary ethanol drinking behavior
pointed to a diverse collection of genes and molecular pathways in the predisposition for
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ethanol consumption (Mulligan et al., 2006). An additional meta-analysis of selectively
bred ethanol-naïve mice, recombinant inbred mice, and a large heterogeneous panel of
inbred mice identified greater than 8000 transcripts related to ethanol preference
(Tabakoff et al., 2008). Whole-brain expression profiling differences revealed by the two
meta-analysis strongly suggests the involvement of thousands of genes spanning
several functional pathways are involved in alcohol drinking behavior. Brain-region
specific differences further complicate defining the gene-sets governing alcohol
consumption. Microarray analysis of individual brain regions has demonstrated within
region gene expression differences that correlate with alcohol intake (Mulligan et al.,
2011, Wolstenholme et al., 2011), suggesting numerous genomic integrative processes
across multiple brain regions influence drinking behavior.
A number of laboratories are interested in brain region specific differences
contributing to ethanol behavioral phenotypes. Genotype specific differences have been
demonstrated within individual brain sections using microarray analysis across five
distinct brain regions for eight different strains of inbred mice from priority group A of the
Mouse Phenome Project (Bogue and Grubb, 2004, Letwin et al., 2006). Correlation of
expression profiling results in drug-naïve mice identified a subset of genes solely within
the ventral striatum related to the N-methyl-d-aspartate (NMDA)/glutamate signaling
pathway for total distance traveled following 1.5 g/kg ethanol, suggesting a brain region
specific expression pattern associated with locomotor activity. Correlation of basal gene
expression with an ethanol behavioral phenotype across multiple inbred mouse lines
suggested the potential power of combining genomic profiling with genetic analysis of
ethanol behaviors (Chesler et al., 2005, Letwin et al., 2006).
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C57BL/6J (B6) and DBA/2J (D2) mice are two inbred strains, commercially
available from the Jackson Laboratory (http://www.jax.org/), that differ in a range of
ethanol behavioral phenotypes (McClearn and Rodgers, 1959). For example, D2 mice
demonstrate greater acute ethanol-induced locomotor activation, withdrawal-induced
seizures, and reduced ethanol preference/consumption compared to B6 mice
(Goldstein, 1973, Belknap et al., 1993, Phillips et al., 1994, Metten et al., 1998a). An
initial global whole-brain expression profiling experiment of B6 and D2 mice acutely
treated with 6 g/kg ethanol revealed a small number of genes responding to ethanol
related to cell signaling, gene regulation, and homeostasis/stress response (Treadwell
and Singh, 2004). Several of the ethanol-responsive genes differing between B6 and D2
mice resided within known ethanol behavioral QTLs; however, only small number of
genes (16 total) were differentially regulated by acute ethanol. The low extent of
differential expression between the two strains was attributed to heterogeneity of the
brain tissue from performing genomic comparisons on whole brain homogenates.
Basal and acute ethanol-responsive neurogenomics differences within the ventral
tegmental area (VTA), nucleus accumbens (NAC), and prefrontal cortex (PFC) between
D2 and B6 mice have also been recently characterized (Kerns et al., 2005). Extensive
multivariate analysis of VTA, NAC, and PFC uncovered basal and ethanol-evoked brain
region specific gene expression profile differences. Acute ethanol induced coordinated
changes in gene expression patterns that suggested an overall functional involvement
with neuroplasticity. Region specific functional relationships were determined for retinoic
acid signaling (VTA), Bdnf signaling and neuropeptide expression (NAC), and
glucocorticoid signaling and myelination (PFC). A subset of differentially expressed
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genes mapped to QTLs that have been previously implicated in acute ethanol
behavioral phenotypes. The overlap of ethanol-responsive genes and genes contained
within support intervals identified for behavioral QTLs provided a glimpse of the power
that microarrays might have for prioritizing candidate genes for quantitative traits.
Overall, this study strongly suggested that the activity of divergent brain region–specific
gene expression patterns, and their cognate signaling mechanisms, might play an
important role in the differing ethanol behaviors witnessed between B6 and D2 mice.
The studies from Kerns et al. (2005) also defined coordinate regulation of myelin
associated genes within the prefrontal cortex. Myelin-associated genes showed
divergent basal and ethanol-responsive effects between the B6 and D2 mice, which
might be determinants in acute ethanol sensitivity and long-term drinking behavior
(Figure 6). Ethanol regulation of myelin gene expression is further supported by
genomic analysis of postmortem human brain tissue, which demonstrates a coordinate
decrease of myelin gene expression within the frontal cortex (Figure 7) (Lewohl et al.,
2000, Mayfield et al., 2002, Iwamoto et al., 2004). Co-ordinate down-regulation of
myelin expression was also confirmed at the level of protein (Lewohl et al., 2005) as
well as neuropathology and neuroimaging studies (Kril and Harper, 1989, Rosenbloom
et al., 2003). Microarray evidence of myelin gene dysregulation has also been identified
in studies on schizophrenia and cocaine addiction, suggesting that PFC myelin gene
expression may be sensitive to dopaminergic signaling (Sokolov, 2007).
A number of other functional categories, such as glutamate signaling, protein
trafficking, and cyclic adenosine monophosphate (cAMP) signaling, has also been
revealed through genomic studies of postmortem alcoholic brain tissue (Mayfield et al.,
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Figure 6. Microarray analysis of acute ethanol-responsive gene expression in B6
and D2 mice. Cluster shows differential basal and acute ethanol-responsive gene
expression across B6 and D2 mice PFC. Triplicate experiments were conducted on
saline- or ethanol-injected (2 g/kg) B6 AND D2 mice. Brain sections were microdissected after 4 hours and RNA prepared for microarray analysis using Affymetrix
Mg_U74A2 oligonucleotide arrays. Red= increased expression. Green= decreased
expression. Black = no change in expression. Figure amended from Kerns et al. 2005.
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Figure 7. Decrease myelin-associated gene expression from human PFC. Bar
graph showing coordinate decrease fold change in myelin-associated gene expression
in frontal cortex from post-mortem alcoholic brain tissue; derived from data presented in
(Lewohl et al., 2000).
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2002, Sokolov, 2007). These changes reflect a large cohort of cell signaling
mechanisms cooperating in an orchestrated series of CNS plasticity occurring with
prolonged ethanol exposure. The cAMP-signaling pathway, for example, has been
implicated in a large number of experimental models relevant to alcohol abuse
(Diamond and Gordon, 1997). A potential weakness of microarray studies on
postmortem brain tissue is they only represent the final end point of the disorder, and
not necessarily the neuroadaptations occurring over time that lead to the development
of dependence. The possibility of other confounding environmental or population
stratification factors affecting the microarray results also cannot be discounted.
Although challenging in terms of experimental design, chronic ethanol exposure in
animal models is a significant etiological factor for understanding the neurobiology of
alcoholism (McBride and Li, 1998, Knapp and Breese, 2012). Animal models lack many
of the functional criteria for clinical diagnoses of alcoholism, but are able to mimic
different phenotypic components of the disorder. Brain region–specific differences in
gene expression have been detected in the NAC shell and central nucleus of the
amygdala of alcohol-preferring rats following an 8-week model of alcohol binge–like
behavior (McBride et al., 2010). Little overlap in gene expression results was found
between this study and a previous analysis from the same research group of the NAC
within the same strain following ethanol operant self-administration, suggesting that
differences in behavioral procedures and the neural circuits they activate may contribute
to deviations in expression-profiling results (Rodd et al., 2008, McBride et al., 2010).
Chronic intermittent rather than continuous ethanol exposure causes increased
ethanol self-administration (O'Dell et al., 2004, Lopez and Becker, 2005). Intermittent
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episodes of ethanol vapor exposure permits control over dose and duration of exposure,
maintaining stable blood-ethanol concentrations, producing dependency and withdrawal
in mice and rats (Becker, 2000). Expression profiling on cingulate cortex and amygdala
in rats exposed to the chronic intermittent ethanol exposure found striking alterations in
expression for genes involved with glutamate neurotransmission, synaptic plasticity, and
mitogen-activated protein kinase signaling (Rimondini et al., 2002). Expression changes
were detected three weeks after withdrawal from the last ethanol vapor exposure,
suggesting important molecular adaptations underlying escalating ethanol intake.
However, these studies used only a single time point and only two microarrays per
treatment/ brain region group, and thus may be susceptible type I and type II errors.
Altered gene expression profiles have been demonstrated for acute and chronic
ethanol withdrawal within hippocampi for B6 and D2 mice, revealing strain and
treatment specific changes for ethanol-induced withdrawal behavior (Daniels and Buck,
2002). Contrasting gene expression patterns for ethanol-induced withdrawal
phenotypes for B6 and D2 mice is associated with the neural circuitry of physical
dependence and tolerance (Chen et al., 2009a). Combining genomics with genetic null
mutations that target specific behavioral traits can help refine the potential molecular
pathways and candidate genes for ethanol-responsive endophenotypes. Protein kinase
C gamma (γ-PKC), confined to the CNS (Yoshida et al., 1988), is an influential substrate
for tolerance to ethanol (Bowers et al., 1999). Microarray analysis of cerebellar tissue
from γ-PKC knockout mice, which do not develop tolerance to ethanol, identified a novel
potassium channel (Twik-1) dependent on the presence of γ-PKC for the development
of tolerance (Bowers et al., 2006). However, the association of γ-PKC and tolerance, as
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well as shared differential gene expression, is dependent on genetic background
(Bowers et al., 1999). Additionally, basal differences in gene expression arise in γ-PKC
mutants that may be important for interpreting the behavioral response to ethanol
(Smith et al., 2006). Although it is difficult to establish a causative association between
variation in gene expression and complex traits, convergent evidence from multiple
resources can help to determine novel relationships beyond our existing knowledge
(Ponomarev et al., 2004, Baker et al., 2012). Cross-species analysis incorporating
human genetic variation and gene expression can also prioritize candidate genes for a
comprehensive translational approach for novel genes and gene networks underlying
complex traits (Bertsch et al., 2005, Rodd et al., 2007).
Neuropsychiatric conditions including alcoholism are multifaceted diseases of
complex origin. Extensive efforts across multiple fields of scientific research have
actively sought to explain the origins of alcoholism; however, no solitary molecular
mechanism has yet been established. Evidence from genetic epidemiology, genetic
variation, and differential gene expression studies has demonstrated multiple genes
may account for the manifestation of psychiatric disease. Variation in gene expression
may act as an intermediate phenotype between genotypic differences and
neurobehavioral responses (Abiola et al., 2003, Cheung et al., 2003, Nica and
Dermitzakis, 2008). In order to understand the functional importance of genetic variation
and differential gene expression, visualizing the shared interconnection among gene
products using network-based approaches may become essential for the analysis of
complex traits.
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Bioinformatics and Network Analysis of Gene Expression
Once genes differentially expressed across different conditions or animal strains
relative to the disease model have been identified or robust expression data has been
collected across a panel of phenotypes and genotypes, a relational network needs to be
established across individual genes. A gene network could be considered either a set of
genes that interact functionally (e.g. metabolite processing, protein–protein interaction,
or protein modification) with one another to accommodate the needs of the cellular
environment or a set of genes that share a common regulatory mechanism and show
highly correlated expression patterns. In many cases these two factors may overlap
within a given gene network. However, associating biological function with a gene
network for a behavioral phenotype might lead to new hypotheses regarding the
underlying molecular mechanisms and avenues for intervention. Such an approach is
certainly the hope of using genetical genomics and bioinformatics for studies on
ethanol-related phenotypes. The types of analyses required are however contingent
upon the source of gene expression data and the hypothesis in question (Slonim, 2002).
Organizing gene expression data entails determining whether or not a given gene
set has some coherent biological function and if the results are greater than expected
by chance. Performing over-representation analysis requires proficient databases of
known gene ontologies covering individual categories nested within three broad
domains: cellular component, biological process, and molecular function (Ashburner et
al., 2000). These interconnected domains are derived from the existing biomedical
literature, and defined by their shared functional involvement such as protein–protein
interactions, gene–gene interactions, or cellular signaling systems. Although gene
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ontologies have drawbacks and limitations, including incomplete categories and preexisting biases, the collaborative effort is continually evolving to incorporate new
biological discovers and meet the needs of the scientific community (Harris et al., 2004,
Khatri and Draghici, 2005). A number of resources and bioinformatic tools are readily
available to determine if a particular data set is enriched for a functional category (http//
www.geneontology.org/). The Database for Annotation, Visualization and Integrated
Discovery (DAVID) for example provides a comprehensive package for determining
biological meaning behind extensive gene sets (Dennis et al., 2003, Huang et al., 2009).
DAVID also links to additional shared resources such as the Kyoto Encyclopedia of
Genes and Genomes (KEGG), which is a database of manually curated molecular
pathways (Kanehisa, 2000). Pathway analysis of gene expression data, or other largescale methodologies, may help determine common genes and molecular pathways
underlying drug addiction (Li et al., 2008).
ToppGene Suite is another multifaceted resource that can mine gene expression
outcomes for enrichment of ontologies, as well as human and mouse phenotypes (Chen
et al., 2009c). Additionally, ToppGene prioritizes candidate genes for targeted validation
of genes in downstream molecular and behavioral processes. The ranking or prioritizing
of candidate genes is assigned based upon functional annotation and phenotypic data
(Chen et al., 2007) or protein–protein interaction networks (Chen et al., 2009b).
Conducting over-representation analysis of gene expression results can thus help
organize an abundance of results into biologically meaningful information current with
existing knowledge. Additionally, gene ontologies can be used to help construct gene
networks, generate novel predictions regarding gene function, and identify genes
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potentially missed in up-stream analyses (Mostafavi et al., 2008, Warde-Farley et al.,
2010).
Literature association analysis is a complementary bioinformatics approach to
gene ontology analysis that is often used for querying the functional and chemical
relationships existing within large-scale gene sets. Biological databases solely derived
from manual input cannot keep pace with the exponential growth of peer-reviewed
literature (Hunter and Cohen, 2006, Krallinger et al., 2008), and thus have integrated
text mining approaches for probing the underlying biology gene expression data, or
other omic technologies (Krallinger et al., 2010). Ingenuity Pathway Analysis (http://
www.ingenuity.com/) is an example of bioinformatics program for exploring and
visualizing the network structure of data sets based on computer-generated and
manually curated literature associations, biological function, and cell signaling
mechanisms. Other commercial programs such as GeneGo (http://www.genego.com/)
and free programs such as Chilibot (Chen and Sharp, 2004) are available for literature
mining and composing network diagrams among gene sets. The network structure of
gene sets can reveal innovative associations between genes outside of predetermined
functional categories, leading to novel hypotheses and follow-up experimental biology.
The Search Tool for the Retrieval of Interacting Genes/ Proteins (STRING; http://
string-db.org/) is an in-depth meta-resource tool for illustrating functional network
associations of genes and proteins across 630 organisms (Snel et al., 2000, Jensen et
al., 2009). Networks are based upon a composite of known functional associations and
protein–protein interactions existing within the biomedical literature, as well as predicted
relationships in order to potentially provide a more comprehensive systems biology
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outlook (Szklarczyk et al., 2011). The predicted functional relationship among given
gene sets are deter- mined through an array of experimentally derived conditions from
phylogenetic and co-expression profiles (von Mering et al., 2007). Additionally, predicted
associations are incorporated into STRING using natural language processing of the
peer-reviewed literature (Saric et al., 2006) and conserved organismic transfer of
protein interactions (von Mering et al., 2005). Resulting networks can be filtered for
confidence scores, and used as a prominent exploratory tool for investigating all of the
possible biological relationships within a potentially more limited user-defined gene set.
Caution must be exercised in over-interpreting the results of such network associations
and verifying the implied literature interrelationships (Auffray et al., 2009). Deriving the
same or similar network structure from different bioinformatics resources or through
combinations of literature association, functional group over-representation, and
expression correlation is a reassuring indication of some meaningful functional
relationship amongst gene expression data.
Empirical assessments may also be determined de novo for gene network analysis
or gene–gene relations, based upon expression/expression, expression/genotype or
expression/phenotype correlations. Partnerships between expression, genotype, and
phenotype depend upon the inherent correlation structure generated by datasets, such
as microarray expression studies. Clustering of expression profiles due to genes with
highly correlated mRNA abundances across a large number of different experimental
conditions or genotypes are hypothesized to share biologically relevant relationships.
Cluster analysis of the inherent patterns produced by correlated gene expression can
provide insights into the function of uncharacterized genes or the biological mechanisms
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underlying a given drug action or phenotypic trait (Eisen et al., 1998, Hughes et al.,
2000). However, without sufficient biological variance in the expression of individual
genes, correlation based network approaches can produce statistically parsimonious
relationships between genes that might have little biological relevance (Baginsky et al.,
2010). In view of the fact environmental or technical factors can produce artifactual
correlations, experimental biases should also be considered in the statistical and
biological principles of pattern recognition (Kerr and Churchill, 2001).
Despite the potential problems and limitations facing the identification of
coordinately regulated gene expression patterns, the concept of gene networks is
successfully and increasingly being used in systems biology of complex traits (Chen et
al., 2008, Horvath and Dong, 2008). A large number of methodologies exist and are
continually emerging to classify co-expression networks (Butte et al., 2000; Baldwin et
al., 2005; Chesler et al., 2005; Zhang and Horvath, 2005). Not surprisingly, correlation
matrices can clarify the role of genes with unknown function (van Noort et al., 2003);
however, gene co-expression networks can also identify components specific to a
singular model organism or conserved across an evolutionary diverse set of species
(Stuart et al., 2003). Although many genes remain stationary over time, dynamic
relevance networks may also exist in response to differing stimuli and adapt throughout
an organisms’ lifetime (Reis et al., 2001, Yeung et al., 2011). Combined with genetic
mapping strategies (i.e. QTL analysis) and detailed phenotyping, heritable variation in
gene expression networks can help chart complex traits associated with human disease
(Rockman and Kruglyak, 2006, Sieberts and Schadt, 2007, Cookson et al., 2009).
Although human interactome data is receiving increased attention for network-

66

based approaches to human disease (Barabasi et al., 2011), model organisms and in
silico analysis provide an experimental platforms for fundamental questions in network
biology (Joyce and Palsson, 2006). Yeast models have successfully demonstrated that
integrating gene expression with transcription factor binding information and proteinprotein interaction data can reconstruct gene networks capable of predicting complex
system behavior (Zhu et al., 2008). Characteristic patterns in gene expression emerge
from elaborate global networks, often referred to as sub-networks or modules, which
function as a group and may be essential in physiological or pathophysiological
processes (Milo et al., 2002, Yeger-Lotem et al., 2004). Genes forming tightly coregulated gene expression patterns comprising sub-networks are more likely to be
interacting protein complexes cooperating in a shared molecular function (Laub et al.,
2000, Ge et al., 2003). Additionally, distinct functional modules existing within a larger
framework are more likely to be evolutionary conserved across species (Wuchty et al.,
2003). The global organization and interaction of biological networks is controlled
through intra-modular genes that may be prime targets for therapeutic intervention (Han
et al., 2004). Pharmaceutical agents can however functionally interact, as well as
potentially impact interlinked genomic and proteomic networks (Yeh et al., 2006, Yildirim
et al., 2007, Nichols et al., 2011). The majority of disease-oriented genes do not
necessarily encode for essential hub genes in humans (Goh et al., 2007), further
suggesting the focus for understanding disease mechanisms should part ways with
reductionism and be directed towards perturbed gene expression networks rather than
single alleles (Nelson, 2008, Schadt et al., 2009).
Treating gene expression as a quantitative trait has helped identify some of the
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key drivers of physiological and behavioral phenotypes within living systems (Brem et
al., 2002, Schadt et al., 2003); however gene expression networks have also illuminated
the substantial complexity underlying disease mechanisms (Schadt, 2009). Using a
conditional correlation model for gene expression data, genotypic variation, and
phenotypic measures, approximately one hundred gene expression traits have been
predicted for the susceptibility to obesity across a segregating mouse population
derived from C57BL/6J and DBA/2J mice (Schadt et al., 2005). Knockout or transgenic
mouse models in a subsequent analysis validated eight out of nine top candidate genes
for abdominal obesity, originally identified by the conditional correlation results (Yang et
al., 2009). Importantly, expression profiling of the mouse models for abdominal obesity
determined they influenced common pathways and gene networks, suggesting gene
networks and not a singular gene is responsible for common human diseases (Yang et
al., 2009). In addition to obesity, gene co-expression networks have also been widely
implicated in a variety of other complex traits associated with human health, including
neural development disorders and psychiatric disease (Chen et al., 2008, Derry et al.,
2010, Miller et al., 2010, Potkin et al., 2010, Penagarikano et al., 2011).

Concluding Remarks
Higher-order organizational frameworks composed of biological relationships,
physical interactions, expression correlation structures, and predicted associations
encompass some of the current network approaches designed for understanding the
molecular basis of disease. Multiple sources of information and theoretical frameworks
can be readily utilized to obtain gene networks. How to build the most informative
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networks is open to interpretation, but undoubtedly will rely on some type of an
organizing framework such as correlation structures or functional associations. The
infrastructure of gene networks shares similar properties with other complex systems,
namely scale-free topology (Price, 1965, Barabasi and Albert, 1999, Barabasi and
Oltvai, 2004, van Noort et al., 2004). In some instances gene co-expression networks
may be evolutionary conserved with coherent biological function (Milo et al., 2002,
Stuart et al., 2003). Genetic and genomic studies have identified a large number of
candidate genes that may contribute to a variety of phenotypic traits related to
alcoholism; however, the adoption of network analyses for understanding alcoholism is
still in a state of infancy. Transcriptional variation and insertional mutagenesis within
Drosophila melanogaster has indicated gene networks, rather than an individual gene,
are important for sensitivity to alcohol (Morozova et al., 2011).
Heterogeneity and complexity of the mammalian brain has hindered the progress
of functional genomics for elucidating the mechanisms of neurological and psychiatric
disease (Mirnics et al., 2000, Geschwind and Konopka, 2009). Expression profiling of
brain tissue from humans and animals, in combination with existing research, is opening
the door to the discovery of fundamental networks inherent in alcohol use disorders
(Spanagel, 2009). Through systems biology brain region-specific networks can be
constructed for endophenotypes associated with alcohol abuse and dependence
(Figure 8). Although each individual layer of detail may hold novel insights, coordinately
regulated gene expression networks can serve as an informative intermediate between
the genotype-phenotype relationship (Nica and Dermitzakis, 2008, Cheung and
Spielman, 2009). Identifying gene networks with a conserved role in both biological and
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phenotypic variation may be essential for understanding the neurobiology of drug
actions and susceptibility to disease (Berger and Iyengar, 2009, Pujol et al., 2010).
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CHAPTER 3:
GENE NETWORKS OF CHRONIC ALCOHOL ADMINISTRATION ACROSS SPECIES

Introduction
Alcoholism is a chronic relapsing condition resulting from excessive alcohol
consumption associated with altered cognition and behavior. Individual differences as
well as disrupted homeostatic control over brain mechanisms involving positive and
negative reinforcement underlie the neurobiology of maladaptive alcohol drinking
behavior (Koob, 2003, Spanagel et al., 2010). Although no animal model completely
encompasses every aspect of alcoholism (McClearn, 1979, Crabbe, 2008), preclinical
models have been valuable tools for investigating the genetic and environmental factors
influencing alcohol consumption (Becker, 2000, Pautassi et al., 2010). Non-human
primate models in particular are powerful experimental models due to their genetic,
neuroanatomical, physiological, behavioral, and social similarities to humans (Barr et
al., 2003, Weerts et al., 2007). Alcohol drinking behavior in non-human primates
parallels several factors witnessed in some rodent models and human alcoholics,
potentially demonstrating one or more components related to alcohol consumption:
voluntary self-administration, intoxication, dependence, withdrawal, and significant
variation in individual alcohol intake (Grant and Bennett, 2003). The biological and
behavioral similarities between non-human primates and humans, as well as certain
facets of other animal models, present a unique opportunity for translational studies on
alcohol abuse and dependence (Barr and Goldman, 2006, Zahr and Sullivan, 2008).
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Non-human primates have played an important role in understanding the
neurobiology of disease (Capitanio and Emborg, 2008). Comparative transcriptomics
reveals an elaborate array of gene expression differences between non-human
primates and human brain (Caceres et al., 2003, Hsieh et al., 2003). Expression
differences, largely resulting from increased gene expression in human brain, may be a
consequence of accelerated brain evolution (Enard et al., 2002, Gu and Gu, 2003),
which is reflected in the increased volume and complexity of the human brain
(Gazzaniga, 2009). Differing regions of the mammalian brain are remarkably
heterogeneous, potentially capable of accommodating hundreds of contrasting cell
types (Levitt et al., 1997, Geschwind, 2000). Despite the inherent and evolving
complexity, coordinately regulated gene expression networks are conserved among
discrete brain regions (Oldham et al., 2006). Additionally, there is a robust organization
to the mammalian brain transcriptome (Oldham et al., 2008). Deciphering the overall
framework of gene co-expression networks among brain regions provides a systematic
approach to understanding the neurobiology of disease mechanisms (Miller et al., 2010,
Torkamani et al., 2010, Voineagu et al., 2011). The extent to which co-expression
networks are associated with the underlying neurobiology of addiction remains to be
elucidated; however, integrative cross-species analyses provides important details
concerning the molecular biology of phenotypes involved in neuropsychiatric diseases
(Konopka and Geschwind, 2010).
Genetic factors explain approximately 50% of the vulnerabilities leading to
excessive alcohol intake (Schuckit, 2009b). Cross-species investigations have focused
on individual genes associated with specific endophenotypes related to alcohol abuse
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and dependence (Kapfhamer et al., 2008, Corl et al., 2009, Lasek et al., 2011,
Schumann et al., 2011), suggesting there are evolutionary conserved factors in the
pathogenesis of alcoholism. Whole-brain microarray meta-analysis of alcohol naïve
mice known to differ markedly in alcohol drinking behavior demonstrates variation in
gene expression contributes to the predisposition for abuse (Mulligan et al., 2006,
Tabakoff et al., 2008). Basal and drug-responsive differences in expression patterns are
dependent upon both genotype and brain-regions, conferring distinct neurobehavioral
phenotypes (Sandberg et al., 2000, Kerns et al., 2005, Letwin et al., 2006). Gene
expression differences within discrete brain-regions are correlated to individual
differences in alcohol drinking behavior (Mulligan et al., 2011, Wolstenholme et al.,
2011). The gene expression abundance for GABA and NMDA receptor subunits is
altered in cynomolgus monkeys (Hemby et al., 2006, Acosta et al., 2010). Changes in
the expression of receptor subunits alter receptor and behavioral sensitivity to alcohol
(Haughey et al., 2008, Hurley et al., 2009), suggesting variation in gene expression is
important for the acute and long-term effects of alcohol. Inter- and intra-species
variation in gene co-expression networks are significantly associated with phenotypic
differences in alcohol intake. Defining conserved gene networks across species permits
a translational approach for understanding the molecular mechanisms governing
alcohol-drinking behavior, and a foundation for further scientific hypotheses.
As part of the Integrative Neuroscience Initiative on Alcoholism (INIA) consortium,
a comparison of microarray profiles from brain tissue are discussed herein for differing
evaluations of alcohol drinking behavior in non-human primates and mice, as well as a
previous microarray analysis of human alcoholic brain tissue. Female cynomolgus

74

macaques were analyzed across the prefrontal cortex (PFC), nucleus accumbens
(NAC), hippocampus (HIP), and amygdala (AMY) in comparison to control subjects.
Gene expression profiles within prefrontal cortex were also analyzed for male
cynomolgus macaques, a separate cohort of male rhesus macaques, and a panel of
heterogeneous mice. The prefrontal cortex is part of the mesocorticolimbic
dopaminergic ‘reward’ pathway involved in numerous behavioral functions and the
neurobiology of addiction (Ross and Peselow, 2009, Goldstein and Volkow, 2011).
Previous research from our laboratory and others has shown chronic alcohol abuse
causes decreased expression of myelin-associated genes within the frontal cortex of
postmortem brain tissue (Lewohl et al., 2000, Mayfield et al., 2002). Coordinate downregulation for the expression of a myelin-associated gene network may be an underlying
component in CNS plastic events of alcohol dependence. Rather than emphasizing
individual genes, gene expression networks are constructed to illustrate some of the
global properties presiding over alcohol drinking behavior in mammalian species (Zhao
et al., 2010b). We hypothesize that variation in an evolutionary conserved gene
networks, including a network related to myelin-associated gene expression, are
important determinants of alcohol behavioral phenotypes. Networks are not directly
intended to infer causality, but are meant to convey an integrative viewpoint of
molecular signatures underlying the neurobiology of endophenotypes associated with
alcohol dependence, as well as set the stage for additional scientific inquiries. Our
approach imparts a unique systems hypothesis of an evolutionary conserved network(s)
involved in alcohol drinking behavior across mice, monkeys, and humans.
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Materials and Methods
Non-human primate subjects and Self-Administration of Alcohol: Studies of non-human
primates were part of a collaborative study through the Integrative Neuroscience
Initiative on Alcoholism (INIA). Primate procedures were approved by the Oregon
National Primate Research Center Animal Care and Use Committee and carried out
according to the National Institutes of Health Guidelines for the Care and Use of
Mammals in Neuroscience and Behavioral Research. Overall three different groups
were analyzed for gene expression differences: female cynomolgus macaque (Macaca
fascicularis; INIA cohort #3, n = 12 alcohol drinkers and n = 4 controls), male
cynomolgus macaque (Macaca fascicularis; INIA cohort #2, n = 11 alcohol drinkers and
n = 4 controls & n = 7 housing keeping controls) and male rhesus macaque (Macaca
mulatta, INIA cohort #4&5, n = 19 alcohol drinkers and n = 5 controls). As part of the
INIA collaborative effort by our group, nucleus accumbens, amygdala, hippocampus,
and prefrontal cortex (areas 24, 25, and 32 pooled together) were sampled from
subjects for microarray analysis of INIA cohort #3. Prefrontal cortex (areas 24, 25, and
32 pooled together) was sampled from subjects for microarray analysis of INIA cohort
#2, as well as INIA cohorts #4 and #5. Cynomolgus macaques were purchased from a
commercial vendor (World Wide Primates, Miami FL); rhesus macaques were obtained
from the Oregon National Primate Research Center with verified birth dates and
pedigree information.
The schedule-induced polydipsia (SIP) method for inducing monkeys to drink
alcohol was utilized to establish alcohol self-administration (Vivian et al., 2001).
Monkeys were trained to operate a drinking panel in their cage and to place a finger
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inside an opening that broke a light beam to deliver a banana pellet. This training was
used to document food intake during scheduled meals (Grant et al., 2008). Monkeys
then were induced to consume water (in the volume of a 1.5 g/kg dose of 4% (w/v)
ethanol in water) in daily 22-h sessions by delivering banana pellets at a fixed time
interval of 300 s in which no response was required.
After 1 month of induction, ethanol (4% w/v) was the only fluid present for the
initial SIP component of each daily 22-h session. The dose of ethanol induced by SIP in
the first component of the session was increased in a stepwise fashion over 30-session
epochs. Monkeys were induced to drink ethanol, 0.5 g/kg/day (two or three drinks), for
30 days, then 1 g/kg/day (four or five drinks) for 30 days, and finally 1.5 g/kg/day (six or
seven drinks) for 30 days. For these purposes a drink is operationally defined as the
equivalent of 0.25 g/kg ethanol (17 grams of alcohol in a 70 kg human) (Kalant and
Poikolainen, 1999). After the induced dose of ethanol was consumed, only water
was available for a period of 3 hours. Following that period, water and the remaining
food were available for the remaining session time. Voluntarily alcohol selfadministration was started in the fifth month, wherein monkeys were allowed free
access to 4% ethanol and water for 22 hours/day (11:00 AM to 9:00 AM). The quantity
and pattern of self-administered ethanol was measured accurately by mass
displacement from a fluid reservoir and highly correlated with measurements of blood
ethanol concentration (Figure 9).
After one year of open access to ethanol, monkeys in the chronic intoxication (CI)
group were killed and necropsied (INIA Cohorts #3, 4, and 5). INIA cohort #2 was
subjected to repeat sustained abstinence or repeated bouts of withdrawal. INIA cohort
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Figure 9. Correlation of blood ethanol concentration (BEC) with ethanol
self-administration in cynomolgus macaques. Blood ethanol concentrations
at 7th hour of self-administration session and corresponding ethanol intake at the
time of sample, taken every 5th day for 12 months of ethanol drinking. Courtesy
of Dr. Kathleen Grant and colleagues, Oregon Health and Science University.
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#2 group self-administered ethanol according to the same protocol as the chronic
intoxication monkey groups, but were given an additional 4 months of open access
followed by 28 days of abstinence; this sequence was repeated two more times, and
then were necropsied at the end of the third abstinence period.
The necropsy procedures were performed by trained staff members at Oregon
Health and Science University according to published protocols (Daunais et al., 2010).
Monkeys were sedated with ketamine (15 mg/kg, i.m.), and hair was removed from the
head, neck, and calves. A catheter was inserted into the saphenous vein and secured to
the skin with tape. A surgical plane of anesthesia was established by slowly injecting
20–35 mg/kg sodium pentobarbital through the i.v. catheter and flushing with an equal
volume of saline. The adequacy of surgical anesthesia was verified by the absence of
the corneal, palpebral, and hindlimb withdrawal reflexes. Oregon Health and Science
University affiliated veterinarian monitored cardiac and respiratory function and blood
pressure closely throughout the procedure. Incisions were made in the scalp along the
sagittal suture from bregma to the third cervical vertebra and perpendicularly along the
coronal suture and occipital ridge. Then the skull was exposed by reflecting the
temporal, frontal, and occipital muscles and by reflecting the muscles along the sagittal
suture and the occipital ridge. The craniotomy was carried out using bone rongeurs after
drilling a hole 1 cm in diameter in the right parietal bone. Once the bone was removed,
the calvaria was removed from the dura mater, and the occipital ridge was removed.
The exposed brain was covered gently with saline-soaked gauze. The animal was
turned onto its back, and sequential incisions were made through the skin from the
clavicle to the pelvis and then through the abdominal and pectoral muscles and
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diaphragm. The ribcage was cut, and the pericardium was opened. The right atrium was
cut to drop blood pressure, and a 16-gauge cannula was inserted into the ascending
aorta and clamped into place. The descending aorta was clamped in the lower thorax.
The animal was perfused over 2 min with 1.5 L of oxygenated artificial cerebrospinal
fluid (ACSF) containing (in mM) NaCl 124, KCl 5, NaH2PO4 3, MgSO4 2, D-glucose 10,
NaHCO3 26, and CaCl2 2 (290–300 mOsm, pH 7.3–7.4, adjusted by 95% O2/5% CO2).
After perfusion, the animal was turned over immediately, and the dura mater was cut at
the posterior extent of the occipital lobes and along the mid-sagittal line and was
reflected. The falx cerebri was removed, the occipital lobes were elevated with a scalpel
handle, and then the tentorium cerebelli was removed. The cervical cord was cut at C3
using a scalpel, and the cranial nerves were dissected bluntly from the brain using the
scalpel’s handle. The brain was removed from the skull in a caudal-to-rostral fashion.
The brainstem was separated using a razor blade by sectioning just rostral to the
pontomedullary junction and by sectioning the cerebellar peduncles. The tissue block
was submerged in a small beaker of oxygenated, low sodium, ice-cold ACSF (in mM)
composed of sucrose 220, KCl 2, NaH2PO4 1.5, MgSO4 1.2,D-glucose 10, NaHCO3
26, and CaCl2 0.2 and was transported to the electrophysiology laboratory. Once the
brainstem was isolated, the remaining brain and tissues of the body were prepared for
additional studies by other investigators. Individual brain sections for the purposes of
the studies performed here at Virginia Commonwealth University were flash frozen
using liquid nitrogen and stored at -80°C until over-night shipment on dry ice.
Administration of Chronic Ethanol and Micro-dissection in Mice: A total of 121
mice (85 males and 36 females representing 43 BXD RI strains along with progenitor
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strains, F2 generation, and positive controls) were initially included in the study BXD
recombinant inbred mice (Figure 2) were obtained from University of Tennessee Health
Science Center (Memphis, Tennessee); C57BL/6J mice (positive controls) obtained
from Jackson Laboratories (Bar Harbor, ME). This study was conducted as the first part
of an overall design, with the second part to be completed using complementary male
and female mice of the corresponding genotypes used in the present study. The
general study design involved typically one mouse per experimental cell (n= 1/genotype/
sex/group). A positive control condition (C57BL/6J male mice) was included in the study
(n = 6-8/group).
An established mouse model for dependence and repeated bouts of alcohol
drinking behavior was utilized for investigating the molecular signatures underling
alcohol consumption (Becker and Lopez, 2004, Lopez and Becker, 2005). Alcohol intake
was measured using a two-bottle choice (15% v/v ethanol vs. water) limited access (2
hr/day) drinking model; baseline intake was determined for each mouse genotype over
a period of six weeks of access. After establishing baseline intake, mice from each
genotype received 4 weekly cycles of chronic intermittent ethanol (CIE) vapor exposure
(EtOH group) or air exposure (CTL group) in inhalation chambers (16 hr/day x 4 days +
72 hr forced abstinence) alternated with weekly test cycles in which ethanol intake was
measured during five consecutive limited access daily drinking sessions. Mice were not
food or water deprived throughout the duration of the study. Ethanol concentrations in
the inhalation chambers were uniformly set for all genotypes to yield blood ethanol
levels in the range of 200-300 mg/dl, using the aldehyde dehydrogenase inhibitor
pyrazole (Griffin et al., 2009). Blood samples were collected from all mice on the 2nd and

81

4th day of each exposure cycle (mean BEC values for each exposure cycle are
presented).

Body weights were recorded weekly for each subject to determine the

amount of alcohol intake per kilogram of body weight. All mice received a fifth-cycle of
CIE exposure cycle and EtOH and CTL groups were sacrificed by decapitation at 72 hr
post removal from inhalation chambers. As part of the INIA collaboration blood and
tissue samples were collected from brain and various organ systems during the same
necropsy sessions. Per our part of the genomics investigation, brain tissue from
prefrontal cortex, nucleus accumbens, and ventral tegmental area was acquired via a
micro-punch dissection and stored as previously described (Kerns et al., 2005). The
analysis herein will focus on data derived from prefrontal cortex; results from additional
brain regions collected shall be presented in future investigations.

Human Alcoholic Brain Tissue: Raw gene expression data was retrieved from the Gene
Expression Omnibus (GEO; GSE29555) for alcoholic and control brain tissue from
frontal cortex, central nucleus of amygdala, and basolateral nucleus of amygdala
(Ponomarev et al., 2012). Expression profiling was processed using the Illumina
HumanHT-12 V3.0 Expression beadchip. Autopsy brain samples were obtained from the
New South Wales Tissue Resource Centre at the University of Sydney. The Centre is
funded in part by the National Institute on Alcohol Abuse and Alcoholism to provide brain
tissue for alcoholism research. Fresh-frozen sections of tissue from the central (CNA)
and basolateral nucleus (BLA) of amygdala, as well as the superior frontal cortex (CTX),
were obtained from 32 cases (17 alcoholics and 15 matched controls; 30 males and 2
females). These regions are important substrates in the reward circuitry that is involved
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in the development of alcohol dependence and alcoholism (Koob and Volkow, 2010).
Cases were matched as closely as possible by age, gender, postmortem interval (PMI),
and brain pH. Diagnoses were confirmed by physician interviews, review of hospital
medical records, questionnaires to next-of-kin, and pathology, radiology, and
neuropsychology reports. Cases were also chosen on the basis that agonal hypoxia did
not appear to have differed significantly from the study group. Moreover, none of the
brains showed evidence of hypoxic encephalopathy; further suggesting that agonal
hypoxia was minimal. We did not accept cases that suffered prolonged agonal states.
Cases with a history of polydrug abuse were excluded. Cases were matched for
smoking history. In addition, cases with concomitant diseases, such as cirrhosis of the
liver, Korsakoff psychosis, or Wernicke or hepatic encephalopathies, were excluded.
The concentration and quality of all RNA samples was determined, and degraded (RNA
integrity number, RIN <4) and/or contaminated RNA samples were excluded from the
analysis. The Diagnostic and Statistical Manual of Mental Disorders-IV diagnosis
assigned to each case was based on a detailed and standardized clinical assessment
summary created by specially trained staff with a background in psychiatry and/or
psychology (Ponomarev et al., 2012).

Sample Processing, Microarray Hybridization and Scanning: Brain tissue for each
sample from individual mouse and monkey subjects was homogenized in STAT-60
reagent (Tel-Test, Friendswood, TX) using a Tekmar homogenizer. Total RNA was
isolated according to the manufacturer’s protocol (http://www.tel-test.com/prod02.htm).
RNA concentration was determined by absorbance at 260 nm, and RNA quality was
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analyzed by agarose gel electrophoresis and 260:280 nm absorbance ratios. Total RNA
derived from each sample was reverse transcribed into double-stranded cDNA using the
One-cycle Targeting and Control Reagent kit (Affymetrix, Santa Clara, CA). Biotinlabeled cRNA was synthesized from cDNA, purified, and fragmented according to
Affymetrix instructions. Individual samples per experiment, treatment, and brain-region
were hybridized to an individual microarray for each of all of the brain-regions studied.
Labeled cRNA non-human primate samples were analyzed on Affymetrix
oligonucleotide microarrays (Rhesus Macaque Genome Array; Affymetrix, Santa Clara,
CA) that contain over 52,000 probe sets to interrogate the known genes in the monkey
genome. Labeled cRNA mouse samples were analyzed on Affymetrix oligonucleotide
microarrays (Mouse Genome Array 430 2.0; Affymetrix, Santa Clara, CA) that contain
over 45,000 probe sets targeting over 34,000 well substantiate mouse genes.
Hybridization and scanning were performed separately for each experiment, and exactly
according to the protocol of the manufacturer and as described previously (Thibault et
al., 2000, Kerns et al., 2005). Arrays were the washed, stained with streptavidinphycoerythrin, and scanned according to standard protocols supplied Affymetrix.

Microarray Data Acquisition and Analysis: Microarray data were initially processed
GeneChip Operating Software (GCOS; Affymetrix). Arrays were normalized to median
total hybridization intensity, target average intensity, equal to 190). Array quality was
assessed by accepting only arrays with a scaling factor of < 3.0 and a 3'-5'-actin ratio of
<2 and by examining chip validity and linearity of intensity values. Arrays passing quality
control measures were subjected to microarray suite version 5.0 (MAS 5.0) to eliminate
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probesets consistently called ‘absent’ across all samples (McClintick and Edenberg,
2006), using the R environment for statistical computing (Team, 2010). Probe-level data
from MAS5.0 filtered datasets were further summarized using robust multi-array
average (RMA) algorithm (Irizarry et al., 2003) and the significance scores algorithm (Sscore) (Zhang et al., 2002). The S-score algorithm compares hybridization signals from
two differing treatment samples (e.g. Control Sample #1 versus Alcohol Sample #1); for
monkey samples controls were averaged to a single factor for calculating the S-score of
each individual probeset. S-scores for mouse samples were calculated using the within
genotype air control sample, but an average of C57BL/6J air controls was used for
calculation of the positive controls group. The relatively low number of replicates (e.g.
only 4 control samples for female cynomolgus macaques) may have limited detection of
more subtle changes in gene expression, particularly of low-abundance genes;
however, the S-score analysis methodology is useful for having limited number of
Affymetrix arrays because the method uses the statistical power of all oligonucleotide
pairs for a given probeset (Zhang et al., 2002). Additionally, the S-score algorithm
provides summary statistic which is normally distributed with a mean = 0 and standard
deviation = 1, with signals correlated to fold-change in gene expression between alcohol
treatment and controls. An S-score of 2.0 corresponds to a p-value = 0.0455, not
corrected for biological variability or multiple comparisons. INIA cohorts #3 and #2
(female and male cynomolgus macaques) were tested separately using the rank-based
permutation method statistical analysis of microarrays (SAM) (Tusher et al., 2001) to
evaluate genes differentially expressed between brain-regions (for female cynomolgus
macaques) and treatment groups. SAM significant genes were further filtered for an
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average S-score of ≥ 1.5 or ≤ -1.5 representing a composite significance of p-value <
0.01, uncorrected for multiple comparisons. All SAM analyses used a false discovery
rate of ≤ 5% to avoid eliminating genes that may be biologically important and could
assist in interpretation of expression patters in multivariate studies. Multivariate and
bioinformatic analyses were conducted on gene lists determined by SAM using The
Institute for Genome Research Multi-experiment Viewer (TMeV) (Saeed et al., 2003,
Saeed et al., 2006). Mouse Affymetrix probesets were annotated using the information
available through the data sharing zone of GeneNetwork (http://www.genenetwork.org/),
current as of November 11, 2011. Monkey Affymetrix probesets were annotated using
information available through Ingenuity Pathway Analysis (http://www.ingenuity.com/),
current as of November 15, 2011.

Bioinformatics Analysis of Microarray Data: Hierarchical (Eisen et al., 1998) or k-means
clustering (Soukas et al., 2000) of gene expression data using TMeV or Cluster 3.0 and
TreeView (Page, 1996, de Hoon et al., 2004). Toppgene Suite (Chen et al., 2009c) and
was used for data exploration of functional classification among gene expression
profiles using gene ontology categories, mouse phenotype data, and public pathway
databases. ToppFun (functional enrichment analysis within the Toppgene Suite)
calculations were set to a 5% false discovery rate, with gene limits of n ≥ 3 and ≤ 300 to
identify representative a priori ontological categories. Primary categories investigated
were those defined by the Gene Ontology Consortium: biological processes, molecular
function, and cellular component (Ashburner et al., 2000). Literature association
analysis of statistically significant genes was investigated using Ingenuity Pathway
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Analysis (http://www.ingenuity.com/), a curated bioinformatic resource for the discovery
of biological interaction among differing genes based on literature association, biological
function, and cell-signaling mechanisms. GeneGo was additionally used to identify
shared literature and pathway relationships among gene products.

Results
Differential Gene Expression Among Brain regions in Female Cynomolgus Macaques
Basal differences in the expression of genes among disparate brain regions may
be a contributing factor to alcohol drinking behavior in human populations. Non-human
primates provide a sensible substitute as an experimental model for studying the
underlying neurobiology of substance abuse. In order to illustrate some of the potential
factors that may influence the predisposition for alcohol drinking behavior, and highlight
individual differences among brain regions within the reference samples, we analyzed
the RMA expression measures for differences among the prefrontal cortex (PFC),
nucleus accumbens (NAC), hippocampus (HPC), and amygdala (AMY) in the female
cynomolgus macaques non-drinking control samples (Figure 10A and 10B). Gene
expression differences were unevenly distributed among the four brain regions with
PFC >> AMY > HPC > NAC (Figure 10C). Relative to the average intensity across the
four brain structures, the PFC exhibited the largest number of differentially expressed
genes with more genes down regulated than up regulated. (Figure 10D) By and large,
functional over-representation analysis suggests differential expression of genes
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Figure 10. Basal gene expression differences among different brain regions in
female cynomolgus macaques. (A) K-means clustergram relative gene expression
showing differential gene expression among prefrontal cortex (PFC), nucleus
accumbens (NAC), hippocampus (HPC), and amygdala (AMY); Red= increased
expression. Green= decreased expression. Black = no change in expression. Figure
amended from Kerns et al. 2005. (B) Expression graphs for clusters presented in 10A,
grey lines show expression for individual genes, pink line indicates mean expression
across all genes for each sample, y-axis corresponds to S-score values and x-axis
corresponds to samples for each brain region. (C) 4-way venn diagram showing overlap
of basal gene expression among the PFC, NAC, HPC, and AMY. (D). Bar graph
showing the number of total probesets up-regulated and down-regulated in their
expression pattern.
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involved in nerve growth factor signaling (PFC), GTPase activity and synaptic vesicles
(NAC), cAMP metabolic process (HPC), and kinase activity (AMY) (Table 1). The
biological processes operating within each brain region may underlie variation in alcohol
drinking behavior. For example, nerve growth factor plasma concentrations are
abnormal in alcohol-dependent patients (Yoon et al., 2006), and has been suggested as
a biomarker for the differing stages of alcohol abuse and dependence (JockersScherubl et al., 2007). Nerve growth factor activity also interacts with chronic alcohol
exposure in rodents (Aloe et al., 1993, Gericke et al., 2006), suggesting variation in
nerve growth factor signaling may influence alcohol-drinking behavior.

Gene Expression in Chronic Alcohol Drinking Female Cynomolgus Macaques
Persistent alterations in the transcriptome as a result of chronic alcohol
consumption may be a key-determining factor in compulsive behavior and alcoholism
(Saito et al., 2004, Worst et al., 2005). SAM analysis, using an FDR correction less than
or equal to 5%, identified shared and discrete gene expression differences between the
PFC, NAC, HPC, and AMY (Figure 11 A&B). All four brain regions demonstrated more
genes were up-regulated than down-regulated, with unequal overall differences showing
the PFC > HPC > NAC > AMY (Figure 11C). A total of 169 probesets (representing ~113
unique genes), differentially regulated by alcohol drinking female cynomolgus
macaques, are in common among the PFC, NAC, HPC, and AMY (Figure 11 A&B). The
overlapping genes are over-represented for kinase signaling, sphingomyelin synthesis
(SGMS2 and SPTLC1), ribosomal components, and mitochondrial function (Table 2).
Abnormal expression of mitochondrial genes and mitochondrial dysfunction actively
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AMY

HPC

NAC

PFC

Category
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
Human Phenotype
Human Phenotype
Human Phenotype
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
Mouse Phenotype
Mouse Phenotype

ID
GO:0048011
GO:0046039
GO:0030427
GO:0016585
GO:0004842
GO:0003713
GO:0019900
HP:0002311
HP:0001251
HP:0001268
GO:0003924
GO:0045664
GO:0016358
GO:0048489
GO:0030424
GO:0030426
GO:0008021
MP:0002207
MP:0002204
MP:0002945
GO:0051020
GO:0015185
GO:0042923
GO:0031402
GO:0007212
GO:0046058
GO:0042136
GO:0005834
GO:0030665
GO:0043197
GO:0003735
GO:0019900
GO:0015108
GO:0003714
GO:0006414
GO:0006415
GO:0043624
GO:0022626
GO:0043197
GO:0044309
GO:0005891
MP:0004753
MP:0001417

Name
nerve growth factor receptor signaling pathway
GTP metabolic process
site of polarized growth
chromatin remodeling complex
ubiquitin-protein ligase activity
transcription coactivator activity
kinase binding
Incoordination
Ataxia
Mental deterioration
GTPase activity
regulation of neuron differentiation
dendrite development
synaptic vesicle transport
axon
growth cone
synaptic vesicle
abnormal long term potentiation
abnormal neurotransmitter level
abnormal inhibitory postsynaptic currents
GTPase binding
L-gamma-aminobutyric acid transmembrane transporter activity
neuropeptide binding
sodium ion binding
dopamine receptor signaling pathway
cAMP metabolic process
neurotransmitter biosynthetic process
heterotrimeric G-protein complex
clathrin coated vesicle membrane
dendritic spine
structural constituent of ribosome
kinase binding
chloride transmembrane transporter activity
transcription corepressor activity
translational elongation
translational termination
cellular protein complex disassembly
cytosolic ribosome
dendritic spine
neuron spine
voltage-gated calcium channel complex
abnormal miniature excitatory postsynaptic currents
decreased exploration in new environment

Table 1. Functional over-representation for brain-region differences in female cynomolgus macaques
P-value % Targeted in Category
4.00E-06
60.71428571
1.28E-03
55.51470588
2.27E-03
63.26530612
4.01E-03
61.61616162
2.00E-06
60.18099548
2.87E-04
56.41025641
1.20E-03
53.53535354
5.65E-03
45.52845528
5.65E-03
44.32624113
5.65E-03
47.8021978
4.20E-05
15.48672566
7.14E-03
12.83018868
9.30E-03
19.1011236
9.30E-03
25.53191489
1.00E-06
15.4676259
4.50E-05
21.27659574
2.88E-04
18.34862385
2.90E-05
19.8757764
5.08E-03
25.3968254
5.36E-03
25.86206897
4.18E-04
11.88811189
9.74E-04
60
1.08E-03
17.77777778
3.18E-03
42.85714286
1.00E-06
43.47826087
2.00E-05
13.60544218
2.40E-05
42.85714286
3.27E-04
21.05263158
1.67E-03
12.63157895
2.11E-03
12.94117647
3.00E-06
26.70807453
1.10E-05
22.22222222
1.28E-04
57.14285714
1.54E-04
23.52941176
1.00E-06
33.06451613
1.00E-06
36.17021277
1.00E-06
30.51948052
1.00E-06
37.5
5.20E-05
29.41176471
5.20E-05
29.41176471
5.30E-05
47.82608696
5.00E-06
43.75
2.10E-05
36.61971831
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Category
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
Human Phenotype
Human Phenotype
Human Phenotype
Human Phenotype
Human Phenotype
Human Phenotype
Human Phenotype
Human Phenotype

ID
GO:0019887
GO:0019207
GO:0016455
GO:0003735
GO:0030551
GO:0006686
GO:0006684
GO:0042775
GO:0042773
GO:0046513
GO:0006119
GO:0005840
GO:0016592
GO:0030426
GO:0030427
GO:0030175
GO:0032983
HP:0000712
HP:0001296
HP:0100852
HP:0003380
HP:0010993
HP:0003546
HP:0002520
HP:0000231

Name
protein kinase regulator activity
kinase regulator activity
RNA polymerase II transcription mediator activity
structural constituent of ribosome
cyclic nucleotide binding
sphingomyelin biosynthetic process
sphingomyelin metabolic process
mitochondrial ATP synthesis coupled electron transport
ATP synthesis coupled electron transport
ceramide biosynthetic process
oxidative phosphorylation
ribosome
mediator complex
growth cone
site of polarized growth
filopodium
kainate selective glutamate receptor complex
Emotional lability
Mood alterations
Abnormal fear/anxiety-related behavior
Decreased number of myelinated fibers
Abnormality of the cerebral subcortex
Exercise intolerance
Abnormal myelination
Thin vermillion border of upper lip

P-value % Targeted in Category
2.24E-03
4.04040404
4.34E-03
3.361344538
1.12E-02
6.896551724
1.24E-02
2.48447205
1.27E-02
6.451612903
2.96E-04
40
2.25E-03
15.38461538
4.62E-03
4.918032787
4.62E-03
4.918032787
5.88E-03
9.523809524
6.25E-03
4.411764706
5.23E-03
2.380952381
1.17E-02
6.451612903
1.37E-02
3.191489362
1.53E-02
3.06122449
2.00E-02
4.87804878
2.10E-02
25
8.63E-04
6.52173913
1.62E-03
5.263157895
4.00E-03
3.846153846
7.54E-03
6.451612903
8.52E-03
6.060606061
1.06E-02
5.405405405
1.13E-02
2.654867257
1.30E-02
33.33333333

Table 2. Functional over-representation for overlapping expression profiles between PFC, HPC, NAC, and AMY in female cynomolgus macques

Figure 11. Microarray analysis of alcohol-responsive gene expression for female
cynomolgus macaques. (A) 4-way venn diagram of alcohol-responsive probesets
among differing brain regions. (B) 4-way venn diagram of alcohol-responsive genes,
based on unique annotated gene symbols, among differing brain regions. (C) Bar graph
for number of probesets up-regulated (black) and down-regulated (white) for each brain
region, clustergrams for each brain region are shown beneath the x-axis; Red=
increased expression. Green= decreased expression. (D) Selected alcohol-responsive
genes overlapping within all four brain regions; prefrontal cortex (PFC), nucleus
accumbens (NAC), hippocampus (HPC), and amygdala (AMY).
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participates in alcohol drinking behavior and neurotoxicity (Li et al., 2002a, Sapag et al.,
2009). The overlapping expression profiles between PFC, HPC, NAC, and AMY may
thus represent system-wide brain targets of chronic alcohol exposure that contribute to
continued drinking behavior. In addition to mitochondrial genes, several potential key
alcohol-responsive targets were differentially expressed in all four-brain structures
(Figure 11D).
The transcription factor CREB1 is significantly down regulated in all four regions,
which is consistent with previous reports of decreases in CREB leading to escalated
alcohol intake (Misra and Pandey, 2003, Pandey et al., 2004). Signaling components
upstream of CREB, such as cAMP-dependent protein kinase (which may include
regulatory subunits such as PRKAR2A), modulates alcohol consumption (Wand et al.,
2001); however, differing PKA subunits show different outcomes on alcohol intake
(Thiele et al., 2000). Decreased expression of CREB1 alongside increased PRKAR2A
expression in drinking non-human primates may suggest compensatory effects within a
signaling pathway. Additional intersecting targets among the differing brain structures
suggest GABAergic (GABRA4) and glutamatergic (GRIK2) processes are important for
heavy alcohol consumption. Variation in the expression GABRA4 will mediates alcohol
intake and preference (Rewal et al., 2009). GRIK2 encodes for an ionotropic glutamate
receptor subunit belonging to the kainate family. The expression of GRIK2 is also
altered in PKCγ knockout mice consuming a chronic alcohol diet (Bowers et al., 2006),
suggesting GRIK2 is an important downstream element of chronic alcohol exposure.
Although these 169 probesets are differentially expressed within all four-brain structures
examined, they also work in concert with brain-region specific differences in gene

93

expression. Brain region specific differences are important for substance abuse and
alcohol-related behavioral phenotypes (Kerns et al., 2005, Melendez et al., 2011).

Amygdala Chronic Alcohol Gene Expression
The amygdala is a critical brain structure in stress, anxiety, and alcohol
dependence (Heilig and Koob, 2007, Tye et al., 2011). As shown in Figure 11A and 11B
~338 genes were differentially regulated by chronic alcohol administration in amygdala.
These genes primarily participate in axonogenesis, construction and organization of
cellular components, and abnormal long-term potentiation (Table 3). Literature
association analysis established connections among gene products surrounding
histones and histone deacetylase (Figure 12A). Histones and histone deacetylases
contribute to chromatin remodeling underlying enduring epigenetic modifications
(Hondele and Ladurner, 2011). Acute and chronic alcohol induces amygdaloid
chromatin plasticity through histone modification (Pandey et al., 2008). Systemic
treatment with a histone deacetylase inhibitor augments the anxiolytic effects of alcohol
and alcohol drinking behavior in rodents (Wolstenholme et al., 2011, Sakharkar et al.,
2012). Epigenetic modifications in mammalian brain underlie transcriptional alterations
in human drug abusers and alcoholics (Zhou et al., 2011). The non-human primate
amygdala network (Figure 12A) indicates a series of gene expression differences with
shared biological function bordering epigenetic targets of chronic alcohol exposure,
suggesting these expression changes are influential in alcohol drinking behavior and
associated behavioral traits such as anxiety.
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HPC

NAC

PFC

AMY

Category
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
Human Phenotype
Human Phenotype
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
Human Phenotype
Human Phenotype
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype

ID
GO:0019207
GO:0019887
GO:0004740
GO:0043624
GO:0050772
GO:0048169
GO:0000118
GO:0045211
HP:0100705
HP:0100852
GO:0016917
GO:0047485
GO:0051020
GO:0016358
GO:0048489
GO:0048169
GO:0019717
GO:0033267
HP:0001251
HP:0002311
GO:0005487
GO:0004725
GO:0050780
GO:0015459
GO:0051967
GO:0051028
GO:0007416
GO:0045471
GO:0014069
GO:0042734
GO:0047485
GO:0017075
GO:0050890
GO:0048489
GO:0007269
GO:0048169
GO:0030665
GO:0008021
GO:0030135
GO:0019717
MP:0002064
MP:0002910
MP:0000950

Name
kinase regulator activity
protein kinase regulator activity
pyruvate dehydrogenase (acetyl-transferring) kinase activity
cellular protein complex disassembly
positive regulation of axonogenesis
regulation of long-term neuronal synaptic plasticity
histone deacetylase complex
postsynaptic membrane
Abnormality of the glia cells
Abnormal fear/anxiety-related behavior
GABA receptor activity
protein N-terminus binding
GTPase binding
dendrite development
synaptic vesicle transport
regulation of long-term neuronal synaptic plasticity
synaptosome
axon part
Ataxia
Incoordination
nucleocytoplasmic transporter activity
protein tyrosine phosphatase activity
dopamine receptor binding
potassium channel regulator activity
negative regulation of synaptic transmission, glutamatergic
mRNA transport
synapse assembly
response to ethanol
postsynaptic density
presynaptic membrane
protein N-terminus binding
syntaxin-1 binding
cognition
synaptic vesicle transport
neurotransmitter secretion
regulation of long-term neuronal synaptic plasticity
clathrin coated vesicle membrane
synaptic vesicle
coated vesicle
synaptosome
seizures
abnormal excitatory postsynaptic currents
abnormal seizure response to pharmacological agent

P-value % Targeted in Category
3.30E-05
8.403361345
2.62E-04
8.080808081
1.65E-03
50
4.88E-03
5.194805195
5.05E-03
9.756097561
1.54E-02
9.677419355
7.32E-03
8.510638298
2.32E-02
4.093567251
4.95E-04
6.818181818
2.04E-03
6.41025641
1.76E-04
27.27272727
1.60E-03
11.45833333
1.86E-03
9.79020979
1.30E-05
15.73033708
9.50E-05
19.14893617
1.95E-04
22.58064516
1.30E-05
12.76595745
7.50E-05
12.12121212
1.87E-03
6.737588652
6.34E-03
6.504065041
5.50E-05
38.46153846
8.40E-05
12.38095238
4.38E-03
30
4.96E-03
15.625
9.90E-05
50
6.95E-04
10.61946903
1.10E-03
13.55932203
2.73E-03
10.84337349
4.28E-04
11.00917431
6.90E-04
14.28571429
4.33E-04
12.5
2.42E-03
26.66666667
4.00E-06
12.90322581
1.40E-05
21.27659574
1.80E-05
14.42307692
1.90E-04
22.58064516
0.00E+00
17.89473684
1.00E-06
15.59633028
2.00E-06
11.46788991
3.00E-06
13.4751773
7.00E-06
10.75268817
4.50E-05
16.4556962
4.66E-04
13.13131313

Table 3. Functional over-representation for alcohol-responsive genes in different brain regions of female cynomolgus macaques

Figure 12. Literature association networks using Ingenuity Pathway Analysis for
alcohol-responsive gene expression in female cynomolgus macaques. (A)
Amygdala network showing the potential for epigenetic modifications. (B) Prefrontal
cortex network related to GABA receptor function. (C) Nucleus accumbens network for
an extended dopamine signaling mechanisms (D) Hippocampus network demonstrated
increased expression of glutamate receptors. Red= increased expression. Green=
decreased expression.
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Prefrontal Cortex Chronic Alcohol Gene Expression
Multivariate analysis of PFC microarrays revealed this brain region had the
greatest overall differences in gene expression due to chronic alcohol administration
(Figure 11A&B). This may suggest relative to the other brain areas examined the PFC is
the most malleable CNS structure subsequent to habitual alcohol intake. At least five
GABA receptor subunits were all up-regulated following chronic alcohol exposure
(Figure 12B). The PFC is one of the most complex brain areas of the mammalian brain
(Abernathy et al., 2010), shows complex regional variation in GABA receptor expression
for alcohol dependence (Grobin et al., 2000). GABRA5 and GABRB3, next to the
previously discussed GABRA4, had the highest changes in expression. GABRA5 and
GABRB3 are part of the chromosome 15 cluster associated with alcoholism during
paternal transmission (Song et al., 2003). However, the network suggests these two
receptor subunits may cooperate with a group of genes altered by chronic alcohol.
Deletion of GABRD subunits does not alter the discriminative stimulus properties of
alcohol (Shannon et al., 2004), but subjected to certain assemblies can be highly
sensitive to low concentrations of alcohol (Glykys et al., 2007). Consistent with other
investigations (Kerns et al., 2005) a number of genes regulated by alcohol within the
PFC are neuronal development or plasticity and synaptic vesicles (Table 3). Some of
these synapse related elements might be involved in alcohol behavioral phenotypes.
For example, alpha-synuclein (SCNA) is differentially expressed and maps to a QTL for
alcohol preference in alcohol-preferring and non-preferring rats (Carr et al., 1998, Liang
et al., 2003). Additionally, genetic variation in alpha-synuclein is associated with craving
in human populations (Foroud et al., 2007). In contrast to microarray studies on
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postmortem alcoholic frontal cortex (Figure 7) (Lewohl et al., 2000) no myelinassociated genes were found to be decreased or regulated in alcoholic female
cynomolgus macaques.

Nucleus Accumbens Chronic Alcohol Gene Expression
The nucleus accumbens is a major component of the mesocorticolimbic reward
pathway (Volkow et al., 2011). Chronic alcohol self-administration regulated the
expression of an extended dopaminergic network with the NAC (Figure 12C). The
dopamine receptor (DRD2) was up regulated and connected to multiple factors within
the alcohol-drinking network. Alcohol and drug addiction phenotypes are significantly
associated with dopaminergic receptors, including DRD2 (Le Foll et al., 2009). The
DRD2 receptor physically interacts with the adenosine receptor (ADORA2A) (Kamiya et
al., 2003), which is associated with functional antagonism (Tozzi et al., 2011). Neurons
within the NAC containing adenosine A2 receptors and dopamine D2 receptors are
hypersensitive to alcohol, synergistically activating downstream signaling cascades
(Mailliard and Diamond, 2004). Inhibition of adenosine A2 receptors with 3,7dimethylpropargylxanthine decreases alcohol consumption (Thorsell et al., 2007),
suggesting increased expression of ADORA2A is directly correlated to increased
alcohol drinking behavior. Expression of the mu (OPRM1) and kappa (OPRK1) –opioid
receptor are increased in alcohol drinkers. Similar to the adenosine A2 receptor,
pharmacological blockade of the mu- and kappa-opioid receptors reduces alcohol intake
(Anton et al., 2008, Walker et al., 2011). Regulator of G-protein signaling 9 (RGS9) is
largely localized to ventral striatum where it indirectly inhibits the mu-opioid receptor
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(Rahman et al., 1999), as well as modulates dopaminergic signaling and behavior
(Rahman et al., 2003). To the best of our knowledge no studies have directly addressed
the role of RGS9 in alcohol drinking behavior; however, increased expression of RGS9
in alcohol consuming cynomolgus macaques suggests it may be a viable target
mediating alcohol-drinking behavior. Genetic deletion of Trpv1 (transient receptor
potential cation channel subfamily V, member 1) in mice, which is decreased in the NAC
of alcohol consuming macaques, increases alcohol consumption and preference
(Blednov and Harris, 2009). The neuropeptide Y receptor (NPY2R) is increased in
expression in response to chronic alcohol administration. Alcohol dependence and
alcohol withdrawal symptoms are significantly associated with sequence variation in
NPY2R (Wetherill et al., 2008). Under voluntary access conditions mice carrying a nullmutation for Npy2r consume less alcohol compared to controls (Thiele et al., 2004),
which might argue increased expression of this NPY receptor may lead to increased
alcohol drinking behavior, as evident in the network analysis of NAC. Collectively,
literature association analysis within the NAC identified a core group of genes with
prominent roles in alcohol drinking behavior that are consistent with directional changes
observed in cynomolgus macaques. This provides experimental evidence of a gene
expression network overseeing alcohol-drinking behavior within a discrete brain region.

Hippocampus Chronic Alcohol Gene Expression
Alcoholism causes long-term changes in hippocampal structure (Sullivan et al.,
1995, Laakso et al., 2000). Deficits in hippocampus function induced by alcohol can
lead to behavioral complications, such as impaired learning and memory (Ryabinin,
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1998). Chronic alcohol self-administration resulted in the increased gene expression for
a host of glutamate receptors (Figure 12D). The largest increased expression was
observed for the obligatory NMDA receptor subunit GRIN1. Chronic alcohol exposure in
rodents also triggers an up-regulation of glutamate receptors in hippocampus (Trevisan
et al., 1994, Snell et al., 1996). Increased abundance of excitatory glutamate receptors
may act as a compensatory mechanism for persistent inhibition of glutamate. However,
the rise of excitatory glutamate receptors within the hippocampus causes a biological
kindling process. This process results in CNS hyper-excitability and seizures during
alcohol withdrawal episodes (Becker, 1998). Over-representation analysis identified
seizures and abnormal post-synaptic currents as consequences of chronic alcohol
regulation of genes confined to the hippocampus (Table 3). Avoidance of negative
withdrawal states related to CNS dysfunction has been suggested to drive the
compulsive use of alcohol and other drugs of abuse (Koob, 2009).
In addition to an up-regulation of glutamate receptors, chronic alcohol selfadministration led to an increase in NRXN1, NCAM1, and NTRK2 expression connected
to the glutamate sub-network (Figure 12D). Neurexin (NRXN1) is involved in the
recruitment of NMDA receptors and other neuronal synapse components in CNS
plasticity (Sudhof, 2008). Sequence variants in NRXN1 and NCAM1 are associated with
alcohol dependence (Yang et al., 2005, Yang et al., 2008). The neurotrophic tyrosine
kinase receptor NTRK2, the cognate receptor for brain-derived neurotrophic factor
(BDNF), is involved in development and maintenance of the nervous system (Lipsky
and Marini, 2007). BDNF plays a prominent role in hippocampal synaptic plasticity (An
et al., 2008). Rodent models of self-administration have shown BDNF mediates alcohol-
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drinking behavior (Hensler et al., 2003, Jeanblanc et al., 2009). Additionally, a
polymorphism in BDNF is associated with treatment outcomes in alcohol dependence
(Wojnar et al., 2009). Elevated BDNF/NTRK2 signaling promotes the interaction of
NTRK2 and NMDA receptors (Wang et al., 2011). NMDA receptor stimulation activates
transcription of BDNF within hippocampal neurons (Tian et al., 2009), suggesting the
interaction of BDNF signaling and a glutamatergic gene network may be important for
alcohol drinking behavior.

Gene Expression in Chronic Alcohol Drinking Male & Female Cynomolgus Macaques
Male cynomolgus macaques were subjected to schedule-induced polydipsia
followed with voluntary self-administration of alcohol with planned bouts of repeated
withdrawal. Microarray analysis of PFC from these non-human primates revealed a total
of 1717 probesets (~1209 unique gene symbols) differentially expressed due to chronic
ethanol exposure (Figure 13A). In contrast to the female cynomolgus macaques there
were more probesets/genes down regulated than up-regulated (Figure 14), with 919
probesets down- and 798 probesets up-regulated in their expression in the males
(Figure 13A). Similar to females, males demonstrated altered GABA receptor subunit
expression; however males and females appear to have a different complement of
GABA receptor subunits (Figure 12B and Figure 13B). Both males and females have
increased GABRA4 and GABRA5 expression, but males have a decreased expression
of GABRA2. Polymorphisms in GABRA2 are associated with alcohol dependence and
endophenotypes related to neural excitability in humans (Edenberg et al., 2004, Lydall
et al., 2011). This particular subunit accounts for approximate 26% of GABA-A receptors
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Figure 13. Alcohol-responsive gene expression in male cynomolgus macaque
prefrontal cortex. (A) Bar graph showing number of alcohol-responsive probesets upregulated (black) and down-regulated (white), and clustergram for alcohol responsive
gene expression; Red= increased expression. Green= decreased expression. Black =
no change in expression. (B) Ingenuity pathway analysis network showing altered
GABA receptor expression. Red= increased expression. Green= decreased expression.
(C) Bar graph showing the top five alcohol-responsive genes up-regulated and downregulated in male cynomolgus macaque PFC.
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Figure 14. Venn diagram for alcohol-responsive gene expression in female and
male cynomolgus macaques PFC. Left column indicates number of probesets altered
by alcohol consumption in PFC, right column indicates number of unique gene symbols.
Pink = Female PFC, Blue = Male PFC. (A) total number of overlapping and nonoverlapping probesets and genes altered by chronic alcohol (B) number of overlapping
and non-overlapping probesets and genes down-regulated by chronic alcohol (C)
number of overlapping and non-overlapping probesets and genes up-regulated by
chronic alcohol.
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in the mammalian brain (McKernan and Whiting, 1996). A genetic knock-in for an
insensitive form of Gabra2 altered alcohol behavioral phenotypes (Blednov et al., 2011),
suggesting decreased expression of GABRA2 in male cynomolgus macaques is
important for increased alcohol drinking behavior.
The BDNF receptor NTRK2 was decreased in females, but increased in
response to chronic alcohol in males. NTRK2 may interact with GABA receptor signaling
through the neuronal assembly protein gephyrin (GPHN) (Figure 13B). Gephyrin
controls the mobility and clustering of GABA receptors to the cell surface of neurons
(Jacob et al., 2005). Increased expression of GPHN may facilitate altered trafficking of
GABA receptors following withdrawal from chronic alcohol (Diaz et al., 2011). Literature
association analysis of gene expression results from male monkeys chronically
consuming alcohol also suggests the cytoskeletal structure is influenced through the
expression of genes involved in ubiquitination (Figure 13B), which is involved in
intracellular trafficking and recycling. Altered expression of ubiquitin genes, such as
decreased expression of USP14 in neuronal tissue, causes motor impairment and
ataxia (Crimmins et al., 2006). Dysregulation of ubiquitin processes may interfere with
neuronal inhibition through altered trafficking of synaptic GABA-A receptors (ArancibiaCarcamo et al., 2009). Thus, interfering with homeostatic expression of a gene network
involving ubiquitin and GABA receptors may influence neuronal signaling and influence
alcohol-drinking behavior.
Previous research conducted in our laboratory has investigated alterations in the
mouse transcriptome due to individual differences in alcohol drinking behavior within a
single inbred strain of mice (Wolstenholme et al., 2011). Gene expression results from
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female and male PFC cynomolgus macaques were overlapped with genes correlated to
alcohol consumption in mice to identify down-stream targets of chronic alcohol
administration (Figure 15). Six genes (CLIC4, STAM2, SLC30A7, SORBS1, PPP2R5C,
and DENR) were identified across species that may serve as critical points of
convergence for alcohol intake. Network analysis suggests these eight genes interact
through common signaling pathways such as PKC, PKA, and Fyn kinase (Figure 15A),
which are involved in various behavioral and molecular aspects of alcohol and other
drugs of abuse (Lee and Messing, 2008).
Cluster analysis illustrated differences and similarities of chronic alcohol induced
expression patterns between male and female cynomolgus macaques (Figure 16A).
Cluster 2 showed increased expression patterns only in females involved in the
regulation of synaptic plasticity (Figure 16A&B). A portion of the genes in cluster 2 are
involved in the regulation of glutamatergic signaling. For example, DLG4 (also known
as post-synaptic density protein 95, PSD95) is a scaffolding protein for NMDA
receptors. Females also showed a unique decreased gene expression pattern in cluster
3, over-represented for DNA binding elements. Interestingly, CREB1 and the
glucocorticoid receptor NR3C1 were decreased in females PFC, but not in male PFC.
Decreased glucocorticoid receptors are consistent with increased brain glucocorticoid
concentrations that are important in the development of alcohol dependence and
neurotoxicity (Rose et al., 2010). There was an inverse relationship between male and
females for not only clusters 2 and 3, but also clusters 4, 5, 6, and 7 suggesting a
diverse set of gene expression patterns driving alcohol consumption in the differing
sexes. However, clusters 8, 9, and 10 showed some commonalities in expression
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Figure 15. Literature association analysis of male & female cynomolgus macaque
PFC overlapping with genes correlating to alcohol intake in mouse PFC. (A)
Extended GeneGo literature association network for six overlapping genes in mice and
monkeys (highlighted with large light blue circles); blue circles = down-regulated
expression in monkeys, red circles = up-regulated expression in monkeys (mouse
correlations derived from two-bottle choice alcohol drinking behavior related to gene
expression in PFC of C57BL/6NCrl mice (Wolstenholme et al., 2011), (B) Bar graph for
average monkey S-scores of overlapping genes from mice and monkeys; pink bars =
Female cynomolgus macaque PFC, blue bars = Male cynomolgus macaque PFC.
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Figure 16. Male and female cynomolgus macaque PFC differential expression and
gene ontology analysis. (A) Heatmap of control and alcohol-responsive expression for
S-scores in male (blue) and female (pink) PFC; Red= increased expression. Green=
decreased expression. Black = no change in expression. Significant gene ontology of
interest are listed to the right of individual clusters (B) Bar graphs for alcohol-responsive
gene expression for individual genes within gene ontology categories for selected kmeans clusters in 16A; pink = female, blue = male, grey dashed line = level of
significant S-score.
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profiles between males and females. Cluster 9 show-increased expressions of genes
involving ion channels and synaptic vesicles (Figure 16 A&B). Contrary to our initial
hypothesis neither males nor females exhibited decreased myelin-associated gene
expression in the PFC in response to chronic alcohol consumption. However, Cluster 8
demonstrates decreased expression of genes involving mitochondrial function and
nicotinamide adenine dinucleotide (NAD) binding, which may be major factors
underlying alcohol drinking behavior and alcohol-induced neurotoxicity (Quintanilla et
al., 2006, Manzo-Avalos and Saavedra-Molina, 2010).
NADH dehydrogenase subunit 4L (NADH4L, Probeset: MMU.6048.1.S1_s_at)
demonstrated the largest relative decrease in gene expression for both female and male
PFC (Figure 11D and Figure 13C). Additionally, NADH4L was also markedly decreased
in female AMY, NAC, and HPC (Figure 11D), making it a viable candidate for follow-up
verification. Two replicated quantitative real-time polymerase chain reaction (Q-rtPCR)
of NADH4L however showed no differences in gene expression for female cynomolgus
macaques PFC (Figure 17A). The Q-rtPCR melt curve product showed two separate
peaks for alcohol drinkers and controls (Figure 17B), suggesting a different product
between the two groups. Principal component analysis (PCA) of the sequencing results
showed a clear separation of alcohol drinkers and controls (Figure 17C). Preliminary
analysis of the sequence differences suggested the NADH4L gene codes for different
protein products between the two experimental groups (Figure 17D). Thus, the
decreased expression results are most likely due to polymorphic differences between
the two groups relative to the design of the microarray probeset for detecting NADH4L.
Combined with the over-representation of mitochondrial genes between alcohol drinkers
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Figure 17. Analysis of NADH4L gene expression and sequencing for female
cynomolgus macaques PFC. (A) Q-rtPCR for non-significant difference in NADH4L
gene expression [t (14) = 1.067, p-value = 0.3041] (B) Melt-curve analysis of Q-rtPCR
results, showing different bands for controls and alcohol drinking monkeys. (C) Principal
component analysis of Q-rtPCR sequencing results indicating polymorphisms between
controls and alcohol-drinking monkeys. (D) Jalview analysis of amino-acid differences
between controls and alcohol-drinking monkeys; overall showing batch differences due
to subspecies differences between cynomolgus macaque groups.
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and controls suggested expression differences might be due to the effect of ancestral or
germline transmission and not solely the result of chronic alcohol exposure. Subsequent
sequencing analysis by our collaborators confirmed our suspicion of differences in the
ancestral origin of controls and alcohol drinkers (Figure 18). Whole genome microarrays
can also be utilized to detect potential problems due to genetic variation within a single
species (Gresham et al., 2008). Pairwise comparison of microarrays for the male
Macaca fascicularis further indicated batch differences, which are likely due to
differences in ancestral origin (Figure 19A); however, pairwise comparison of
microarrays for the male Macaca mulatta revealed no distinguishing differences among
the two groups (Figure 19B). Lack of discernible differences in the male Macaca mulatta
subjects suggests this experimental group may be more suitable for the detection of
differences in chronic alcohol-induced drinking expression. A further advantage of the
rhesus macaques is that they are selected from the pedigreed population at the Oregon
National Primate Research Center. The rhesus macaques also demonstrate a greater
distribution of alcohol consumption compared to the cynomolgus groups (Figure 20),
presenting the opportunity to extend our analysis beyond a two-group analysis and
leverage the variance in gene expression against phenotypic variation for subjects
selected without common grandparents. Using a platform designed against the rhesus
macaque genome, microarrays can accurately assess variation in gene expression
between individuals (Oleksiak et al., 2002).

110

Figure 18. Sequencing confirmation of genetic differences between controls and
alcohol-drinking cynomolgus macaques. Single nucleotide polymorphism analysis
(SNP) showing differences in ancestry for controls and alcohol drinking cynomolgus
macaques; pink indicates control samples (water drinkers). Courtesy of Dr. Kathleen
Grant and colleagues, OregonHealth and Science University.

111

Figure 19. Pairwise comparison of male cynomolgus macaque and rhesus
macaque PFC microarrays. (A) Quality control from pairwise microarray comparisons
for male PFC cynomolgus macaques (Macaca fascicularis) showing batch differences
based on genotype. (B) Quality control from pairwise microarray comparisons for male
PFC rhesus macaques (Macaca mulatta) showing lack of genotype effect ; red = 100
percent correlation.
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Figure 20. Drinking histogram frequencies for each of the three monkey cohorts.
Binned drinking behavior for average g/kg/day intake in (A) female cynomolgus
macaque (n = 12), (B) male cynomolgus macaque (n = 11), and (C) male rhesus
macaque (n = 19).
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Network Analysis of Gene Expression in Rhesus Macaques
Male rhesus macaques ranging from ~5.5 to 10 years of age (the equivalent of
~19-42 years of age in humans) consumed between an average of 0.27 – 4.12 g/kg/day
over a 12 month period. Weighted gene co-expression network analysis (WGCNA) was
conducted for gene expression data from PFC to determine association between the
amount of alcohol consumed and modules of interconnected genes (Langfelder and
Horvath, 2008). Focusing on gene networks, rather than individual genes differentially
regulated due to alcohol, alleviates the multiple testing problems inherent in microarray
data (Zhao et al., 2010b). WGCNA of S-scores derived from rhesus macaques identified
174 modules (gene networks) spanning 30 (lavender) to 1835 (turquoise) probesets in
size (Figure 21). The first principal component of each module, also referred to as the
module eigengene, is a representation of the gene expression profile within a module.
Among the 174 co-expression modules, the module eigengene of 10 differing networks
was significantly correlated (Pearson’s product-moment correlation coefficient, p-value ≤
0.05) to the average daily intake covering twelve months (Figure 22 & 24). Significantly
correlated networks range in size from 31 to 481 probesets (Figure 23). Directionality of
correlations to alcohol intake was evenly split with five networks showing a positive
relationship and five networks showing a decreased relationship. Each of the modules
are involved in differing biological processes (Table 4). The ‘Green’ module, possessing
the greatest number of probesets of any network associated with alcohol drinking, was
over-represented for myelin-associated gene expression. In contrast to the observation
of decreased myelin within the brain tissue of human alcoholics, the myelin-related gene
network was positively correlated to alcohol drinking behavior. Paired with our previous
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Figure 21. Weighted gene co-expression network analysis (WGCNA) for rhesus
macaque PFC. Distribution for the size of 174 modules identified by WGNCA based on
the number of probesets (y-axis), colors correspond to different modules listed on the xaxis; smallest module = 30 probesets (lavender), largest module = 1835 probesets
(turquoise).
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Figure 22. S-scored modules significantly correlated to alcohol drinking behavior
in male rhesus macaque PFC. Heatmap of correlation for the module eigengene for
the 10 modules significantly correlated to average alcohol intake (g/kg/day) for 365 days
of consumption. Red = positive correlation, Green = negative correlation, x-axis =
duration of alcohol drinking exposure, y-axis WGCNA modules from S-score data.
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Figure 23. S-scored modules significantly correlated to alcohol drinking behavior
in male rhesus macaque PFC. (A) Distribution in the number of probesets contained
within PFC modules significantly correlated to alcohol drinking behavior of male rhesus
macaques (B) Representative gene networks for significantly correlated modules,
illustrated networks are based on Pearson correlation coefficients between genes ≥ |
0.70|.
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Salmon2

Category
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
Salmon1
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
Mouse Phenotype
Green
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
Thistle2
GO: Molecular Function
GO: Biological Process
GO: Biological Process
Mediumorchid GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
Human Phenotype
Plum4
GO: Molecular Function
GO: Biological Process
GO: Biological Process
Mouse Phenotype
DarkSeaGreen1 GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
Yellow2
Mouse Phenotype
GO: Biological Process
GO: Biological Process
Mistyrose4
GO: Cellular Component
GO: Molecular Function
GO: Biological Process
Mouse Phenotype
Darkolivegreen2 GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Cellular Component

ID
GO:0004835
GO:0002577
GO:0006221
GO:0006379
GO:0031341
GO:0004955
GO:0003954
GO:0031998
GO:0032228
GO:0016486
MP:0005345
GO:0019911
GO:0004691
GO:0003774
GO:0042552
GO:0048709
GO:0004713
GO:0051983
GO:0043410
GO:0008330
GO:0005246
GO:0004714
GO:0006402
HP:0002721
GO:0004003
GO:0019438
GO:0043954
MP:0005192
GO:0016922
GO:0031669
GO:0016236
GO:0045861
MP:0010948
GO:0090090
GO:0016458
GO:0031227
GO:0008168
GO:0006200
MP:0009937
GO:0004129
GO:0003704
GO:0005979
GO:0014069

Name
P-value % Targeted in Category
tubulin-tyrosine ligase activity
4.87E-03
13.33333333
regulation of antigen processing and presentation 1.50E-04
66.66666667
pyrimidine nucleotide biosynthetic process
5.62E-04
13.04347826
mRNA cleavage
3.73E-03
15.38461538
regulation of cell killing
2.67E-03
7.692307692
prostaglandin receptor activity
1.02E-03
20
NADH dehydrogenase activity
2.01E-02
4.444444444
regulation of fatty acid beta-oxidation
1.49E-03
16.66666667
regulation of synaptic transmission, GABAergic
4.61E-03
9.523809524
peptide hormone processing
5.51E-03
8.695652174
abnormal circulating corticosterone level
2.38E-04
6.557377049
structural constituent of myelin sheath
4.64E-07
80
cAMP-dependent protein kinase activity
6.11E-03
28.57142857
motor activity
3.98E-02
4.225352113
myelination
1.75E-07
15.625
oligodendrocyte differentiation
1.35E-04
13.33333333
protein tyrosine kinase activity
9.51E-03
3.472222222
regulation of chromosome segregation
2.47E-04
21.42857143
positive regulation of MAPK cascade
8.96E-04
4.87804878
protein tyrosine/threonine phosphatase activity
8.26E-04
40
calcium channel regulator activity
9.01E-04
14.28571429
transmembrane receptor protein tyrosine kinase activity
3.56E-03
5.882352941
mRNA catabolic process
2.14E-04
6.451612903
Immunodeficiency
1.57E-02
6.666666667
ATP-dependent DNA helicase activity
6.92E-03
6.451612903
aromatic compound biosynthetic process
7.04E-03
6.666666667
cellular component maintenance
7.04E-03
6.666666667
increased motor neuron number
2.39E-03
12.5
ligand-dependent nuclear receptor binding
3.77E-04
13.33333333
cellular response to nutrient levels
7.34E-04
3.191489362
macroautophagy
9.30E-04
8.333333333
negative regulation of proteolysis
3.11E-03
4.545454545
abnormal double-strand DNA break repair
8.38E-04
13.33333333
negative regulation of canonical Wnt receptor signaling
1.16E-02
pathway
3.773584906
gene silencing
2.52E-02
2.5
intrinsic to endoplasmic reticulum membrane
3.45E-03
2.631578947
methyltransferase activity
1.77E-02
1.098901099
ATP catabolic process
2.67E-02
0.884955752
abnormal neuron differentiation
3.62E-02
0.793650794
cytochrome-c oxidase activity
9.40E-03
6.896551724
specific RNA polymerase II transcription factor activity
1.28E-02
3.125
regulation of glycogen biosynthetic process
1.81E-04
13.63636364
postsynaptic density
1.82E-02
2.727272727

Table 4. Functional over-representation for rhessus macaque PFC modules associated with alcohol drinking behavior

Figure 24. Male rhesus macaque PFC module eigengene correlations to alcohol
intake. Scatter plots for the module eigengene expression (first principal component for
an individual module) based on S-scores from PFC against average daily intake (g/kg/
day) over 12-month period; y-axis = EtOH intake, x-axis = module eigengene based
expression for each separate module listed. Bolded are the associated correlation
coefficients and corresponding p-value.
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expression profiling of mice with differential sensitivity to alcohol (Kerns et al., 2005),
may suggest during acute or short-term alcohol exposure myelin gene expression
influences alcohol behavioral phenotypes.
Substance abuse, as well as other psychiatric diseases, is influenced through the
coordinate regulation of gene expression via microRNAs (Li and van der Vaart, 2011).
MicroRNAs are short ribonucleic acid molecules acting as post-transcriptional elements,
which bind complementary sequences of messenger RNA and influence gene
regulatory networks (Bartel, 2009, Su et al., 2011). Combining the 10 alcohol drinking
associated modules into a single network identified over-represented microRNAs (Table
5) The most abundant microRNA in brain mir-124 (Lagos-Quintana et al., 2002), targets
at least 25 genes in this combined alcohol drinking network (p-value = 0.0001).
Potentially serving as core elements within this network, individual microRNAs target
multiple genes within differing modules (Figure 25). MicroRNA-26B (33 genes, p-value =
0.000042) is an intrinsic factor underlying neural differentiation and neurogenesis (Dill et
al., 2012), which may be important in addiction related plasticity. Susceptibility to
cocaine addiction is regulated through mir-212 (Hollander et al., 2010). The regulation
of cocaine intake involving mir-212 is mediated by dynamic interactions with BDNF and
the transcriptional repressor methyl CpG binding protein 2 (MeCP2) (Im et al., 2010).
MeCP2 is regulated by mir-132 (33 genes, p-value = 0.000042), controlling chromatin
remodeling (Alvarez-Saavedra et al., 2011). Expression of mir-132 is also a necessary
factor for differentiation of dopamine neurons (Yang et al., 2012).
Within the alcohol-drinking combined network (Figure 25) mir-9 and mir-219 were
the top two over-represented microRNAs, p-value < 0.00001 and p-value = 0.000014
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Figure 25. MicroRNA network for rhesus macaque PFC associated alcoholdrinking modules. Cytoscape network for top over-represented microRNAs for the ten
PFC rhesus macaque gene expression networks correlated to alcohol intake.
Connections among microRNAs is based on binding potential, connections among
colored nodes (i.e. genes) are based on Pearson correlation coefficients between genes
≥ |0.70|.
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Category
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
Mouse Phenotype
Mouse Phenotype
MicroRNA
MicroRNA
MicroRNA
MicroRNA
MicroRNA
MicroRNA
MicroRNA
MicroRNA

ID
Name
GO:0019911
structural constituent of myelin sheath
GO:0004714
transmembrane receptor protein tyrosine kinase activity
GO:0015197
peptide transporter activity
GO:0004312
fatty acid synthase activity
GO:0017147
Wnt-protein binding
GO:0022832
voltage-gated channel activity
GO:0007272
ensheathment of neurons
GO:0008366
axon ensheathment
GO:0042552
myelination
GO:0001508
regulation of action potential
MP:0000953
abnormal oligodendrocyte morphology
MP:0003871
abnormal myelin sheath morphology
TAGCTTT,MIR-9:MSigDB
TAGCTTT,MIR-9:MSigDB
GACAATC,MIR-219:MSigDB
GACAATC,MIR-219:MSigDB
hsa-miR-139-5p:TargetScan
hsa-miR-139-5p:TargetScan
hsa-miR-212:TargetScan
hsa-miR-212:TargetScan
hsa-miR-132:TargetScan
hsa-miR-132:TargetScan
TACTTGA,MIR-26B:MSigDB
TACTTGA,MIR-26B:MSigDB
TACTTGA,MIR-26A:MSigDB
TACTTGA,MIR-26A:MSigDB
ATACCTC,MIR-202:MSigDB
ATACCTC,MIR-202:MSigDB

Table 5. Functional over-representation of microRNAs associated with alcohol drinking networks
P-value % Targeted in Category
0.00E+00
100
3.53E-04
17.64705882
4.80E-04
38.46153846
1.56E-03
40
1.71E-03
25
3.94E-03
10.55276382
8.30E-05
19.40298507
8.30E-05
19.40298507
2.16E-04
18.75
6.68E-04
14.5631068
2.00E-05
31.25
8.06E-04
22.5
0.00E+00
14.66666667
1.40E-05
15.67164179
1.90E-05
12.5
4.20E-05
11.66077739
4.20E-05
11.66077739
4.20E-05
11.66077739
4.20E-05
11.66077739
6.40E-05
13.52941176

respectively. Alcohol induces the expression of mir-9, playing a key role in the
behavioral and molecular processes underlying tolerance to alcohol (Pietrzykowski et
al., 2008). Adaptations in the glutamatergic system, such as NMDA receptors,
contributes to alcohol tolerance and the development of alcohol dependence (Krystal et
al., 2003). Inhibition of mir-219 in mouse PFC disrupts NMDA receptor transmission,
disturbing downstream behavioral responses associated with glutamatergic signaling
(Kocerha et al., 2009). Additionally, mir-219 is critical in oligodendrocyte differentiation
and myelination (Dugas et al., 2010), corresponding to the green module, the largest
module within the alcohol-drinking network. Dual regulation of NMDA receptor function
and myelination by mir-219 suggests these two systems may interact in regulating
behavioral response to alcohol and other drugs of abuse. Enrichment for multiple
microRNAs pertinent to neurogenesis, myelin gene expression, and behavioral
responses to substances of abuse suggests the gene expression networks determined
through WGCNA are important intermediate molecular phenotypes underlying alcoholdrinking behavior. The myelin-related network (i.e. the green module) may be
particularly interesting since it demonstrates the most striking correlation between
module membership and alcohol intake for each individual gene (Figure 26).

Conservation of Alcohol-Related Gene Expression Networks Across Species
The known association of decreased myelin in the PFC of alcoholics and
correlation to alcohol intake in rhesus macaques led to the hypothesis that variation in
the expression of a myelin-related gene network may be a substantial factor presiding
over alcohol consumption across species. Issues with inadequate controls for the
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Figure 26. Module membership correlation for rhesus macaque PFC associated
alcohol-drinking modules. Scatter plots for the module membership of individual
genes based on S-scores from PFC against alcohol drinking correlation for individual
genes (gene significance) in each of the ten alcohol drinking modules. y-axis = Pearson
correlation of individual genes to alcohol intake , x-axis = module membership based on
Pearson correlation of individual genes to the module eigengene . Bolded are the
associated correlation coefficients and corresponding p-value.
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cynomolgus macaque cohorts and non-Affymetrix gene expression profiling of human
alcoholic brain tissue available from the Gene Expression Omnibus (GEO) however
necessitated using a probe set expression summarization technique other than the Sscore algorithm. WGCNA of gene expression data using the robust multi-array average
(RMA) algorithm identified eleven networks significantly correlated to alcohol drinking
behavior (Figure 27). Modules ranged between 38 and 582 probesets in size. The red
module was the largest among the eleven identified groups, and demonstrated the
highest correlation to the average daily alcohol intake over 12 months of exposure.
Similar to the largest S-score module, the red RMA module was strongly overrepresented for multiple myelin-related gene ontology categories. A total of 220
probesets were significantly shared between the red RMA module and the green Sscore module (Fisher’s exact test, p-value = 1.42 e-272), suggesting the myelinassociated network is a highly robust module using two different microarray algorithms
for evaluating the correlation structure of genes associated with alcohol drinking
behavior. Additionally, this suggests RMA based expression values are appropriate for
assessing the conservation of myelin-related gene expression network across species.
In order to compare gene expression networks across species, as well as closely
related monkeys, multiple probesets measuring the expression of the same gene needs
to be collapsed into a single representative measurement within each microarray study
(Miller et al., 2011). Ranked gene expression and ranked connectivity for the alcohol
drinking rhesus macaque and BXD recombinant inbred mouse PFC datasets were
compared using four separate collapsing strategies: maximum mean expression (‘Max’),
maximum expression variance (‘Var’), maximum mean expression + maximum
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Figure 27. RMA modules significantly correlated to alcohol drinking behavior in
male rhesus macaque PFC. Right panel shows heatmap of correlation for the module
eigengenes significantly correlated to average alcohol intake (g/kg/day) for 365 days of
consumption. Red = positive correlation, Green = negative correlation, x-axis = duration
of alcohol drinking exposure, y-axis WGCNA modules from RMA data. Left panel shows
the distribution of modules significantly associated with alcohol drinking behavior, based
on the number of probesets within each module. The ‘red’ module was enriched for
gene ontology categories related to myelin-associated gene expression in PFC.
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connectivity (‘kMax’), and maximum expression variance + maximum connectivity
(‘kVar’) (Figure 28). Aggregating the data using the maximum mean expression method
demonstrated the most significant relationship between rhesus macaque PFC and
mouse PFC. The same result was observed when comparing rhesus versus humans,
rhesus versus female cynomolgus, and rhesus versus male cynomolgus, suggesting the
‘Max’ function was the most appropriate method for collapsing the differing microarray
experiments. Ranked expression for each of the independent datasets revealed the
highest correlation coefficient for each of the profiled comparisons (Figure 29). Relative
strength of the overall correlations was dependent upon the microarray platform,
evolutionary distance between species or genus, and sex of the subjects. Human
ranked expression data was also significantly correlated to ranked results from mice
(Pearson’s r-value = 0.5, p-value < 1 e-200).
WGCNA was applied separately within each of the five datasets to identify the
correlation structure of gene expression for well-annotated genes spanning (~6000)
mice, monkeys, and humans (Figure 30). A total of 10 to 21 modules were determined
within each of the five separate studies. Representative modules varied in expression
patterns across individual samples (Figure 31). Comparing mouse, human, male and
female cynomolgus macaques to rhesus macaques determined statistically significant
over-lapping genes among modules (Figure 32). For example, the greenyellow module
in rhesus macaque PFC and the black BXD mouse PFC singled-out 45 common genes
within the two modules, which was the most statistically conserved group between any
of the modules (Fisher’s exact test, p-value = 4.34 e-25). MBP and PLP1 were two of
the characteristic myelin genes shared among the identified 45 common genes. The
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Figure 28. Comparison of methods for collapsing probes to genes across mice
and rhesus macaques. Scatter plots for ranked expression and ranked connectivity of
the PFC RMA expression for BXD RI mice and rhesus macaques using maximum mean
expression (‘Max’), maximum expression variance (‘Var’), maximum mean expression +
maximum connectivity (‘kMax’), and maximum expression variance + maximum
connectivity (‘kVar’).
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Figure 29. Ranked gene expression for maximum mean expression. Scatter plots
for ranked expression using maximum mean expression (‘Max’), comparing rhesus
macaque PFC RMA gene expression (x-axis) to humans (top left panel), mice (top right
panel), female cynomolgus macaque (bottom left panel), and male cynomolgus
macaque (bottom right panel).
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Figure 30. Cross-species weighted gene co-expression PFC dendrograms.
Average linkage hierarchical clustering of gene expression for rhesus macaques, BXD
RI mice, humans, female cynomolgus macaques, and male cynomolgus macaques (top
to bottom), beneath each dendrogram are the identified colored modules based on
correlated expression profiles; width of bars correspond to the number of genes within
the module, grey regions indicated unassigned genes within each species’ dataset.
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Figure 31. Module eigengene expression for collapsed rhesus macaque PFC
dataset. Representative module eigengene (ME) expression for the nineteen modules
identified through weighted gene co-expression network analysis of the collapsed RMA
rhesus macaque PFC dataset; showing variation in relative expression (y-axis) between
individual samples (x-axis / single bars); ME expression is based on the first principal
component of each colored module.
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myelin network was the most robustly conserved across groups: rhesus-human
(Fisher’s exact test, p-value = 2.23 e-40), mouse-human (Fisher’s exact test, p-value =
4.58 e-16), rhesus – female cynomolgus (Fisher’s exact test, p-value = 4.20 e-34), and
rhesus – male cynomolgus (Fisher’s exact test, p-value = 1.34 e--44). Similar to the
gross overall comparison of every gene present within each experiment (Figure 29),
robustness of the myelin module conservation was generally dependent upon
evolutionary distance between species or genus, and sex of subjects. In addition to
conserved correlation structure, myelin-related genes are highly homologous in protein
coding sequence across mice, monkeys, and humans (Figure 33). The major myelinrelated gene PLP1 shows 100% sequence conservation across all three species.
Overlapping all WGCNA results for the myelin-related modules identified 21
genes shared in all five data sets, and 47 genes shared in four out of five data sets.
MBP was present in four of five myelin modules. Network analysis of the non-reduced
datasets showed MBP present within the myelin module, suggesting the MBP gene
should be included for a cross-species network. Over 90% of this conserved gene set is
enriched in oligodendrocytes, the myelin forming cells of the CNS (Cahoy et al., 2008).
All of the genes within the myelin-related modules were positively correlated to one
another, suggesting they may form protein-protein interactions (Ge et al., 2003). Most
importantly, relative expression of individual myelin genes, such as NDRG1, as well as
expression for the myelin-associated gene network significantly correlated to alcohol
drinking behavior in rhesus macaque and BXD RI mice PFC (Figure 34, p-value < 0.01).
Genes within the conserved network were ranked by their average module membership
across all five datasets and correlation to alcohol drinking behavior to highlight some of
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Figure 32. Overlap of weighted gene co-expression modules across species.
Heatmap of fisher’s exact test for significant overlap in the number of genes between
the rhesus macaque WGCNA modules (x-axis) and mouse WGCNA modules (A),
human WGCNA modules (B), female cynomolgus macaque WGCNA modules (C), and
male cynomolgus macaque WGCNA modules (D); numbers correspond to the number
of genes shared between modules, red indicates the –log p-value for fisher’s exact test,
blue circles indicate the significant overlap of myelin-associated gene expression.
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Figure 33. Phylogenetic display of myelin conservation between species.
Phylogenetic profile of myelin protein coding sequence conservation compared to
mouse for twelve representative myelin genes; degree of colored blocks show relative
sequence homology with black indicating 100% homology, and white (or no box)
indicating no homology; arrows point out mice (Mus musculus), rhesus (Macaca
mullata), and humans (Homo sapiens). Myelin is highly conserved across mice,
monkeys, and humans with PLP1 having 100% sequence homology.
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Figure 34. Association of myelin gene expression with alcohol drinking behavior.
Correlation of alcohol intake and myelin-related gene expression within PFC for BXD RI
mice (left side) and rhesus macaque (right side); significant scatter plots are shown for
the within species module (1st row), top 47 myelin-related genes across 4 out of 5 data
sets (2nd row), top 21 myelin-related genes across all 5 datasets (3rd row), and the
individual myelin-related gene Ndrg1 (4th row).
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the most ‘important’ genes. MBP and NDRG1 each ranked within the top-five prioritized
genes. CNTN2, which is a key component of myelin integrity and organization (Savvaki
et al., 2010), also ranked within the top-five priority genes (Figure 35). However, the
expression of all of these genes exists within the confines of a molecular network
(Figure 35). Existing as a molecular network these myelin-associated genes participate
in a shared biological function and are significantly associated to alcohol drinking
behavior across species.

Discussion
Myelin is a vital component of the central nervous system, which facilitates the
efficient transmission of action potentials for neuronal communication. Alcohol abuse
causes a significant decrease in myelin abundance within the frontal cortex of adults
(Mayfield et al., 2002), and successively binge-drinking adolescents (McQueeny et al.,
2009). Abstinence enables the recovery of myelinated membranes from the neurotoxic
influence of chronic alcohol exposure (Ende et al., 2005). Transition to uncontrolled
alcohol drinking behavior is inversely associated with acute behavioral sensitivity to
alcohol (Schuckit, 1994). Expression profiling of mice, known to differ in acute alcohol
sensitivity and long-term alcohol drinking behavior, demonstrated differences in the
coordinate regulation for basal abundance and acute alcohol responsiveness of myelinassociated gene expression (Kerns et al., 2005). Dynamic alterations in the amount of
myelin due to chronic alcohol exposure, abstinence, and acute alcohol responsiveness,
as well as basal variation in myelin gene expression, suggests myelin is a major
constituent underlying CNS plasticity associated with alcoholism. Through a network
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Figure 35. Cross-species myelin gene expression network. (A) Cytoscape network
of myelin-related genes for the frontal cortex with connections among nodes (i.e. genes)
derived from Pearson correlation coefficients between genes ≥ |0.70|; yellow indicates
presence in all five datasets (B) bar plot of top 16 ranked genes within the myelin
network, black indicates the average module membership across all five datasets, white
bars indicated the average correlation coefficient to alcohol intake in BXD RI panel and
rhesus macaques. Data are presented as Mean ± SE.
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approach that uses gene expression as a quantitative trait, our results indicate myelinassociated gene expression is a conserved biological network significantly associated
with variation in alcohol drinking behavior across species.
Inclusion of only four to five non-drinking control subjects for the non-human
primate studies likely limits the detection of gene expression patterns relevant to
individual differences, which may substantially vary between individuals within a single
species (Enard et al., 2002). Sex-differences may significantly influence alcohol drinking
behavior and complications accompanying substance abuse (Ceylan-Isik et al., 2010).
Therefore, considering only brain-region specific differences in female subjects may
also provide an incomplete assessment of gene expression patterns relevant to alcohol
abuse and dependence. As part of the INIA-stress consortium a limited number of
control subjects were utilized to maximize the allocation of resources, as well as ethical
limitations on the number of non-human primates appropriate in biomedical research.
Although important, identifying region-specific expression patterns on alcohol-naïve
subjects that may predispose individuals for an alcohol use disorder was not the
immediate focus of this particular inquiry. The principal objective for characterizing
profiling variation in gene expression among chronically exposed non-human primates,
and additional mammalian models, was to test the hypothesis that myelin-associated
gene expression is intertwined with alcohol intake, and direct future unbiased
hypotheses for understanding the neurobiology of alcohol drinking behavior.
Applying a systems based approach provides a broader perspective of genetic
architecture of neurological diseases (Courtney et al., 2010, Ponomarev et al., 2012).
Gene expression networks serve as molecular signatures driving the manifestation and
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maintenance of complex traits associated with disease (Baudot et al., 2009). Rhesus
macaques are a close phylogenetic relative to humans (Magness et al., 2005), widely
used as a model organism in biomedical and neuroscience research (Carlsson et al.,
2004). Genetic and physiological similarities of non-human primates to humans imparts
a unique animal model for deciphering the origin of multifactorial diseases such as
alcoholism (VandeBerg and Williams-Blangero, 1996). A total of ten gene expression
networks were significantly correlated to the average daily alcohol intake during one
year of voluntary self-administration (Figure 22). These ten gene networks were overrepresented as targets for a common subset of microRNAs important in CNS plasticity
and neurobehavioral dysfunction (Figure 25). Variation in microRNAs, and subsequently
their downstream targets, are suspected factors in the pathogenesis of neuropsychiatric
disorders (Xu et al., 2010) and alcohol dependence (Lewohl et al., 2011). Differences in
the expression of microRNAs were not directly examined; however, our analysis
highlights potential microRNAs associated with alcohol drinking behavior. Additionally,
our analysis provides information regarding the co-expression of specific biological
networks that may serve as key intermediate phenotypes presiding over alcohol
drinking behavior. The largest identified network was enriched for genes localized within
oligodendrocytes and genes involving myelination.
WGCNA defined coherent patterns of gene expression for five separate studies,
comprised of alcohol drinking cohorts from BXD RI mice, rhesus macaques, male and
female cynomolgus macaques, and human alcoholics. Consistent with the high degree
of evolutionary conservation in mammals (Nave, 1994), myelin-related gene expression
was by far the most robust network across each of the independent analyses. In
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addition to alcohol dependence, altered homeostatic expression of myelin-related genes
has been implicated in schizophrenia (Hakak et al., 2001, Katsel et al., 2005), major
depression (Aston et al., 2005), and cocaine abuse (Lehrmann et al., 2003, Bannon et
al., 2005). Dysregulation of myelin-associated gene expression from multiple
neuropsychiatric disorders and substances of abuse may denote a common molecular
substrate in the neurobiology of disease (Thomas, 2006). The heterogeneous nature of
psychiatric illness and addiction nonetheless necessitates defining which behavioral
endophenotypes are associated with coordinate regulation of myelin gene expression.
Variation in myelin-associated gene expression within PFC was significantly
correlated to alcohol drinking behavior in both mice and rhesus macaques. The
correlation does not necessarily infer a causal association with the development of
alcohol dependence; however, it establishes a connection between a conserved
mammalian network of myelin-associated genes and alcohol consumption. In contrast
to human alcoholic brain tissue that shows decreased myelin gene expression (Lewohl
et al., 2000), a two-group analysis (alcohol drinkers versus non-drinkers) of model
organisms failed to identify chronic alcohol-induced changes in myelin gene expression.
Systematic decreases of myelin in alcoholic brain tissue compared to controls may be
related to a longer duration of alcohol exposure than the time-course applied to mice or
monkeys (Sullivan et al., 1995). Alterations in myelin-associated gene expression may
be secondary to the direct effects of alcohol, or may function as a predisposing factor in
the susceptibility of persistent alcohol drinking behavior. To our surprise, rather than
inversely correlated to average alcohol intake as might be advocated by decreased
myelin in the PFC of alcoholics (Lewohl et al., 2000), myelin was positively correlated to
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alcohol drinking behavior in both mice and nonhuman primates. Given the shorter
duration of alcohol exposure than witnessed in humans, a positive correlation may
suggest a higher relative abundance of myelin gene expression is associated with
increased alcohol intake during initial drinking behavior.
Overall, our results support the hypothesis that a myelin-associated gene
network acts as an underlying factor in alcohol behavioral phenotypes. The conserved
expression of myelin-related genes within the frontal cortex and correlation to alcohol
consumption behavior across species provides experimental evidence that mice are an
appropriate animal model for testing future hypotheses regarding the role of myelin
gene expression in acute alcohol sensitivity and long-term drinking behavior.
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CHAPTER 4:
ALCOHOL-RELATED BEHAVIORAL PHENOTYPES
AND VARIATION OF MYELIN GENE EXPRESSION IN PREFRONTAL CORTEX

Introduction
Myelination is a dynamic process accomplished by oligodendrocytes within the
central nervous system (Zuchero and Barres, 2011). Proper formation of the myelin
sheath is essential for the cytoskeleton structure of neuronal axons (Brady et al., 1999),
and downstream behaviors. Improved function of prefrontal cortex (PFC) neurocircuitry
during development occurs with ongoing myelination (Clark et al., 2008). Abnormalities
within the PFC lead to the dysregulation of behaviors associated with addiction
(Goldstein and Volkow, 2011). Variation in gene expression is a contributing factor the
vulnerability of neurobehavioral diseases such as alcoholism (Geschwind, 2003).
Characterizing myelin-associated gene expression in PFC may thus provide novel
insights into the neurobiology of the neurobiology of alcohol-related behaviors and the
susceptibly for an alcohol use disorder.
Marked decreases in protein trafficking and myelin-associated genes are
witnessed in the frontal and motor cortices of alcoholics (Lewohl et al., 2000, Mayfield et
al., 2002). Alterations in gene expression detected within postmortem human brain
samples are not due to confounding aspects involving death (Franz et al., 2005).
Observed decreases in myelin mRNA expression translate to the down regulation of
myelin structural proteins in alcoholic brain tissue (Lewohl et al., 2005). Although myelin
genes are consistently reduced in the frontal cortices of alcoholics, individual variability
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exists within their gene expression profiles (Liu et al., 2004b, Liu et al., 2006). The risk
of developing a substance abuse disorder is influenced by individual differences of
tasks directed by the PFC (Perry et al., 2011). Differences between C57BL/6J and DBA/
2j mice within the PFC for basal and ethanol-responsive increases in myelin-associated
gene expression are suggested to be important determinants of acute alcohol sensitivity
and compulsive drinking behavior (Kerns et al., 2005). Although limited to only two
genetically divergent strains of mice, this latter study provides preliminary evidence that
Individual differences in sensitivity to alcohol or baseline abundance of myelin may
contribute to the long-term effects of alcohol.
Gene expression can serve as a quantitative trait linked with variability to
molecular, anatomical, and behavioral phenotypes (Williams, 2006). Animal models
mimic differing behavioral aspects of human delineations meeting the criterion for a
DSM-IV-R diagnosis of alcohol dependence (Crabbe et al., 2011). Genetic factors
influence the level of behavioral responses to alcohol in humans and animal models
(Foroud and Li, 1999). The initial level of response to alcohol is inversely associated
with the risk of maladaptive alcohol drinking behavior (Schuckit and Smith, 1996,
Schuckit et al., 2006). Large-scale gene expression studies from mouse whole brain
have identified a complex web of genes involved in alcohol drinking behavior (Mulligan
et al., 2006, Tabakoff et al., 2008). Variation gene expressions among discrete brain
regions affect behavioral and molecular differences between two or more strains of mice
(Pavlidis and Noble, 2001). Merging functional genomics data from whole brain
homogenates and separate brain regions with quantitative trait loci (QTL) for behavioral
phenotypes facilitates the identification of candidate genes responsible for complex
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traits (Hitzemann et al., 2004). Selection of the proper brain region for investigation is
challenging given limited resources and inadequate knowledge regarding which brain
region(s) are accountable for alcohol or drug-related behavioral traits. Altered alcoholinduced expression of myelin-associated basic protein (Mobp) within mouse whole brain
resides within a known QTL region on chromosome 9 for alcohol preference, suggesting
Mobp is a candidate gene for alcohol consumption (Weng et al., 2009). Our previous
analysis of mice, monkeys, and humans chronically exposed to alcohol indicated the
expression of Mobp varies along with a network of myelin-associated genes in PFC that
is correlated to alcohol drinking behavior.
Myelin asserts protective effects on axonal integrity and function (Nguyen et al.,
2009). Changes in myelin gene expression leads to blunted neuronal conduction
velocities that cause altered anxiety-like behaviors, reduced prepulse inhibition, deficits
in spatial learning, and working memory impairments (Tanaka et al., 2009). Majority of
drug-induced adaptations in gene expression are short-lived, returning to baseline
between 4-12 hours post drug exposure (Rhodes and Crabbe, 2005). However, drugs of
abuse can lead to sustained aberrations in gene expression which linger long after drug
exposure ceases (Nestler, 2008). The duration of alcohol exposure required for
persistent reductions of myelin-associated gene expression within the PFC of alcoholics
is unknown. Down-regulation of myelin-related gene expression in postmortem brain
tissue contrasts with acute alcohol-induced up-regulation of myelin gene expression in
the PFC of mice. Differential effects of acute and chronic alcohol, as well as basal
differences, on myelin gene expression may be important in alcohol-related behaviors.
We hypothesize that coordinate baseline variation of myelin-associated gene
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expression within the PFC of animals are important determinants in the short and longterm behavioral effects of alcohol. Weighted gene co-expression network analysis
(WGCNA) of two alcohol naïve recombinant inbred reference panels (LXS and BXD)
demonstrates significant correspondence for the expression of a myelin-associated
gene network in PFC across 72 strains of mice. Expression of this myelin network is
largely dissimilar than observed in the NAC and VTA, suggesting a unique myelin gene
expression profile in PFC. Correlation of the PFC myelin gene expression pattern
against a public repository for phenotypes derived from BXD mice revealed that basal
variation of myelin-associated gene expression is associated with multiple behavioral
measures of acute alcohol sensitivity and alcohol drinking behavior. These results
independently reaffirm and extend our previous observations regarding baseline
differences in myelin gene expression between C57BL/6J and DBA/2J mice (Kerns et
al., 2005). Examining single nucleotide polymorphisms (SNPs) of myelin genes in
humans determined no association for myelin genes in alcohol dependence; however,
SNPs within a set of myelin genes demonstrate a clustering pattern for intermediate
phenotypes in alcohol use disorders. Overall, our analysis suggests individual
differences for a myelin-associated gene network is a relevant biological factor
underlying endophenotypes associated with alcohol abuse and dependence.

Materials and Methods
BXD Recombinant Inbred (RI) Mice from a previous study conducted in the laboratory of
Dr. Michael Miles were used as a reference population for prefrontal cortex (PFC),
nucleus accumbens (NAC), and ventral tegmental area (VTA) mRNA expression in
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response to a saline injection across 27-35 RI mice, as well as C57BL/6J and DBA/2J
progenitors. All samples from a total of 468 adult male animals were obtained from
Jackson Laboratory and housed in a standard laboratory environment. An average of 8
males per strain were used to measure anxiety-like behavior in response to restraint
and saline treatment in the light-dark transition model of anxiety. Four hours after
treatment, animals were rapidly sacrificed by cervical dislocation, brains were removed,
chilled in saline for one minute, and micro dissected on ice as previously described by
our laboratory (Kerns et al., 2005). All RNA isolation and subsequent probe generation
and hybridization to microarrays were completed using a supervised randomization
procedure to minimize potential technical batch effects. Affymetrix M430 type 2.0
microarrays were used for hybridization according to the manufacturer’s protocol.
Expression analysis was conducted by estimating the relative abundance of over
45,000 transcripts in the PFC, NAC, and VTA in response to a saline injection using
Robust Multi-array Average (RMA) (Irizarry et al., 2003).
Male mice were obtained at 8-9 weeks of age from the Jackson Laboratory (Bar
Harbor, ME). Animals were treated, behaviorally tested for anxiety-like behavior, and
dissected as described above by member of Dr. Michael Miles’ laboratory. Following an
hour acclimation period to the behavioral room, animals were restrained for 15 minutes,
immediately given an intraperitoneal injection (I.P.) of physiological saline or 1.8 g/kg of
ethanol, and 5 minutes later placed in the light-dark box for a 10-minute session. All
behavioral testing occurred between 10:00 AM and 1:00 PM during the light phase over
a 12-month period beginning August 2005. Four hours after treatment, animals were
rapidly sacrificed by cervical dislocation; brains were removed, cooled and micro-
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dissected as previously described. Prefrontal cortex tissue was isolated by microdissection using a wedge-shaped slice taken from a 4-mm thick brain slice extending
rostrally from the optic chiasm. The wedge was centered on the inter-hemispheric
fissure and extending 2-mm laterally on each side and ventrally to just above the corpus
callosum. This tissue and all other brain regions (including the NAC and VTA) were
dissected in less than 5 minutes per mouse and were immediately frozen in liquid
nitrogen followed by storage at -80 °C prior to RNA isolation. Individual brain regions
were pooled from 3 individual mice of the same strain to generate RNA samples for
hybridizing to an individual microarray. Samples were randomized across all strains and
treatment groups for each stage of data collection.

LXS Recombinant Inbred (RI) Mice from a previous collaborative study with Drs. Beth
Bennett, Chris Downing, and Thomas E. Johnson at the Institute of Behavioral
Genetics, University of Colorado Boulder, were used as a second reference population
of mice. The LXS genetic reference panel of recombinant inbred strains has been
inbred for more than 23 generations (F23). The LXS data set provides gene expression
estimates for basal expression of mRNA from the prefrontal cortex (PFC) of 43 inbred
strains of mice generated by crossing Inbred Long Sleep (ILS) and Inbred Short Sleep
(ISS) mice. All samples are from a total of 376 adult male animals raised in a standard
laboratory vivarium. An average of 8 males per strain were habituated to intraperitoneal
injection (I.P.) of physiological saline for a period of two days. Following habituation, four
animals of each strain were then given I.P. of saline or ethanol (4.1 g/kg). Abiding by
previous protocols in our laboratory animals were rapidly sacrificed by cervical
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dislocation and brains removed, cooled and micro-dissected as described previously
(Kerns et al., 2005). All animal treatments and dissections were conducted by Dr. Chris
Downing and colleagues at the Institute for Behavioral Genetics, between 9:30 AM and
11:30 AM. The PFC was isolated as described above. Individual PFC samples from 3-4
mice, balanced for strain and treatment group, were pooled for a single biological
replicate. All RNA isolation and subsequent cDNA generation and hybridization to
microarrays were done using a supervised randomization procedure to minimize
potential batch effects due to technical artifacts. Unlike the BXD samples, LXS samples
were hybridized to Affymetrix M430A 2.0 arrays according to the manufacturer’s
protocols. Affymetrix 430A 2.0 arrays capture expression of approximately 14,000 wellcharacterized mouse genes. Basal expression measurements were collected using
Robust Multi-array Average (RMA) (Irizarry et al., 2003).

Gene Expression of Chronic Ethanol Inhalation. Global transcriptome expression data
for chronic alcohol treatment across six brain regions, including frontal cortex, was
collected Courtesy of Dr. Susan E. Bergeson at Texas Tech University Health Sciences
Center. Data is available through the Alcohol Research Integrator Data Base, an
interactive repository for microarray data (http://aridb.ttuhsc.edu/cgi-bin/genedb.pl).
Adult male DBA/2J were given a 1.5 g/kg loading dose of ethanol (i.p.) and chronically
exposed to 72 hours of ethanol vapor. Dissected tissue from DBA/2J mice was
immediately frozen in liquid nitrogen and stored at -80 °C. RNA (2µg) was extracted
according to the manufacturer’s protocol using RNA STAT-60TM (Tel-Test, Inc.
Friendswood, TX, USA). The Genisphere Array 350 kit (Hatfield, PA, USA) was used for
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creation of labeled cDNA, hybridized to custom in-house complementary DNA (cDNA)
microarrays printed at the University of Texas (Mulligan et al., 2006, Mulligan et al.,
2008). A total of 13801 probes are present on the array, using SOURCE as a reference
database (http://source.stanford.edu/cgi-bin/source/sourceSearch).

Alcohol-Related Behavioral Differences for C57BL/6J AND DBA/2J Mice. Male C57Bl/6J
(B6) and DBA/2J (D2) mice were obtained from Jackson Laboratory (Bar Harbor, ME)
from 8-9 weeks of age. Animals were treated according to protocols for animal care
established by Virginia Commonwealth University and the National Institute of Health.
Mice were singly housed with ad libitum access to water and standard rodent chow
(catalog #7912; Harlan Teklad, Madison, WI) for a one-week habituation period prior to
testing. Following habituation, B6 and D2 mice were studied for alcohol drinking
behavior using a two-bottle choice protocol similar to those described elsewhere
(Blednov et al., 2003). Mice were given a period of 3 days of two-bottle access to water
tubes in order to acclimate to behavioral testing, establish baseline intake, and prevent
possible neophobia. After 3-days of water baseline, mice were allowed to choose
between water and ethanol. Ethanol containing tubes increased in concentration every
5 days for 3%, 6%, 10%, and 15% (w/v) ethanol. Water and ethanol tubes were
switched every other day to mitigate any potential side biases. Animals were weighed
weekly during cage cleaning to monitor general health and calculate the amount of
ethanol consumed per kilogram of bodyweight.
A separate cohort of mice (house 4 per cages) was assessed for locomotor
activity behavior using an open-field activity chamber (30 cm x 30 cm x 30 cm). Animals
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were placed into the behavioral room and allowed to habituate for a period of one hour
prior to testing. All animals were tested between 8:00 AM and 12:00 PM eastern
standard time. Following habituation animals were given an intraperitoneal injection of
saline or 2 g/kg of ethanol and immediately placed inside the activity chamber. Boxes
are enclosed in a sound attenuating chamber equipped with overhead lighting and
ventilation system, interfaced with Med Associates software (Med Associates Inc., St.
Albans, VT, USA). The software enables automatic measurement of activity using a set
of 16 infrared beam sensors along the X-Y plane. All animals were tested for a total of
10 minutes in the chambers and then returned to their home cage environment.
Between sessions all chambers were cleaned with ammonia and paper towels, then
given 2 to 5 minutes to air dry. At completion of the experiment all animals were
returned to the animal vivarium and monitored for a period of 24 hours.

Statistical Analysis. All data are reported as mean ± standard error of the mean and
analyzed separately using an unpaired t-test, factorial analysis of variance paired with a
Tukey-Kramer post-hoc analysis, or Pearson product-moment correlations. Statistical
analyses were conducted using either the R project for statistical computing (Ihaka and
Gentleman, 1996) or GraphPad Prism (Motulsky, 1999), with a p-value ≤ 0.05
considered statistically significant.

Results
Myelin-associated genes are highly conserved across differing classes of
mammalian species in terms of protein coding sequence and gene co-expression
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networks. Alcohol drinking behavior is significantly correlated to variation in a network of
myelin-associated genes within the PFC of mice and rhesus macaques (Figure 34).
Transitioning from gene expression networks to a phenotypic outcome measure may
essentially be explained by three experimental models: (i) causal association, (ii)
independent association, (iii) and interaction of basal variation with environmental or
drug exposure (Figure 36). First, alcohol-related behavioral traits such as drinking
behavior may be caused by the initial action of alcohol on primary and secondary
targets. These initial targets of alcohol in turn lead to alterations in myelin gene
expression that drives phenotypic behaviors (i.e. alcohol consumption). Secondly, the
variance in myelin-related gene expression and behavioral phenotypes might be
independently acted upon by alcohol. Or lastly, the phenotypic outcome(s) of alcohol
action may be influenced by baseline variation in myelin gene expression, which with
repeated exposure to the neurotoxic effects of alcohol changes in expression over time.

Chronic Alcohol Effects on Myelin Gene Expression.
Adult male DBA/2J mice, which are more acutely sensitive to the effects of
alcohol on myelin gene expression and behavioral traits, were chronically exposed to
alcohol vapor for a period of 72 hours following a 1.5 g/kg (i.p.) loading dose of alcohol.
Gene expression was sampled from frontal cortices for alcohol-exposed animals
immediately post vapor exposure, six-hours post alcohol, twenty-four hours post
alcohol, and air exposed controls. Similar to our previous findings in DBA/2J mice
(Kerns et al., 2005) the relative abundance of myelin gene expression was increased six
hours following alcohol exposure. However, 24 hours post alcohol exposure the
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Figure 36. Model for genotype to phenotype relationship. Transitioning from gene
expression networks to a phenotypic outcome measure may be explained by three
experimental models: (i) causal association, (ii) independent association, (iii) and
interaction of basal variation with environmental or drug exposure causing feedback on
the gene expression network over time.
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expression of myelin-associated genes returns to baseline levels (Figure 37). Transient
increases in myelin-related gene expression may reflect that the expression of myelin
genes is reactive to alcohol exposure and not an enduring CNS adaptation underlying
maladaptive alcohol-drinking behavior.

Basal Variation in Myelin Gene Expression.
C57BL/6J (B6) and DBA/2J (D2) mice are distinct inbred strains of mice that
serve as progenitors for the BXD recombinant inbred panel (Figure 2). B6 mice
voluntarily consume more alcohol ([F (3, 56) = 3.310, p-value = 0.0265]) and are less
sensitive to acute locomotor activating effects of alcohol in comparison to D2 mice ([F
(1,20) = 5.86, p-value = 0.0253]) (Figure 38). These results are consistent with several
previous alcohol behavioral studies in B6 and D2 mice (Phillips et al., 1994, Metten et
al., 1998b); suggesting the phenotypic variance for these two differing inbred strains of
mice is reproducible across different environmental settings. The baseline abundance of
major myelin-associated genes, including Mbp and Plp, is higher in B6 mice compared
to D2 mice within the PFC (Figure 39). Derived from B6 and D2 mice, the BXD
recombinant inbred panels represent a mosaic of background genotypes, each strain
with a differing pattern of gene expression. The PFC of alcohol naïve BXD recombinant
inbred mice also exhibits baseline variation in myelin gene expression, with some stains
having higher and other strains having lower myelin expression than their progenitors
(Figure 39). We hypothesize those differences in baseline levels of myelin-associated
genes within the PFC are a contributing factor to the phenotypic variance inherent in
acute alcohol sensitivity and long-term drinking behavior.
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Figure 37. Time-course of myelin-associated gene expression from DBA/2J mice.
Relative expression of available myelin gene expression for Mbp, Plp1, Mobp, and
Cldn11, following removal from alcohol vapor exposure at 0-hr, 6-hr, and 24-hrs
compared to air exposed (control) group. Data available courtesy of work performed by
Dr. Susan Bergeson through the Alcohol Research Integrator Data Base (http://
aridb.ttuhsc.edu/cgi-bin/genedb.pl).
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Figure 38. Subset of alcohol behavioral phenotypes for C57BL/6J and DBA/2J
mice. (A) Distance traveled in locomotor chamber following 2 g/kg (i.p) alcohol
administrations [F (1,20) = 5.86, p-value = 0.0253], (B) Two-bottle choice alcohol intake
[F (3, 56) = 3.310, p-value = 0.0265], (C) Two-bottle choice alcohol preference [F (3, 56)
= 5.626, p-value = 0.0019], (D) Total fluid intake; * p-value < 0.05.
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Figure 39. Myelin gene expression variation between C57BL/6J and DBA/2J, and
BXD RI mice. Control (saline) relative mRNA expression for the PFC of (A) Myelin
basic protein (B) Proteolipid protein (C) N-myc downstream-regulated gene 1, and (D)
principal component of myelin-associated network; red arrow denotes location of DBA/
2J, blue denotes location of C57BL/6J.
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Network Analysis of Basal Variation in the PFC of Mice.
Weighted gene co-expression network analysis (WGCNA) was applied to mouse
PFC datasets to identify a basal network of coordinately expressed myelin-associated
genes. In addition to the PFC of saline treated BXD mice and progenitors (n = 29),
WGCNA was also used on the PFC of alcohol naïve LXS mice (n = 43). The LXS RI
panel is a completely separate mouse population from BXD mice, derived from inbred
long sleep (ILS) and inbred short sleep (ISS) mice. ILS mice and ISS mice were
selectively bred for maximum differences to the sedative-hypnotic effects of high-dose
alcohol (McClearn and Kakihana, 1981). LXS RI strains of mice demonstrate marked
differences for an assortment of acute alcohol related behaviors influenced by both high
and low-doses of alcohol (DeFries et al., 1989, Erwin et al., 1990). The BXD and LXS
gene expression measurements were collapsed to include only the probesets common
to both datasets (n = 22,626 probesets). WGCNA identified 40 modules for the LXS
basal PFC dataset, and 62 modules for the BXD basal PFC dataset (Figure 40). The
LXS darkorange module (170 probesets) and BXD orangered4 module (104 probesets)
significantly overlapped with one another (Fisher’s exact test, p-value = 2.71 e -21).
Using the biological network gene ontology tool (BiNGO) (Maere et al., 2005), each of
these modules were over-represented for gene ontology categories related to myelin
and ensheathment of neurons (Figure 41). Functional enrichment for genes involved in
myelination firmly shows coordinate basal expression of myelin-associated genes within
the PFC across 72 genetically distinct strains of mice.
Initial expression profiling between B6 and D2 mice indicated differences in basal
abundance for myelin-associated genes were uniquely observed in the PFC (Kerns et
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Figure 40. Weighted gene co-expression network analysis of LXS and BXD PFC.
Network analysis of common probesets between LXS and BXD datasets, showing
distribution in the size of modules for (A) LXS and (B) BXD saline PFC. The darkorange
module in LXS and the orangered4 module in BXD is enriched for myelin gene
expression and significantly overlap between the two PFC basal datasets.
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Figure 41. Functional over-representation analysis of LXS and BXD PFC modules.
Network visualization of the myelin-associated modules using the biological network
gene ontology tool (BiNGO) (Maere et al., 2005), showing enrichment for genes related
to multiple myelin-related categories. Categories are colored based on p-values with
darker orange indicating ‘high’ enrichment’ and white indicating no association.

159

al., 2005), and not in NAC or VTA. A subsequent investigation using WGCNA extended
this myelin observation across the BXD RI panel. Principal component analysis of the
myelin module identified by WGCNA in the PFC across B6, D2, and BXD mice showed
a wide distribution for myelin-related gene expression (Figure 39D). Replicating our
previous results, baseline expression for the PFC myelin gene network had higher
relative expression in B6 mice than detected in D2 mice. The 104 probesets from the
PFC myelin module were collectively compared to gene expression for NAC and VTA
across the BXD RI panel (n = 37). At this time gene expression data for the NAC and
VTA is not available across the LXS RI panel. Principal component analysis of NAC and
VTA for basal expression of the same 104 probesets constituting the myelin gene
network in PFC did not identify any significant association between PFC and NAC or
VTA (Figure 42A). The PFC demonstrated higher average module membership than the
other two brain regions (Figure 42B, [F (2,100) = 360.5, p-value < 0.001]). However, the
average basal expression for these 104 probesets was significantly lower in the PFC
than compared to either the NAC or VTA (Figure 42C, [F (2,741) = 95.63, p-value <
0.001]). Thus, the basal expression of a closely regulated myelin-associated gene
network within PFC is differently expressed and not associated with the same group of
genes in the NAC or VTA across 29 strains of mice.

Myelin Gene Expression Network and Behavioral Phenotypes.
An integrated public repository, known as WebQTL or GeneNetwork, maintains a
large collection of alcohol-related behavioral traits for the BXD recombinant inbred panel
(Chesler et al., 2005) (http://genenetwork.org/webqtl/main.py). The open web resource,
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Figure 42. Brain-region specific differences in the myelin-associated gene
network. (A) Correlation matrix for the BXD myelin module comparing PFC, NAC, and
VTA; Spearman rank correlation are across the top, with Pearson’s correlation across
the bottom, (B) Mean module membership for genes with the PFC myelin module
compared to the NAC and VTA data sets * [F (2, 309) = 45.36, p-value < 0.0001] (C)
Mean relative saline expression for the PFC myelin module compared to the NAC and
VTA datasets * [F (2, 309) = 544.4, p-value < 0.0001]. PFC = prefrontal cortex, NAC =
nucleus accumbens, VTA = ventral tegmental area.
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GeneNetwork, also contains all of the raw gene expression data generated by the
arrays described herein. Correlating alcohol naïve expression data from the PFC of
BXD mice against variance in phenotypic traits will determine if basal variation of a
myelin-related gene network is associated with alcohol behavioral phenotypes. The
basal PFC myelin expression network was pared down to 13 high-priority genes (MBP,
PLP1, CNP, OLIG1, QDPR, MOBP, MAL, NDRG1, UGT8A, RHOG, PDE8A,
PPP1R14A, and ANLN) using the network of myelin-associated genes conserved
across species chronically consuming alcohol. All 13 of these genes are localized to
oligodendrocytes, with several of these genes, such as MBP, PLP1, and NDRG1,
coding for myelin structural proteins. The first principal component of these 13 genes
significantly correlated to 126 phenotypic records within GeneNetwork (Pearson
product-moment correlation, p-value < 0.05). Strikingly, basal variation in gene
expression for the myelin network showed a significant positive correlation to several
studies on alcohol consumption and a negative correlation to studies related to acute
alcohol sensitivity and acute functional tolerance (Table 6). The inverse associations
relative to myelin-related gene expression suggests that basal variation of myelin within
the PFC is a contributing factor in acute alcohol sensitivity and long-term drinking
behavior. Similar results are obtained from basal expression of the 47 myelin-related
genes from the cross-species investigation of PFC (Figure 35) and the 104 probesets
determined by WGCNA of basal expression data across the PFC of BXD, B6, and D2
mice. A total of 12 strains are in common between the BXD mice chronically exposed to
alcohol and acute saline treated animals. Although limited in number, basal variation in
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Table 6. Alcohol behavioral phenotypes associated with myelin gene expression in PFC

Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol

PUBMED IDSAMPLE R N

P-VALUE

response (10% in water po), preference during free choice period for females using two bottle choice [mls 10 % ethanol/mls total fluid]
8651451
0.86
9
1.33E-03
response (10% in water po), ethanol preference ratio using a two bottle choice test [ratio of 10% ethanol/total fluid]
8651451
0.86
9
1.65E-03
response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x
6683363
1 hour measurements)
-0.83
9 in 24-28
4.03E-03
week-old males, first experimental replication (Table 4) [area
response (10% in water po), voluntary consumption ratio using a two bottle choice test [gms ethanol/kg body weight]
8651451
0.83
9
4.05E-03
response (10% in water, po), consumption during free choice period for females using two-bottle choice [gms ethanol/kg body weight/day]
8651451
0.81
9
5.99E-03
response (10% in water, po), preference during 3-week free choice period using two bottle choice test for males [mls 10% ethanol/mls total fluid]
8651451
0.77
9
1.15E-02
response, 2-bottle choice consumption, 2 hour access after cycle 2 of ethanol exposure in vapor chamber, average of 5 days ethanol intake [g/kg/2h]
0.64
10
4.34E-02
response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x
6683363
1 hour measurements)
-0.64
14 in 24-28
1.19E-02
week-old males, all three experiments averaged (not in Table
response (dose route), tolerance measured as the fold-increase to ethanol-induced ataxia [ratio of maximal threshold divided by onset threshold]
8627537
-0.63
22
1.36E-03
response, 2-bottle choice 2 h access consumption, week 4 [log transformed g/kg/2h]
0.62
12
2.99E-02
response (4 g/kg ip), handling-induced convulsion (HIC) score 7 hr after injection
8748968
-0.62
21
2.34E-03
Response, 2-bottle choice consumption, 2h access after cycle 1 of Air exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. Air_T1_Etgkgave.
0.60
11
4.81E-02
response (dose route), tolerance, difference between ethanol induced ataxia (maximal threshold) minus onset threshold
8627537
-0.60
22
2.62E-03
response (10% in water po), acceptance, total consumption over 24 hr for females [g/kg]
7695038
0.59
19
6.57E-03
response, 2-bottle choice 2 h access consumption, week 1 [log transformed g/kg/2h]
0.57
12
4.99E-02
response (3%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access
7978106
period [g/kg/day]
0.57
17
1.65E-02
response (2 mg/kg ip), locomotor tolerance or sensitization in males [difference between activity after fourth ethanol trial and first trial]
7480533
-0.54
18
1.90E-02
response, withdrawal severity, handling-induced convulsion (HIC) score [corrected area under the HIC curve after voluntary ethanol consumption]
7978106
0.54
17
2.49E-02
response (10% in water po), acceptance and consumption of 10% ethanol in 24 hours after 24 hours of water deprivation [g/kg]
7625571
0.53
19
1.70E-02
response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for males [sec]
19958391
0.51
22
1.41E-02
response (2.25 g/kg ip), time on rotarod after saline minus time on rotarod after ethanol for males and females [sec]
19958391
0.49
23
1.68E-02
response (10%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day7978106
24-hr access period
0.49[g/kg/day]
17
4.70E-02
response (dose ip), ethanol-induced ataxia following first of five injections (initial sensitivity), onset threshold [mg/kg]
8627537
0.48
22
2.31E-02
response (2 mg/kg ip), locomotor tolerance or sensitization in males, difference between experimental group (two prior exposures to ethanol) and saline control
7480533
group on fourth
-0.48conditioning
18
day
4.38E-02
[activity counts/min]
response (2 mg/kg ip), locomotion from 1-5 min after injection, conditioning trial 4 in males [activity counts per min]
7480533
-0.47
18
4.84E-02
response (dose route), maximal threshold to ethanol induced ataxia [mg/ml]
8627537
-0.47
22
2.77E-02
response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males and females [sec]
19958391
-0.43
22
4.28E-02

ALCOHOL BEHAVIORAL PHENOTYPE

myelin-associated gene expression is significantly correlated to alcohol intake within the
mouse cohort chronically exposed to alcohol (Pearson’s r = 0.62, p-value = 2.99 e-02).

Myelin Single Nucleotide Polymorphisms and Alcoholism.
Approximately 40% to 60% of the risk for developing an alcohol use disorder is
explained by genetic factors (Schuckit, 2000). In recognition of a genetic basis for
alcoholism the Collaborative Studies on the Genetics of Alcoholism (COGA) was
established to identify specific genes conferring the risk of developing alcohol
dependence (Almasy and Borecki, 1999). In collaboration with Dr. Danielle Dick of
Virginia Commonwealth University, a member of COGA, the basal myelin-related gene
network was assessed for polymorphisms associated with a diagnosis for alcohol
dependence and a subset of alcoholism-affiliated endophenotypes. Similar to previous
genome wide association studies (GWAS) no polymorphisms in myelin genes reached
genome-wide significance (Figure 43). However, using the nominal p-values for the
differing myelin genes as descriptive measure may suggest that genotypic variation in
myelin-associated genes underlie more immediate endophenotypes of alcoholism.
Clustering the descriptive p-values inside a heatmap shows single nucleotide
polymorphisms (SNPs) for a set of myelin genes are grouped according to self-reports
for the maximum number of drinks consumed within a 24-hour period, alcohol craving,
and subjective measures of alcohol withdrawal (Figure 43). Combined with the WGCNA
of basal and chronic alcohol exposure of myelin-associated gene expression may imply
that myelin variation within the PFC is an underlying risk factor for alcohol related
behavioral traits.
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Figure 43. Pilot study on genome wide-association of myelin genes for
endophenotypes of alcohol dependence. K-means clustergrams for nominal p-values
of individual single nucleotide polymorphisms (SNPs) associated with ‘Max Drinks in 24
hours,’ ‘Craving,’ and ‘Withdrawal.’ Listed left to right (ALD4DPDX = DSM-IV Alcohol
Dependence, ALD4DP_SX = DSM-IV Alcohol symptom counts, ASDRB = Conduct
disorder, ASDRC = Anti-Social Personality, ASP_SX = Anti-Social Personality symptom
counts, CD_SX = Conduct disorder symptom counts, CRAVING = Craving, FS_4LOG =
-log factor score of alcohol related variables, ID_SX = Illicit drug symptom counts,
MAX24 = Maximum number of drinks in 24 hours, SU2 = Suicide, WITH_FS =
withdrawal items factor score).
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Discussion
A large degree of biological and environmental heterogeneity exists among
individuals afflicted with a substance abuse disorder (Sturgess et al., 2011). Structural
variation within fronto-striatal brain systems are involved in neurocognitive impairments
associated with addiction to psychoactive stimulants (Ersche et al., 2012). The PFC in
particular, is a major brain area underlying vulnerability for the development of addiction
(Perry et al., 2011). Degradation of white matter in frontal and limbic fibers is detected
consistently within the brains of alcohol dependent subjects (Buhler and Mann, 2011). A
mouse model of chronic alcohol exposures causes transient changes in myelin gene
expression; however, our analysis suggests basal variation of a myelin-associated gene
network is associated with acute behavioral sensitivity and the long-term risk of drinking
behavior in mice.
Sequence variation of myelin genes may be pertinent risk factors entailing
endophenotypes associated with alcohol dependence. Withdrawal and craving are two
endophenotypes that contribute to compulsive drinking behavior and alcoholic
recidivism (Koob, 2003). The quantity of myelin changes during chronic alcohol abuse,
withdrawal, and abstinence (Agartz et al., 2003). In contrast to decreased myelin gene
expression in frontal and motor cortices of alcoholics (Liu et al., 2004b), adult DBA/2J
mice showed an increased relative abundance for myelin gene expression following a
continuous 72-hr exposure to alcohol. Repeated episodes of withdrawal from chronic
alcohol exposure lead to reduced brain volume and neurotoxicity, which may be related
the expression and sensitivity of NDMA receptors (Self et al., 2005, Raeder et al.,
2008). NMDA receptors are expressed in the myelinating processes of oligodendrocytes
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(Karadottir et al., 2005), and may cause damage and eventual loss of the myelin sheath
during disease states (Micu et al., 2006, Burzomato et al., 2010). Pharmacological
antagonists for NMDA receptors facilitate neurocognitive improvements in alcoholdependent patients (Cheon et al., 2008). Symptomatic improvements are also seen with
NMDA receptor antagonists in Wernicke-Korsakoff syndrome (Rustembegovic et al.,
2003), a myelin-related disorder often associated with alcoholism (Harper, 2009). The
lack of reduced myelin gene expression in mice continuously exposed to alcohol may
therefore be related to the absence of intermittent withdrawal and accompanying
neuroadaptations. Increases in myelin gene expression do support our previous findings
on acute ethanol regulation of myelin genes in DBA/2J mouse PFC (Kerns et al., 2005).
The regulation of myelin-associated gene expression may also depend upon genetic
differences in initial sensitivity to alcohol or the complexities of alcohol drinking behavior
in preclinical models (Crabbe et al., 2010b).
Susceptibility for psychiatric disorders is conferred by the complex interaction of
environment influences and multiple genetic variants (Collins et al., 2003). Single
nucleotide polymorphisms in myelin genes did not achieve statistically significance for a
genome-wide association approach. Identifying the genetic variants responsible for
complex traits has shown limited success with few genes achieving genome-wide
significance due to a lack of adequate phenotypes and methodological issues (i.e. poor
sample size) (Bondy, 2011). Complex traits manifest through the additive actions from
multiple genes of small effect size (Plomin et al., 2009). Studying function and structure
distinct brain regions is beginning to elucidate the role of individual genes and groups of
genes in complex traits (Thompson et al., 2010). Dysfunction in PFC dopaminergic
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transmission occurs in drug addiction and schizophrenia (Meyer-Lindenberg et al.,
2002, Luscher and Malenka, 2011). Specific genetic variants for the dopamine
metabolizing enzyme catechol-O-methyltransferase (COMT) are associated abnormal
neuronal transmission in PFC (Meyer-Lindenberg et al., 2006). The volume of gray
matter within discrete brain regions is altered due to the presence of a SNP in the
promoter region of COMT (Honea et al., 2009). COMT is also in epistasis with sequence
variants for other candidate genes implicated in disease processes and regulate
prefrontal cortical GABA function (Nicodemus et al., 2007, Marenco et al., 2010).
Genetic variation of myelin-related genes can lead to CNS demyelination.
Polymorphisms within specific myelin genes are associated with vulnerability to
schizophrenia (Wan et al., 2005, Georgieva et al., 2006, Peirce et al., 2006). The
presence of polymorphisms in myelin genes predicts decreased expression within the
PFC of schizophrenics (Mitkus et al., 2008). Little attention has been directed at SNPs
for myelin-associated genes in the risk of developing an alcohol use disorder. Our
analysis shows variation in expression and sequence of myelin genes may be important
in endophenotypes relevant to alcohol abuse and alcoholism.
Previous examination of gene expression for mice, monkeys, and humans
chronically consuming alcohol revealed a conserved network of myelin-associated
genes across species. Expression profiling across the BXD RI panel of mice chronically
exposed to alcohol vapor with periodic two-bottle choice drinking determined a
correlation between the expression for a network of myelin-associated genes and
alcohol intake. Analyzing a separate cohort of alcohol naïve BXD RI mice indicated the
association between alcohol consumption and myelin is due to genetic variation in the
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basal abundance of myelin gene expression. Genetic differences between mice
contribute to acute alcohol sensitivity (Chesler et al., 2012) and control over alcohol
drinking behavior (Ozburn et al., 2010). Acting as a molecular intermediate, variation
within the expression for a particular gene network may underlie the susceptibility for
disease (Schadt et al., 2005, Schadt, 2009). Genetic factors can influence the overall
abundance and integrity of myelin in different brain regions, which impacts the
neurodevelopment and cognitive function of healthy individuals (Jahanshad et al.,
2012). The etiology of alcoholism and other complex diseases is attributed to the
combination of genetic variants and biological networks (Li et al., 2011). Co-variation in
a conserved myelin gene network alongside alcohol-related behavior implies myelin
gene expression may be a risk factor in the development of alcohol dependence.
Further investigation is needed to ascertain the extent of basal differences in the
myelin gene expression in alcohol behavioral phenotypes, as well as the molecular
components that regulate myelin gene expression. Myelin is tightly regulated by a
number of differing signaling mechanisms and demonstrates substantial plasticity
throughout the lifetime of a vertebrate nervous system (Emery, 2010). Reciprocal
communication between axonal impulse activity and myelin form an intricate CNS
framework controlling cognition and behavior (Lee and Fields, 2009). In spite of
mounting evidence for the role of myelin in psychiatric illness, little information exists
regarding which intermediate phenotypes are directly affected by variation in myelin
gene expression and myelin dysfunction (Takahashi et al., 2011). Probing the molecular
mechanisms governing myelination and the myelin-associated gene network itself will
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further our understanding for the neurobiology of acute and lasting behavioral
phenotypes underlying alcohol abuse and dependence.
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CHAPTER 5:
FYN-DEPENDENT GENE NETWORKS IN ACUTE ALCOHOL SENSITIVITY

Introduction
Acute sensitivity to alcohol is a predictive indicator of the long-term risk of
abusive drinking behavior in humans and animal models (Schuckit, 1994, Metten et al.,
1998b). Fyn kinase, a non-receptor protein tyrosine kinase widely expressed in the
central nervous system, modulates the acute sedative-hypnotic properties of alcohol
(Miyakawa et al., 1997, Yaka et al., 2003b) and in some studies has been shown to
reduce two-bottle choice consumption in rodents (Boehm et al., 2003, Cowen et al.,
2003). A large number of studies suggest that Fyn modulation of NMDA and GABA
receptor function (Kitazawa et al., 1998), particularly in regard to the NR2B subunit of
NMDA receptors, at least partially underlies Fyn modulation of alcohol behavioral traits.
Genetic variation in Fyn kinase is associated with alcohol dependence and alcohol
related phenotypes such as withdrawal and craving behavior in humans (Schumann et
al., 2003), supporting the premise that Fyn modulation of acute alcohol behaviors
contributes to the risk for the development of alcohol dependence.
In addition to acute sensitivity to alcohol, Fyn kinase has also been show to
important in complex aspects of neurodevelopment (Liu et al., 2004a, Chen and
Charness, 2008), myelination (Sperber et al., 2001), and learning and memory (Kojima
et al., 1997). Although gene-targeting strategies, such as those mentioned above for
Fyn have been widely used to study the neurobiology of alcohol and drug abuse
(Crabbe et al., 1994a, Crabbe et al., 2006b), the interpretation of such results is difficult

171

given the multiple system-wide effects of genes such as Fyn and the multivariate nature
of complex diseases such as alcohol use disorders (AUDs). Even ignoring
complications such as developmental compensation in gene-targeted animals, the
deletion of a single gene such as a kinase of widespread action like Fyn, could augment
alcohol behavior by triggering network-wide alterations in the function or expression of
genes downstream of Fyn, in addition to mechanisms related to direct targets of Fyn
phosphorylation.
The mesolimbic dopaminergic reward pathway, encompassing the prefrontal
cortex (PFC), nucleus accumbens (NAC), and ventral tegmental area (VTA), is activated
by acute alcohol and other drugs of abuse (Koob, 1992). Baseline differences or druginduced alterations in gene expression within the mesolimbocortical dopamine pathway
may play an important role in the transition from initial drug exposure to the
development of dependence (Nestler and Aghajanian, 1997, Farris et al., 2010).
Previous research from our laboratory has shown divergent basal and acute alcoholevoked patterns of gene expression within the dopamine reward pathway may
contribute to acute alcohol behavioral sensitivity (Kerns et al., 2005). It is our hypothesis
that altered expression or function of Fyn kinase may produce network level changes in
gene expression within the mesolimbic dopamine pathway. Thus, providing a
mechanism modifying subsequent behavioral responses to alcohol.
Using expression profiling we sought to define Fyn-dependent gene networks
underlying alcohol behavioral traits; with emphasis on alcohol-induced loss of righting
reflex (LORR) due to the reproducible association of Fyn kinase genotype with this
particular behavioral phenotype (Miyakawa et al., 1997, Boehm et al., 2003, Yaka et al.,
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2003b, Boehm et al., 2004b). Expression profiling has been previously used to
determine downstream signaling mechanisms altered by singe gene knockout animals
exposed to acute (Repunte-Canonigo et al., 2010) and chronic alcohol exposure
(Bowers et al., 2006). However, a detailed characterization of alcohol-responsive gene
expression patterns in mice carrying a null mutation for Fyn has yet to be reported.
Given the fundamental role of Fyn kinase in neurodevelopment, receptor function,
behaviors, and mediating numerous signaling cascades, identifying gene expression
patterns in Fyn kinase knockout animals is important for understanding the neurobiology
of Fyn kinase and regulation of acute alcohol sensitivity.
Our expression profiling and bioinformatics results suggest multiple Fyn-related
mechanisms, especially those affecting the expression for a myelin-associated gene
network within the medial PFC, as contributing factors to the sedative-hypnotic
properties of alcohol. Variation in the expression of these Fyn-dependent gene networks
may be critical molecular endophenotypes affecting the initial level of response to acute
alcohol and lasting phenotypes associated with the development of an alcohol use
disorder.

Materials and Methods
Animal micro-dissection and acute alcohol administration. Animals were treated
according to protocols for animal care established by Virginia Commonwealth University
and the National Institute for Health. Adult (requested 8-9 weeks of age at time of their
shipment) male B6129SF2/J and B6;129S7-Fyntm1Sor/J mice from the Jackson
Laboratory were housed 4-5 animals per cage with ad libitum access to water and
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standard rodent chow (Harlan Teklad #7912, Madison, WI, USA). Animals were
observed daily for general health and wellness with bedding (Harlan Sani-chips,
#7090A, Harlan Teklad) changed weekly. All animals were allowed to habituate to the
animal vivarium on a 12-hour light/dark cycle for at least two weeks prior to start of the
experiment.
Mice were administered intraperitoneal (i.p.) injections of saline for 3 days to
habituate animals to the injection process; on day 4 mice received either an injection of
saline or 3 g/kg (20% v/v) of alcohol, a sedative-hypnotic dose (Ponomarev and Crabbe,
2004). Animals were sacrificed by cervical dislocation at a 4-hour time-point. Previous
work in our laboratory has shown the 4-hour time-point captures a spectrum of early,
intermediate and late gene expression responses to alcohol. Mouse brains were then
extracted and chilled for one minute in phosphate buffer saline solution on ice before
micro-dissection. Micro-dissection of individual brain regions was conducted as
previously described (Kerns et al., 2005). Individual brain sections were immediately
frozen using liquid nitrogen, and subsequently stored at -80°C until isolation of total
RNA.
Brain tissue pooled from three mice was homogenized in PureZol Reagent (BioRad Laboratories, Hercules, CA) using a Tekmar homogenizer. Total RNA was isolated
according to standard protocols following the Aurum Total RNA Fatty and Fibrous Tissue
Kit. RNA concentrations were determined by absorbance at 260 nm and RNA quality
was assessed by 260:280 nm absorbance ratios and electrophoretic analysis (Experion;
Bio-Rad Laboratories, Hercules, CA) with RQI values ≥ 8.0. Double-stranded cDNA and
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biotin-labeled cRNA was synthesized according to instructions provided by Affymetrix
protocols.
Microarray hybridization and scanning. Biological replicates (n = 3) from pooled samples
within each treatment group and genotype were hybridized to an individual microarray
for prefrontal cortex (PFC), nucleus accumbens (NAC), and ventral midbrain areas
(VMB) (n = 36 total microarrays). Arrays for a single brain region were processed
together in a single day, using a supervised randomization method to order samples to
minimize potential batch effects. Labeled cRNA samples were analyzed on
oligonucleotide arrays (Affymetrix Mouse Genome 430 2.0 arrays; Affymetrix, Santa
Clara, CA) that contain ~36,000 genes and expressed sequence tags. Hybridization,
washing, staining, and scanning were performed according to the manufacturer’s
protocols (http://www.affymetrix.com/estore/index.jsp).

Microarray data analysis. Microarray data were initially processed using the Gene Chip
Operating Software (GCOS), formerly referred to as Microarray Suite version 5.0.
Arrays were normalized to common median total hybridization intensity values (target
average intensity = 190). Arrays passing quality control were computationally processed
for any potential batch effects (Johnson et al., 2007). Processed microarrays were first
filtered for MAS 5.0 absent and present calls (McClintick and Edenberg, 2006) to
eliminate probesets consistently called “absent’ across all samples, and then subjected
to Significance score (S-score) analysis (Zhang et al., 2002). The S-score algorithm,
developed in Dr. Miles’ laboratory for analyzing Affymetrix arrays was applied to
compare hybridization signals between two arrays from differing treatment samples.
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Resulting S-scores are independent of initial analysis from the MAS 5.0 algorithm, and
has a normal distribution with a mean of 0 and standard deviation of 1, which are
correlated to the fold-change in gene expression. An S-score equaling 2 corresponds to
a p-value = 0.0455, uncorrected for biological variability or multiple comparisons. Sscores were generated using all of the pairwise comparisons between alcohol treated
controls and Fyn kinase knockout mice, as well as basal differences between
genotypes. The average S-score from all individual pairwise comparisons between
subjects was used to represent a single biological replicate and downstream
bioinformatic analyses. Within each brain structure and treatment, S-scores were
divided by the greater of 1 or the group standard deviations from same/same
comparisons to reduce the contribution of biological or technical noise. Our laboratory,
as well as others, has found this method to reduce the contribution of technical variance
across experimental replicates, although at the cost of generating a more conservative
estimate of gene expression (Hughes et al., 2000).
A one-class statistical analysis of microarrays (SAM) was used within each
treatment group and brain region to determine those genes with S-scores significantly
different from zero (Tusher et al., 2001). Differences in alcohol-induced regulation of
gene expression were determined using a two-class SAM within each brain region (i.e.
Fyn KO versus Control). Within each independent SAM analysis S-scores were filtered
for an average ≥ 1.5 or ≤ -1.5 (composite significance, p-value < 0.01) to focus on more
biologically relevant measurements. All SAM analyses were corrected for a median
false-discovery rate (FDR) ≤ 5%. An FDR of 5% was chosen to avoid eliminating genes
that may be biologically important and could assist in the interpretation of functional
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expression profiles for multivariate studies. All significant genes/probesets were
subsequently combined and subjected to k-means clustering procedures (Eisen et al.,
1998) to determine coordinately regulated gene expression patters, and demonstrate
brain-region, treatment, and genotype specific differences in gene expression. The
number of groups for k-means clustering was estimated using principal component
analysis that accounted for ≥ 90% of the total experimental variance.
The inclusion of only three biological replicates likely limited detection of more
subtle expression changes, particularly of low-abundance genes that may be important
for complex psychiatric conditions. The S-score methodology, however, is particularly
useful for studies having limited numbers of Affymetrix microarrays because the
methods uses the statistical power of all of the oligonucleotide pairs for a give gene
(Zhang et al., 2002). Additionally, incorporating a method for decreasing the contribution
of technical or biological noise increases the yield of statistical filtering measures such
as SAM, by decreasing the overall variance within the data set. Such measures are
unlikely to contribute misleading results because the replicated bioinformatic studies
should only detect genes with coherence in their biological function.

Bioinformatics analysis of microarray data. Toppgene Suite (Chen et al., 2009c) and
ErmineJ (Lee et al., 2005a) were used for data exploration of functional classification
among gene expression profiles operating within the limits of gene ontology categories,
mouse phenotype data, signaling pathways, and public empirical databases. Function
enrichment analysis within the Toppgene Suite, referred to as ToppFun, was performed
using a 5% FDR, with gene limits set between 3 and 300 to identify representative a
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priori ontological groups. ErmineJ gene set analysis was implemented for overrepresentation analysis (ORA) using the best scoring gene replicate and a gene score
threshold of 1.5; ErmineJ reported p-values are corrected for the ErmineJ default of a
10% FDR. Literature association analysis of statistically significant genes were also
investigated using Ingenuity Pathway Analysis (http://www.ingenuity.com/), a curated
bioinformatics resource for the discovery of biological interaction among differing genes
based on literature association, biological function, and cell-signaling mechanisms.
Fyn-centric correlation networks were constructed using the intersection of Fyn
kinase knockout data and gene expression correlates for Fyn kinase mRNA abundance
(Pearson’s product moment correlation, p-value ≤ 0.01) across the BXD and LXS
recombinant inbred mouse lines (available at http://genenetwork.org/webqtl/main.py).
Due to the redundant design of Affymetrix microarrays with multiple probesets
representing a single gene, all probesets representing a single gene were considered
for analysis with multiple probesets represented as a single node, but with the removal
of duplicated edges between two genes and self-loops among the same gene.
Visualization of gene correlation networks was rendered in the platform for complex
network analysis and visualization: Cytoscape (http://genenetwork.org/webqtl/main.py)
(Shannon et al., 2003). Resulting Fyn-centric correlation networks were submitted to
GeneMANIA (Mostafavi et al., 2008) to separately assess potential protein and genetic
interactions, cell-signaling pathways, co-expression, co-localization, and protein domain
similarity as well as identify candidate genes no directly identified through our
microarray analysis.
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Results
Literature association, using Ingenuity Pathway Analysis of our previous
microarray data contrasting gene expression profiles for C57BL6/J and DBA/2J mice
pointed to a few selected genes, which may confer basal and alcohol-evoked
differences in the molecular and behavioral responses between strains (Figure 44A). A
subsequent investigation using the Search Tool for the Retrieval of Interacting Genes/
Proteins (STRING) (Szklarczyk et al., 2011) largely corroborated the Ingenuity findings
(Figure 44B). Fyn kinase directly targets the NMDA receptor subunit NR2B (Grin2b)
through NMDA receptor scaffolding proteins (Yaka et al., 2003a). Fyn kinase is
suggested to mediate acute functional tolerance through phosphorylation of the NR2B
subunit (Miyakawa et al., 1997). NMDA receptor signaling events also activate the
transcription factor cAMP response element-element binding protein (Creb1) (Almeida
et al., 2009), regulating downstream effects on gene expression. The transcription factor
CREB1 promotes expression of the major myelin-associated gene myelin basic protein
(Mbp) (Afshari et al., 2001) and other myelin genes such as claudin-11 (Cldn11) (Lui et
al., 2007). Participating within the confines of a molecular network, Fyn kinase may thus
be a key factor controlling myelin-associated gene expression and the short- and longterm consequences of alcohol exposure.

Gene Expression Pattern Changes in Fyn knockout mice
Genome-wide expression profiling across the mesolimbocortical dopamine
pathway of saline or ethanol-treated Fyn null mice was conducted in order to
characterize the molecular mechanisms underlying altered behavioral responses to
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Figure 44. Literature association analysis of myelin gene expression. (A) Ingenuity
Pathway analysis of myelin-associated genes from Kerns et al., 2005 (Cluster 2)
identifying Fyn kinase; blue circle denotes the location of Fyn kinase, blue arrows
denote location of other myelin-related genes not identified by Kerns et al., 2005 (B)
Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) network of myelinassociated genes and Fyn kinase.
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ethanol in this mutant mouse line. Direct or indirect changes in gene expression
resulting from elimination of Fyn were determined through one-class and two-class SAM
analysis of S-scores for either basal or ethanol-responsive gene expression. SAM
results were additionally filtered for absolute expression values greater than or equal to
1.5 to further reduce the potential contribution of technical or biological noise.
Multivariate analysis using k-means clustering identified region specific patterns of gene
expression (Figure 45A); basal and ethanol-treated gene expression across each of the
three brain regions was combined to increase the statistical power of k-means
clustering. As expected from the overall expression distributions (Figure 45B & C), most
clusters showed basal (KO/CTL) differences that were unique to a single or two brain
regions. Several clusters showed possible trends toward differences in ethanol
responses, as well as basal expression changes with the Fyn KO, particularly in the
VMB (see clusters 2, 3, 4, 6, 9, 11 and 12 for VMB). By and large, differences in basal
and ethanol-responsive gene expression were distributed unevenly among the three
brain regions with basal alterations ranging NAC > VMB > PFC (Figure 45B) and
ethanol- response varying in the order of VMB > NAC > PFC (Figure 45C).

Bioinformatics analysis of basal expression changes in Fyn Knockout Mice
In order to assess the potential biological significance of basal expression
differences due to a null mutation for Fyn, we performed a functional overrepresentation analysis for each individual brain-region using the ToppGene Suite webportal (FDR ≤ 0.05, Table 7 Basal Gene Ontology Categories;). Evaluation of functional
changes may be important for determining the role of Fyn within different brain-regions
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Figure 45. Basal and alcohol-responsive gene expression differences between
Fyn knockout mice and controls. (A) K-means clustering analysis of differential gene
expression for S-scores; green = decreased relative expression, red = increased
relative expression, black = no change in expression (Control EtOH = CTL EtOH, KO
EtOH = Fyn Knockout EtOH, KO / CTL = Fyn Knockout Saline / Control Saline). (B)
Venn diagram of overlapping and non-overlapping genes differentially expressed
between saline treated Fyn knockout mice and controls. (C) Venn diagram of
overlapping and non-overlapping genes differentially expressed between acute ethanol
(3 g/kg) treated Fyn knockout mice and controls. (NAC = nucleus accumbens, PFC =
prefrontal cortex, and VMB = ventral midbrain).
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VTA
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NAC

Category
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process

ID
GO:0008022
GO:0019911
GO:0005158
GO:0022843
GO:0007612
GO:0050890
GO:0001508
GO:0007611
GO:0019228
GO:0001505
GO:0071375
GO:0035254
GO:0019900
GO:0019901
GO:0008022
GO:0019911
GO:0005250
GO:0022843
GO:0005516
GO:0017124
GO:0003924
GO:0017075
GO:0005057
GO:0005249
GO:0015271
GO:0015276
GO:0022834
GO:0015631
GO:0048167
GO:0050804
GO:0051969
GO:0031644
GO:0006813
GO:0048169
GO:0007215
GO:0018107
GO:0032886
GO:0031111
GO:0001505
GO:0031644
GO:0071845
GO:0022411
GO:0051969

Name
protein C-terminus binding
structural constituent of myelin sheath
insulin receptor binding
voltage-gated cation channel activity
learning
cognition
regulation of action potential
learning or memory
regulation of action potential in neuron
regulation of neurotransmitter levels
cellular response to peptide hormone stimulus
glutamate receptor binding
kinase binding
protein kinase binding
protein C-terminus binding
structural constituent of myelin sheath
A-type (transient outward) potassium channel activity
voltage-gated cation channel activity
calmodulin binding
SH3 domain binding
GTPase activity
syntaxin-1 binding
receptor signaling protein activity
voltage-gated potassium channel activity
outward rectifier potassium channel activity
ligand-gated ion channel activity
ligand-gated channel activity
tubulin binding
regulation of synaptic plasticity
regulation of synaptic transmission
regulation of transmission of nerve impulse
regulation of neurological system process
potassium ion transport
regulation of long-term neuronal synaptic plasticity
glutamate signaling pathway
peptidyl-threonine phosphorylation
regulation of microtubule-based process
negative regulation of microtubule polymerization or depolymerization
regulation of neurotransmitter levels
regulation of neurological system process
cellular component disassembly at cellular level
cellular component disassembly
regulation of transmission of nerve impulse

Table 7. Functional over-representation for Fyn knockout mice basal gene expression
P-value % Targeted in Category
1.90E-05
18.27956989
1.90E-05
100
1.90E-05
33.33333333
4.60E-02
18
7.79E-03
26.92307692
2.57E-02
19.35483871
2.57E-02
22.33009709
2.63E-02
19.44444444
2.63E-02
23.52941176
2.63E-02
19.56521739
4.65E-02
15.85365854
1.25E-04
31.03448276
1.25E-04
9.427609428
1.25E-04
9.881422925
1.25E-04
10.75268817
1.25E-04
80
1.25E-04
100
1.25E-04
10.66666667
1.25E-04
10.66666667
1.25E-04
11.47540984
1.25E-04
8.849557522
1.25E-04
33.33333333
1.25E-04
11.40350877
1.26E-04
12.12121212
1.42E-04
44.44444444
1.52E-04
10.60606061
1.52E-04
10.60606061
4.97E-02
10.60606061
7.42E-04
18.60465116
4.29E-03
11.95652174
7.44E-03
11.16751269
7.44E-03
10.69767442
7.44E-03
11.35135135
2.87E-02
25.80645161
3.85E-02
24.24242424
3.85E-02
23.52941176
3.85E-02
16.17647059
3.85E-02
26.92307692
3.85E-02
11.5942029
6.77E-03
13.48837209
1.61E-02
12.24489796
1.61E-02
12.04819277
3.50E-02
12.69035533

and subsequent phenotypic impact of a Fyn null mutation. Although some categories
are certainly redundant, the overall number of differentially expressed genes for each
brain-region was disproportionate to the number of significant functional groups. PFC
had the smallest change in total number of genes among the three brain structures, but
this region also showed the largest number of significant functional categories.
The medial PFC has important modulatory effects on the dopaminergic reward
system through glutamatergic feedback to the nucleus accumbens and ventral midbrain
(Sesack and Pickel, 1992). Functional over-representation analysis implicated
glutamate receptor binding (GO:0035254; p-value = 0.000125) and glutamate signaling
pathway (GO:0007215 p-value = 0.038472), with a decrease in the NMDA receptor
obligatory subunit Grin1 and increase in Grin2b expression. Other genes in these
functional groups that showed basal expression differences in the Fyn KO, included
Dlg4 (Psd-95) and Homer1, which both showed decreased expression in the null mice.
Basal variation in this system within PFC is important due to prior evidence of ethanolmediated long-term facilitation of glutamate receptors containing the NR2B (Grin2b)
subunit, which is phosphorylated by Fyn kinase in a brain region specific manner (Wang
et al., 2007). In addition to Fyn kinase, H-ras and Src can also regulated glutamatergic
receptors function in response to alcohol (Suvarna et al., 2005). Fyn null mice exhibited
increases in basal transcript abundance of Hras and Src, suggesting a compensatory
response to loss of Fyn activity. Hras and Src were contained in multiple overrepresented ontological categories including regulation of synaptic plasticity (GO:
0048167, p-value = 0.000742) and regulation of synaptic transmission (GO:0050804, pvalue = 0.004285). NMDA subunit receptor composition is altered following exposure to

184

ethanol with a relative increase in the NR2B subunit within the membrane. This
functional change in receptor subunit composition is due to H-Ras activation and
inhibition of Src kinase (Suvarna et al., 2005).
Clusters 7 and 8 (Figure 45A) showed strong inverse relationships in basal gene
expression within NAC. Although the NAC is important in the neurobiology of addiction,
it also has a recognized role in learning and memory (Setlow, 1997). Gene ontology
analysis of NAC showed a broad range of categories centered on the abnormal
expression of genes in Fyn knockout mice involving neuronal transmission and
biological processes related to learned behavior (Table 7). In support of these findings,
Fyn knockout mice have been previously reported to exhibit abnormal spatial learning
(Grant et al., 1992) and hyper-responsiveness to fear inducing stimuli (Miyakawa et al.,
1994). Our expression results suggest that Fyn-regulated gene expression in the NAC
may contribute to observed learning and memory differences exhibited by Fyn kinase
knockout animals.
Tissue from the ventral midbrain (VMB), encompassing the ventral tegmental
area, had several clusters differentially expressed between knockouts and controls (see
Clusters 4, 7, 8, and 12). The overall functional impact of these expression patterns as a
whole for VMB was less obvious compared to PFC and NAC with ontologies related to
altered nervous system function (Table 7. GO: 0031644 & GO:0051969) and the
breakdown of cellular components (Table 7. GO: 0071845, GO:0022411). Expression
profile of genes altered in the knockout mouse within VMB is possibly consistent with
the known role of Fyn kinase in neurodevelopment (Chen and Charness, 2008).
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Myelin-Associated Gene Expression
In agreement with previously published research (Umemori et al., 1994, Goto et
al., 2004), our analysis detected a significant decrease of myelin-associated gene
expression in Fyn kinase knockout mice. The 74 genes with altered basal expression
across all three brain regions (Figure 45B) were over-represents for members of
‘structural constituent of the myelin sheath (GO: 0019911; p-value = 0.000105
uncorrected for multiple comparisons). Unfortunately, this ontological category is limited
by the inclusion of only 5 reference genes (Mal, Mbp, Plp1, Tspan2, and Mobp), only 2
of which (Mbp and Plp1) were determined to have decreased expression in the
knockout mice. To perform a more comprehensive gene ontology analysis for genes
involved in myelination we used ErmineJ (Lee et al., 2005a) to test functional overrepresentation for a dozen myelin-associated genes based on their absolute expression
within each individual brain region (Figure 46 A&C, FDR ≤ 10%). As shown in Figure
46C, the NAC and PFC but not the VMB was significantly over-represented for a
decrease in myelin-related gene expression. Literature-association analysis (Figure
46B) further showed the functional relationship between Fyn kinase and myelin, as well
as other interesting genes such as prodynorphin (Pdyn) and myelin basic protein
expression factor 2 (Myef2). Both Pdyn and Myef2 both reside within the Lore2
quantitative trait loci (QTL) for alcohol-induced loss of righting reflex (Ehringer et al.,
2001). Decreased myelin gene expression results suggest that a hypomyelination
phenotype for Fyn knockout animals may be important for the interpretation of alcohol
behavioral phenotypes. As previously mentioned, our previous transcriptome study on
B6 and D2 mice also identified divergent basal levels of myelin-associated gene
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Figure 46. Over Representation Analysis (ORA) of Myelin-Associated Gene
Expression. (A) ErmineJ heatmap of NAC gene expression showing a coherent
decrease for myelin-related basal gene expression in Fyn knockouts compared to
control. (B) Ingenuity Pathway Analysis (IPA) of myelin-related genes and literature
associations; numbers shown are mean S-score of three biological replicates. (C) Table
of ErmineJ corrected p-values (10% FDR) for myelin gene expression in NAC, PFC,
and VMB.
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expression in PFC as an important determinant for alcohol behavioral phenotypes
(Kerns et al., 2005).

Alcohol-Responsive Gene Expression
In addition to alterations in the baseline abundance of gene expression, differences in
alcohol-induced signaling events may contribute to differences the short- and long-term
consequences of alcohol. Using gene expression as a surrogate measure of signaling
mechanisms evoked by acute alcohol, we conducted whole-genome microarray
analysis of NAC, PFC, and VMB from knockout and control animals 4-hours post an
acute alcohol injection (Figure 45A). Preliminary studies from our laboratory showed a
4-hour time-point captures a range of early, intermediate, and late gene expression
responses to alcohol. A 3 g/kg (i.p.) dose of acute alcohol was chosen for our studies on
Fyn kinase knockout mice, attempting to minimize potential oxidative-stress reactions
that may occur during high-dose alcohol exposure (Figure 45A, Cluster 3). A 3 g/kg (i.p.)
dose of alcohol has been previously used in regards to behavioral genetics for alcoholinduced sedative-hypnotic effects (Ponomarev and Crabbe, 2004),
Global changes in gene expression due to acute alcohol administration were
captured for each individual brain structure using a one-class SAM analysis and
included alongside basal differences for k-means clustering (Figure 45A). Differences in
alcohol-responsive gene expression were determined using a two-class SAM analysis
within each brain region (Figure 45 A&C). Unlike our previous studies comparing B6 and
D2 mice, region specific alcohol patterns were difficult to discern visually from k-means
clustering. The lack in obvious alcohol-induced gene expression profiles may be due to
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the large number genes of altered by acute 3 g/kg of alcohol on this particular genetic
background and predominant differences in overall basal abundance (Figure 45B).
Subsequently, we further analyzed these resulting acute ethanol expression differences
for separate brain areas using a multivariate bioinformatics approach described in
Materials and Methods. Surprisingly, unlike our analysis for ORA of basal differences
(Table 7) gene ontology analysis at a 5% FDR yielded few significant groups related to
gene function. This may suggest that basal variation of system-wide changes in
expression (i.e. glutamate receptor function and myelin-associated gene expression) is
a stronger predictor of acute ethanol sensitivity in the Fyn kinase knockout mouse.
Alternatively, it may suggest that our use of a 5 % FDR is overly conservative in
determining ontological groups related to gene function following a transient event such
as with a single ethanol exposure on this specific genetic background. Literature
association analysis using curated resources from Ingenuity Pathway Analysis and
GeneGo were examined for more a detailed account of potential signaling mechanisms
represented by differences in ethanol-responsive gene expression between knockout
and control animals.
Examination of alcohol-responsive networks in the NAC depicts a set of
functionally related genes regulated by acute alcohol, which are essentially blocked in
their mRNA expression for mice carrying a Fyn null mutation. Members of this NAC
network are involved in the phosphoinositide 3-kinase (PI3K)/AKT and phosphatase and
tensin homolog (PTEN) signaling pathway. Acute alcohol causes a coordinate activation
of the AKT signaling within the NAC. Inhibition of AKT signaling events within the ventral
striatum attenuates operant self-administration and binge drinking of alcohol (Neasta et
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Figure 47. Alcohol-Responsive Fyn Gene Network Differences. Ingenuity Pathway
Analysis from two-class SAM analysis for differences in ethanol-responsive gene
expression for the Nucleus Accumbens (A), Prefrontal Cortex (B), and Ventral Midbrain
(C). Qualitative differences in overall gene expression are shown using the cumulative
absolute S-scores for Nucleus Accumbens (D), Prefrontal Cortex (E), and Ventral
Midbrain(F). Genes labeled in green are down-regulated by acute ethanol; Red labeled
genes are up-regulated by acute ethanol. Numbers shown are the mean S-score for 3
biological replicates.
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al., 2011). These published observations and our microarray results suggest that this
Akt/Pi3k/Pten network may both function in mediating basal alcohol seeking behavior
and Fyn-dependent neuroadaptations in response to an initial alcohol exposure for the
nucleus accumbens.
Molecular alterations within alcohol sensitive strains of mice, such as Fyndependent mice, may provide mechanistic information regarding acute alcohol sensitive
behaviors. Although these changes may only occur within the context of a null or loss of
function mutation for Fyn kinase, identifying these neuroadaptations are important for
understanding the molecular pathways involving Fyn kinase and alcohol behavioral
phenotypes. Several genes related to neurogenesis, long-term potentiation, and
synaptic transmission were uniquely regulated by acute alcohol within the PFC of Fyn
kinase knockout mice, but were non-responsive in the control group (Figure 47B). For
example, expression of brain derived neurotrophic factor (Bdnf) and synaptophysin
(Syp) were decreased by acute alcohol in the PFC of Fyn knockout animas but were
unresponsive to alcohol in control animals (Figure 47B).
Fyn is important in the induction of long-term potentiation in adult murine
forebrain neurons (Kojima et al., 1997), but the facilitation of long-term potentiation may
also occur through other effectors. Increased PFC expression of BDNF following
cocaine withdrawal facilitates activity induced long-term potentiation, sensitizing
excitatory synapses within PFC (Lu et al., 2010). Bdnf gene expression is decreased in
response to alcohol in response to alcohol in Fyn kinase knockout animals, which may
suggest these knockout animals are at an enhanced risk for blunted long-term
potentiation in the presence of acute alcohol exposure. Acute alcohol under normal
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conditions can lead to increased neuronal levels of Bdnf and altered voluntary intake
(Logrip et al., 2009).
Glucocorticoid-related gene expression is increased in the PFC following acute
alcohol exposure (Kerns et al., 2005). Alcohol-responsive increases in glucocorticoid
gene expression were blunted in the PFC of Fyn kinase knockout animals in
comparison to alcohol treated controls Figure 47B). Glucocorticoids dose-dependently
decrease the sedative-hypnotics properties of acute alcohol exposure (Sze, 1993).
Thus, decreased responsiveness of glucocorticoid-related gene expression in Fyn null
mutants may contribute to increased susceptibility for alcohol-induced loss of righting
reflex behavior in mice.
Top ranking literature association networks for alcohol-responsive differences
within VMB were broadly related to RNA processing, cell signaling, and neurogenesis.
Acute alcohol caused down-regulation of the Eph receptor 7a (Epha7) in controls, while
leading to increased expression in Fyn knockout mice (Figure 47C). Ephrin receptors
are one the largest families of tyrosine kinase with an important roles in synaptic
function and neurodevelopment (Klein, 2009). Genetic deletion of Epha7 causes a
significant decrease in neural progenitor cell death and expansion of the ventral
forebrain (Depaepe et al., 2005). Additionally, EphA7 activation leads to phosphorylated
ERK (Nakanishi et al., 2007), which can then regulate the expression of downstream
effectors involved in multiple signaling processes involving neuronal development and
plasticity (Thomas and Huganir, 2004). As shown in Figure 47C, acute alcohol alters the
expression of multiple genes targeting ERK within the VMB that are not altered in Fyn
knockout animals.
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Acute alcohol exposure caused a significant decrease for large category of genes
within VMB related to RNA processing, unaltered in the Fyn kinase knockout mouse
(Figure 47C). Conversely, the relative mRNA abundance of Dicer1 was increased in
control animals, but not regulated in the knockouts. DICER is a critical element in
mouse development (Bernstein et al., 2003), processing of microRNAs that in turn then
regulate mRNA expression (He and Hannon, 2004), and has a functional role in
midbrain dopaminergic neurons and associated dopaminergic behaviors (Kim et al.,
2007). Our analysis suggests that Fyn kinase may regulate acute alcohol sensitivity, at
least in part, through the regulation of a gene network involving RNA processing within
the VMB. An RNA processing network has also been implicated in a systems genetic
analysis of alcohol sensitivity for Drosophila melanogaster (Morozova et al., 2011),
further suggesting a network of RNA processing genes in behavioral sensitivity to
alcohol.

Fyn-related Gene Network Analysis of LORR
A null mutation in Fyn increases duration in the loss of righting reflex behavior
following acute alcohol exposures (Miyakawa et al., 1997, Boehm et al., 2003, Yaka et
al., 2003b). However, our microarray results insinuate differences in alcohol behavioral
responses may also be due to developmental compensation and altered signaling
events in Fyn kinase knockout animals. In order to extend these previous studies and
determine a Fyn-dependent behavioral gene network, we compared our microarray
analysis of Fyn null mice with gene expression correlates of LORR or Fyn expression
across the BXD (n = 29) and LXS (n = 42) panels of recombinant inbred mice (Figure
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Figure 48. Fyn-LORR Correlation Network within PFC. Network analysis of
concurrent variation of gene expression amongst PFC Fyn knockout array data, Fyn
expression correlates across the BXD RI PFC, Fyn expression correlates across the
LXS RI PFC, and LORR – BXD gene expression correlates in PFC. (A) Diagram of
general approach used to define a Fyn-dependent gene network for the loss of righting
reflex behavior. (B) Basal Fyn-dependent gene network showing correlations among
BXD RI RMA saline dataset (p-value ≤ 0.01). (D) Alcohol-responsive Fyn-dependent
gene network showing correlations among BXD RI S-score dataset (p-value ≤ 0.01).
Red circle indicates the position of Fyn. (C) 4-way Venn diagram of basal datasets from
Figure 48B; (E) 4-way Venn diagram of Alcohol-Responsive datasets from Figure 48D.
Numbers shown represent unique gene symbols excluding Fyn itself. White = Fyn
kinase array data, Blue = BXD Fyn Correlates, Purple = LXS Fyn Correlates, and Green
= LORR gene expression correlates.
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48A). Additionally, our analysis included gene expression from the PFC of BXD mice
correlated with a previously published LORR study across a subset of BXD RI mice
(Figure 49 GeneNetwork ID: 10589 (Rodriguez et al., 1995)). Combining data from
these four gene expression datasets, allowed us to define a Fyn-LORR gene network
(Figure 48). The intersection of multiple datasets increased the chance of a type ΙΙ error;
the over-lapping dataset defined a distinct set of ‘highly’ correlated genes to a specific
behavioral trait. Although these genes are strongly connected with Fyn kinase, the gene
network correlation is qualitatively greater than Fyn expression alone (Figure 49).
Analysis of basal gene expression from the Fyn null mice by the scheme
mentioned above identified a network of 50 highly inter-correlated genes (Figure
48B&C); the first principal component of these 50 genes significantly correlated to
LORR (r = -0.83, p-value = 5.05 e-06). Functional over-representation analysis of this
gene network highlighted ion channel activity, function/localization to the post-synaptic
density, and regulation of action potentials (Table 8). Neto1, Kcnd2, Dnm3, Gria3, and
Homer1 are all localized to the post-synaptic density and also may play a role in
modulating synaptic N-methyl-D-aspartic (NMDA) acid receptor function. Neto1
knockout mice have abnormal long-term potentiation, learning, and memory due to
altered NMDAR subtype abundance (Ng et al., 2009). Kcnd2, also known as Kv4.2, is a
voltage-gated potassium channel that regulates spontaneous NMDAR activation and
downstream calcium signaling mechanisms (Jung et al., 2008). In the postsynaptic
membrane Dnm3 is a binding partner of Homer1 (Gray et al., 2003), a scaffolding
protein associated with type1 metabotropic glutamate receptors and the NMDAR
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Figure 49. In silico correlation analysis of Fyn and LORR behavior. Pearson
product moment correlations analysis of saline (RMA) and ethanol-responsive (S-score)
alongside the LORR behavior (Rodriguez et al., 1995; WebQTL Record ID: 10589) for
Fyn and Fyn-dependent networks from Figure 48B & 48D.
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Category
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype

ID
GO:0042608
GO:0003690
GO:0000900
GO:0015271
GO:0043566
GO:0030371
GO:0090079
GO:0051015
GO:0022843
GO:0005244
GO:0022832
GO:0045182
GO:0032182
GO:0005267
GO:0005261
GO:0003774
GO:0005516
GO:0005230
GO:0030165
GO:0018107
GO:0043618
GO:0010035
GO:0018210
GO:0032909
GO:0032906
GO:0001508
GO:0043620
GO:0042921
GO:0034765
GO:0031958
GO:0007416
GO:0034644
GO:0046885
GO:0014069
GO:0019717
GO:0044309
GO:0043197
GO:0034702
GO:0060076
MP:0002064
MP:0009745
MP:0008026
MP:0004753

Name
P-value % Targeted in Category
T cell receptor binding
6.80E-05
40
double-stranded DNA binding
7.40E-05
3.012048193
translation repressor activity, nucleic acid binding
1.01E-04
33.33333333
outward rectifier potassium channel activity
2.42E-04
22.22222222
structure-specific DNA binding
3.20E-04
2.202643172
translation repressor activity
3.69E-04
18.18181818
translation regulator activity, nucleic acid binding
5.21E-04
15.38461538
actin filament binding
5.84E-04
4.838709677
voltage-gated cation channel activity
6.51E-04
2.666666667
voltage-gated ion channel activity
1.85E-03
2.010050251
voltage-gated channel activity
1.85E-03
2.010050251
translation regulator activity
3.83E-03
5.714285714
small conjugating protein binding
4.98E-03
5
potassium channel activity
5.63E-03
2.189781022
cation channel activity
6.19E-03
1.433691756
motor activity
6.22E-03
2.112676056
calmodulin binding
7.37E-03
1.986754967
extracellular ligand-gated ion channel activity
1.63E-02
2.702702703
PDZ domain binding
2.02E-02
2.409638554
peptidyl-threonine phosphorylation
9.20E-05
8.823529412
regulation of transcription from RNA polymerase II promoter in response to stress9.80E-05
33.33333333
response to inorganic substance
1.16E-04
2.006688963
peptidyl-threonine modification
1.19E-04
8.108108108
regulation of transforming growth factor beta2 production
1.37E-04
28.57142857
transforming growth factor beta2 production
1.37E-04
28.57142857
regulation of action potential
1.45E-04
3.883495146
regulation of DNA-dependent transcription in response to stress
1.82E-04
25
glucocorticoid receptor signaling pathway
1.82E-04
25
regulation of ion transmembrane transport
2.23E-04
2.336448598
corticosteroid receptor signaling pathway
2.91E-04
20
synapse assembly
4.78E-04
5.084745763
cellular response to UV
5.02E-04
15.38461538
regulation of hormone biosynthetic process
5.02E-04
15.38461538
postsynaptic density
9.00E-06
4.545454545
synaptosome
3.10E-05
3.521126761
neuron spine
6.70E-05
4.705882353
dendritic spine
6.70E-05
4.705882353
ion channel complex
2.28E-04
2.314814815
excitatory synapse
2.88E-04
20
seizures
3.50E-05
3.169014085
abnormal behavioral response to xenobiotic
3.90E-05
3.636363636
abnormal brain white matter morphology
1.60E-04
4.316546763
abnormal miniature excitatory postsynaptic currents
2.30E-04
7.843137255

Table 8. Functional over-representation for Fyn knockout mice basal depedent gene network

complex. The ionotropic glutamate receptor Gria3 is a member of the AMPA-receptor
family, which facilitates fast excitatory synaptic transmission.
In addition to Kcnd2 and Gria3, the ion channels Kcna2, Gabrb3, Cacna2d1,
Scn1a were present in Figure 47B, suggesting Fyn kinase may augment the function of
multiple ion channels in addition to the NMDA receptor. The beta3 subunit of GABA-A
receptor has been previously reported to be functionally altered in Fyn kinase knockout
mice contributing to reduced sensitivity to etomidate, a beta-2/beta-3 selective
compound, in the LORR behavior for Fyn knockout mice (Boehm et al., 2004a). Scn1a
is expressed in the nodes of Ranvier of motor neurons regulating the propagation of
action potentials (Duflocq et al., 2008) and resides on chromosome 2 within a known
QTL for alcohol preference (Bice et al., 2006). The regulation and localization of sodium
channels is altered in mouse models of adult-onset demyelination (Rasband et al.,
2003). The Fyn-dependent basal gene network is significantly over-represented for
‘abnormal white matter morphology’ (p-value = 0.000003; MP:0008026), and as shown
in Figure 45C white matter related genes are significantly decreased in the PFC of Fyn
knockout mice. Fyn is also correlated to quaking (Qk) (Figure 48B). Quaking is an RNA
binding protein that regulates the transport of Mbp mRNA outside of the nucleus
(Larocque et al., 2002). Defects in quaking function results in a severe hypomyelination
phenotype (Larocque et al., 2002, Zhao et al., 2006). Fyn specifically targets the activity
of quaking through phosphorylation of tyrosine residues with the C-terminal domain of
quaking (Lu et al., 2005). Basal variation of gene expression for the Fyn-associated
network may thus be a major determinant of myelin gene expression as well as acute
alcohol-induced behavioral sensitivity to the LORR.
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Establishing both basal and alcohol-responsive gene expression networks may be
crucial for a more holistic understanding of the neurobiology of alcohol behavioral traits.
The S-score provides a reliable measurement of alcohol-response (i.e. EtOH / Saline).
Correlation analysis of alcohol-responsive gene expression identified a set of 32 distinct
genes across the four different datasets. The first principal component of the alcoholresponsive network (Figure 49C) was significantly correlated to the LORR (r = 0.87, pvalue = 2.30 e-07), greater in magnitude for Fyn kinase ethanol-response alone.
Coordinate regulation in the alcohol-response of this network may be an additional
underlying component involved in the LORR behavior mediated by alcohol.
Of the 32 genes identified only 2 genes (Cacna2d1 and Ptprb) were in common
with the basal network other than Fyn kinase itself, suggesting the alcohol-responsive
network is largely distinct from basal differences in expression. This Fyn centric alcoholresponsive network similar to the basal network was over-represented for functional
categories related to ion channels (Table 9); notably including Kcnj9, Cacnb4, Kcnma1,
and Gabra2. Several of these genes have been characterized for their association with
alcohol-related phenotypes in mice and humans; however, their association with Fyn
kinase has yet to be investigated. Kcnj9 has been identified as a potential quantitative
trait gene (QTG) for sedative-hypnotic withdrawal from alcohol (Kozell et al., 2009).
Kcnj9 resides with a portion of mouse chromosome 1 which is syntenic to region of
human chromosome 1 implicated in the vulnerability to alcohol dependence and related
phenotypes (Dick et al., 2002, Hill et al., 2004, Ehlers et al., 2010). Single nucleotide
polymorphisms in Gabra2 are associated with alcohol-elicited cues in the medial frontal
cortical area (Kareken et al., 2010), alcohol dependence (Edenberg et al., 2004), and
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Category
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Molecular Function
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Biological Process
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
GO: Cellular Component
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype
Mouse Phenotype

ID
GO:0022843
GO:0019198
GO:0005261
GO:0015276
GO:0003714
GO:0043021
GO:0005230
GO:0005262
GO:0005249
GO:0017124
GO:0050804
GO:0051969
GO:0001764
GO:0034765
GO:0031644
GO:0006816
GO:0007214
GO:0051932
GO:0051924
GO:0070838
GO:0007628
GO:0045211
GO:0034702
GO:0005891
GO:0034704
GO:0034703
GO:0043195
GO:0043679
GO:0044306
MP:0009745
MP:0002578
MP:0005620
MP:0009747
MP:0002972
MP:0000738
MP:0002189
MP:0004036
MP:0000010
MP:0001522
MP:0002912
MP:0005334
MP:0006319

Name
voltage-gated cation channel activity
transmembrane receptor protein phosphatase activity
cation channel activity
ligand-gated ion channel activity
transcription corepressor activity
ribonucleoprotein complex binding
extracellular ligand-gated ion channel activity
calcium channel activity
voltage-gated potassium channel activity
SH3 domain binding
regulation of synaptic transmission
regulation of transmission of nerve impulse
neuron migration
regulation of ion transmembrane transport
regulation of neurological system process
calcium ion transport
gamma-aminobutyric acid signaling pathway
synaptic transmission, GABAergic
regulation of calcium ion transport
divalent metal ion transport
adult walking behavior
postsynaptic membrane
ion channel complex
voltage-gated calcium channel complex
calcium channel complex
cation channel complex
terminal button
axon terminus
neuron projection terminus
abnormal behavioral response to xenobiotic
impaired ability to fire action potentials
abnormal muscle contractility
impaired behavioral response to xenobiotic
abnormal cardiac muscle contractility
impaired muscle contractility
abnormal myocardial trabeculae morphology
abnormal muscle relaxation
abnormal abdominal fat pad morphology
impaired swimming
abnormal excitatory postsynaptic potential
abnormal fat pad morphology
abnormal epididymal fat pad morphology

Table 9. Functional over-representation for Fyn knockout mice alcohol depedent gene network
P-value % Targeted in Category
1.23E-04
2.67
4.32E-04
11.11
1.28E-03
1.43
1.49E-03
2.27
3.07E-03
1.76
4.32E-03
3.51
7.18E-03
2.70
9.38E-03
2.35
1.26E-02
2.02
1.86E-02
1.64
3.06E-04
2.173913043
3.97E-04
2.030456853
3.98E-04
3.703703704
5.43E-04
1.869158879
5.52E-04
1.860465116
7.11E-04
1.739130435
8.27E-04
8.333333333
8.98E-04
8
1.13E-03
2.586206897
1.15E-03
1.526717557
1.38E-03
6.451612903
1.86E-04
2.339181287
4.51E-04
1.851851852
6.77E-04
8.695652174
1.23E-03
6.451612903
1.68E-03
2.127659574
2.59E-03
4.444444444
6.85E-03
2.702702703
7.78E-03
2.53164557
5.65E-04
2.272727273
7.66E-04
15.38461538
1.27E-03
1.901140684
1.29E-03
4.411764706
2.59E-03
2.173913043
3.83E-03
1.951219512
6.63E-03
2.479338843
9.52E-03
4.347826087
1.03E-02
2.112676056
1.79E-02
3.125
1.79E-02
3.125
1.86E-02
1.694915254
1.90E-02
3.03030303

the acute effects of alcohol in humans (Haughey et al., 2008). Genetic knock-in of an
ethanol insensitive mutant for Gabra2 in mice show increased acute alcohol-induced
hypnosis, loss of motor stimulation, and altered alcohol-drinking behavior (Blednov et
al., 2011). Acute alcohol modulates the voltage and Ca++ sensitivity of BK potassium
channels such as Kcnma1 (Dopico et al., 1998). Activation of Kcnma1 by alcohol
causes acute intoxication in Caenorhabditis elegans (Davies et al., 2003) and is
associated with the level of response to alcohol in humans (Schuckit et al., 2005).
Convergent correlation between Fyn and the aforementioned set of genes following
acute ethanol (Figure 48D&E) may thus suggest modulation of a Fyn kinase dependent
gene network(s) are important for the interpretation of alcohol-behavioral responses.
Resulting Fyn-related basal and alcohol-responsive gene networks were
submitted to GeneMANIA to assess our network across multiple independent datasets
related to gene co-expression, genetic interaction, and protein interaction, and predict
any possible genes that may have been missed by our analysis. The networks from
GeneMANIA are qualitatively similar to our networks within PFC, suggesting these
genes are associated with one another across independent datasets. Strikingly,
approximately 65% of all links between two genes within the basal network is due to
protein-protein interactions (i.e. physical interactions) (Figure 50A). Although not directly
tested, this network provides in silico evidence for coherence in gene and protein
associations surrounding Fyn kinase and the LORR behavior. The alcohol-responsive
network (Figure 50B) is slightly different with approximately 81% of all connections
derived from co-expression of genes; however, a subset of genes showed physical
interactions with Fyn kinase. GeneMANIA datasets do not necessarily address the
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Figure 50. Independent assessment of Fyn kinase correlation networks.
GeneMANIA web-tool (http://genemania.org/) analysis using public resources for Fynrelated gene expression networks: (A) Reconstruction of basal network from Figure
48B. (C) Reconstruction of ethanol-responsive network from Figure 48D. Grey nodes
are query genes and white nodes are genes predicted form the GeneMANIA algorithm.
Red arrow indicates the location of Fyn kinase.
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gene-gene interactions following the effects of alcohol exposure and may underestimate
the degree of physical interactions under such particular experimental conditions.
GeneMANIA predicted the membership of multiple other candidate genes to both
the basal and alcohol-responsive networks (labeled in white). Notably, the GeneMANIA
algorithm predicted the neurotrophic receptor Ntrk2 and the phosphatase Pten for the
basal network, a subunit for the serotonin (Htr2a) and GABA-A (Gabra1) receptor within
the alcohol-response network. All of which have been previously reported to have
associations with the molecular and behavioral responses to alcohol. Therefore, our
analysis has defined a set of Fyn-related correlation networks from the measurement of
steady state mRNA following either an acute dose of saline (basal) or alcohol.
Intersecting these results with behavioral correlates of the LORR across the BXD RI
lines has lead to the identification of a Fyn-dependent network associated with acute
alcohol behavioral phenotypes. Although this approach may have inflated the correlation
coefficient above that of Fyn kinase alone due to our bias LORR correlates, it highlights
coherent networks related to a specific ethanol behavioral trait functionally altered within
Fyn kinase knockout mice.

Discussion
A variety of mouse models, including null mutants, have been widely used to
study the underlying neurobiology of alcohol and associated behavioral phenotypes
(Crabbe et al., 2006b). Fyn kinase has been reproducibly reported to modify the
sedative-hypnotic effects of alcohol as determined by duration of the LORR behavior
(Miyakawa et al., 1997, Boehm et al., 2003, Yaka et al., 2003b). Herein, we have
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conducted a genomic analysis of the mesocorticolimbic system from Fyn knockout mice
in the presence and absence of alcohol (3 g/kg) to determine gene expression patterns
associated with the LORR that may have underlying associations beyond a single null
mutation. The explicit brain-regions involved in acute ethanol sensitivity and preference
is unknown (Wand et al., 2001). Our in silico analysis using the WebQTL database
(Chesler et al., 2005) showed that variation in the expression of Fyn within PFC is
significantly correlated to a published report of the LORR across the BXD recombinant
inbred strains of mice. Additionally, Fyn and the LORR are correlated to a common set
of genes altered in the Fyn knockout mouse, suggesting a Fyn-related network of genes
influencing this behavioral phenotype. In agreement with previous research our analysis
suggested a deregulation of glutamatergic and GABAergic function; however, our
analysis also suggests multiple other systems are perturbed in their expression,
especially those related to abnormal myelin-associated gene expression.
Basal abundance of myelin-associated gene expression was significantly disrupted
in forebrain of Fyn knockout mice. Myelin gene and protein expression is impaired in the
frontal cortex of human alcoholics (Lewohl et al., 2000, Mayfield et al., 2002). Myelin is
also suggested to be a dynamic aspect of substance abuse and comorbid disorders
such as schizophrenia and manic depression (Ogden et al., 2004, Sokolov, 2007).
Differential expression of basal and acute ethanol-responsive myelin gene expression
within medial PFC has also been previously suggested as an important aspect of lasting
alcohol behavioral phenotypes between B6 and D2 mice (Kerns et al., 2005). Alcohol
drinking behavior is correlated to the expression of a dense network of myelinassociated genes within the PFC across species. Extending these observations across
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the PFC a panel of alcohol naïve mice determined basal variation in myelin-related
gene network is associated with alcohol consumption and acute behavioral sensitivity to
alcohol. Acute functional tolerance was one of the behavioral measures significantly
connected to variation in myelin-associated gene expression. The LORR is a behavioral
measure of initial sensitivity and acute functional tolerance (Ponomarev and Crabbe,
2002, 2004, Radcliffe et al., 2006). Thus, we hypothesize variation of a myelinassociated gene expression is a contributing factor in the sedative-hypnotic effects
related to acute functional tolerance and contributes, at least in part, to the previously
documented changes in alcohol-induced LORR for Fyn null mice.
Acute functional tolerance due to various genetic factors, signaling processes, and
neuroadaptations is important for interpretation of the LORR. Fyn kinase
phosphorylation of the NMDA receptor subunit NR2B may account for one mechanism
involved in mediating the duration for LORR behavior. Our analysis has focused
exclusively on coordinate expression of stable steady-state messenger RNA and may
not necessarily reflect phosphorylation events, post-translation modifications, or
changes in protein expression. Concordance between gene expression and protein
levels is not always a simple linear relationship and may depend on the individual
genes, local environment, preexisting conditions, the model organism in question, or
protein half-life (Greenbaum et al., 2003). Although protein abundance and function are
important for cellular machinery transcript abundance may be more predictive of the
overt phenotype (Ghazalpour et al., 2011).
In conclusion we have characterized a set of gene expression patterns or gene
networks are important in the interpretation of acute ethanol sensitivity within a Fyn
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kinase knockout mouse. Our results are consistent with previous research related to
Fyn kinase and behavioral phenotypes previously reported in the literature; however,
they suggest a novel gene network perspective within individual brain regions
contributing to acute alcohol sensitivity. Convergent results from three different
microarray studies as well as genes correlating with the LORR identified a significant
network within PFC related to alcohol-induced behavioral sensitivity. In particular, basal
variation in gene expression identified a set of genes related through protein-protein
interaction, including Fyn kinase. Thus these results may suggest a network of genes,
and down-stream elements such as myelin gene expression, and not just a single allele
such as Fyn are important in the sedative-hypnotic properties of ethanol. Although not a
perfect correlation in all studies, the inverse relationship between acute ethanol
sensitivity and risk of long-term drinking behavior may suggest these networks are
important in underlying processes governing ethanol consumption. Furthermore,
continued inquiry into basal and drug-induced variation in gene networks across
genetically diverse strains of mice, knockout mice, and demyelinated animal models
may assist in our understanding of the neurobiology and pathogenesis of alcoholism.
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CHAPTER 6:
MYELIN GENE EXPRESSION AND THE LOSS OF RIGHTING REFLEX BEHAVIOR

Introduction
Complex behavioral traits are influenced by a collection of genetic factors arising
from two or more segregating populations. Mapping quantitative trait loci (QTLs) in
several model organisms, including mice and rats, has identified multiple regions of the
genome underlying behavioral responses to alcohol and other drugs of abuse (Spence
et al., 2009, Drews et al., 2010). Inbred Long-Sleep (ILS) and Inbred Short-Sleep (ISS)
mice are two inbred strains that were selectively bred for divergent behavioral
responses to the acute sedative-hypnotic effects of alcohol (McClearn and Rodgers,
1959, Sanders et al., 1978, McClearn and Kakihana, 1981). Multiple QTLs have been
identified in mediating the loss of righting reflex (LORR) due to ethanol (LORE) using
recombinant inbred lines (RIs) and an F2 population derived from ILS and ISS mice
(Markel et al., 1996, Bennett et al., 2002). Reciprocal interval specific congenic mice
have been created in order to further genetically dissect QTL intervals inherent to the
LORE, residing beneath four of the largest effect size QTLs: Lore1, Lore2, Lore4, and
Genetic markers, flanking a defined phenotypic region, are used to generate congenic
animals by inserting a QTL interval from a donor strain onto a genetically different
recipient strain (Rogner and Avner, 2003, Armstrong et al., 2006). Polymorphisms
residing within the donor QTL region are suspected to influence phenotypic variability.
The use of reciprocal congenic mice allows for further genetic dissection QTL regions
impacting quantitative traits related to behavioral outcomes for alcohol and other drugs
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of abuse (Ferraro et al., 2005, Palmer et al., 2006, Ferraro et al., 2007, Crabbe et al.,
2010b).
Discerning the regulatory variation for quantitative trait gene(s) underlying QTL(s)
in complex traits has been considerably time-consuming, and will take nearly 1,500
years to track down all the potential QTGs beneath known QTL at the present pace
(Finn et al., 2003, Flint et al., 2005). Isolation of the Lore QTL regions has identified
molecular variants within coding regions for several candidate genes; however, no
causal factor has yet been established (Ehringer et al., 2001, Ehringer et al., 2002).
Genetic disequilibrium may be a prominent factor complicating the identification of QTG,
with polymorphic differences existing among numerous genes beneath a given
phenotypic QTL. Functional evaluation of candidate genes may be facilitated by a priori
knowledge of a biological system, but prioritizing genes based solely on existing
evidence potentially limits novel discovery. Additionally, too many polymorphic genes
may sometimes exist within a QTL for adequate selection and downstream validation.
DNA microarray technologies allow essentially whole-genome expression analysis
(Hughes et al., 2000); enabling non-biased, parallel evaluation of gene expression
linked to suspected QTL regions (Chesler et al., 2005, Schadt et al., 2005). Regulatory
variation of cis- and trans-acting QTL intervals is associated with divergent gene
expression and susceptibility to disease (Farber and Lusis, 2008). Therefore, a
complementary approach for narrowing prospective candidate genes is to restrict the
analysis of differential expression to targets within a defined QTL acting on complex
traits (Wayne and McIntyre, 2002, Hitzemann et al., 2003, Farber and Lusis, 2008). Not
surprisingly, pairing expression profiling with genetic models, including recombinant
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inbred and congenic mice for defined QTLs, has refined a subset of candidates genes
for an array of phenotypic traits (Schadt et al., 2003, Drake et al., 2005, Mehrabian et
al., 2005). Anchoring the suspected causal gene to a reference QTL, genomic profiling
further permits a comprehensive exploration of coordinately expressed gene networks
related to behavioral responses, improving mechanistic insight into more global complex
traits (Chesler et al., 2005, Geisert et al., 2009).
Initially characterized in an F2 cross between ILS and ISS, the Lore5 QTL on
mouse chromosome 15 possessed a maximum logarithm of the odds (LOD) score of
4.0 at approximately 46 cM and accounted for 8.4% of the genetic variance (Markel et
al., 1997). The Lore5 QTL was subsequently introgressed onto both ILS (ILS.ISS-Lore5)
and ISS (ISS.ILS-Lore5) backgrounds, using markers flanking the peak LOD score.
Using oligonucleotide microarray profiling of prefrontal cortex (PFC) from ISS, ILS, and
Lore5 congenic mice we sought to determine important regulatory genes and gene
networks underlying the LORR behavioral response specific to Lore5. Previous
expression profiling of saline and alcohol-responsive gene expression in the PFC of
C57BL/6J and DBA/2J mice (Kerns et al., 2005), as well as the PFC of Fyn kinase
knockout mice, revealed a coordinate regulation of myelin-associated gene expression.
Fyn kinase is key regulatory factor of myelin gene expression (Goto et al., 2004) and
alcohol-induced LORR (Miyakawa et al., 1997). Based on our previous microarray
investigations, we hypothesized that genetic variation in the expression pattern for a
myelin-associated gene network within PFC of ILS, ISS, and reciprocal congenics is a
decisive aspect functioning in the LORR behavior.
Studying both basal and alcohol-responsive gene expression in a selectively bred
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model for the LORR behavior lead to the identification of N-myc downstream-regulated
gene 1 (Ndrg1) as a strong candidate gene underlying the Lore5 QTL. Ndrg1 is a
myelin-related gene expressed within oligodendrocytes (Okuda et al., 2008, King et al.,
2011), suggesting Ndrg1 and myelin oriented gene expression is a selective mediator of
LORR for acute alcohol. Using the cuprizone model of adult onset demyelination (Kipp
et al., 2009) we tested the role of myelin gene expression in a subset of behavioral
phenotypes. Consistent with our previous observations decreased myelin-associated
gene expression in PFC was inversely correlated to acute behavioral sensitivity to
alcohol as demonstrated by the LORR behavior. Our results point towards a novel
genetical-genomics derived network of myelin genes contributing to divergent acute
alcohol behavioral sensitivity.

Materials and Methods
Administration of acute alcohol, animal micro-dissection and RNA Isolation (LORE
study). All animal procedures were approved by the University of Colorado Institutional
Animal Care and Use Committee, in accordance with National Institute of Health
guidelines. Male ILS, ISS, ILS.ISS-Lore5 (hereafter referred to as L.5S) and ISS.ILSLore5 (hereafter referred to as S.5L) mice (10 mice per strain, 55-85 days of age) were
injected intraperitoneal (i.p) with saline for 6 consecutive days. On day 7, mice were
injected with either saline (5 mice per strain) or 4.1 g/kg (w/v) ethanol (5 mice per
strain). Four hours later, mice were sacrificed by cervical dislocation. We chose a 4-hour
time point (post ethanol or saline injection) and prefrontal cortex (PFC) for these initial
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studies based upon our prior work showing a robust collection of ethanol-responsive
genes using this brain region and time point (Kerns et al., 2005). Brains were excised
and chilled for 1 minute in phosphate buffer on ice prior to dissection. Dissections were
completed 5-7 minutes from time of sacrifice. Prefrontal cortex (PFC) was excised,
placed into individual tubes, frozen immediately in liquid nitrogen and subsequently
stored at -80°C until shipment to the Miles laboratory at Virginia Commonwealth
University. Other brain regions were dissected and stored for future analysis. This
experimental protocol was performed in triplicate, for a total of 120 mice.
Tissue pooled from 4-5 animals was homogenized in STAT-60TM reagent (TelTest, Inc., Friendswood, TX) using a Tekmar homogenizer and total RNA was isolated
according to the STAT-60TM protocol. RNA concentration was determined by
absorbance at 260 nm, and RNA quality was analyzed by agarose gel electrophoresis
and 260/280 absorbance ratios. Total RNA (7 µg) derived from each pool was reverse
transcribed into double-stranded cDNA using Invitrogen Superscript II System
(Invitrogen, Carlsbad, CA). Biotin-labeled cRNA was synthesized from cDNA using
BioArray High Yield RNA Transcript Labeling Kit (ENZO Diagnostics, Farmingdale, NY)
according to manufacturer’s instructions, purified using the RNAeasy Mini Kit (Qiagen,
Mountain View, CA), and quantified by absorbance at 260 nm.

Microarray Hybridization, Scanning, and Data Analysis. Each treatment group (saline or
ethanol), strain (ILS, ISS, L.5S or S.5L) or replicate (n=3) was hybridized to an
individual microarray (n=24 total microarrays). Labeled cRNA samples were analyzed
on oligonucleotide microarrays (Murine GeneChipTM U74Av2, U74Bv2, U74Cv2,
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Affymetrix, Santa Clara, CA) that contain over 30,000 named genes and expressed
sequence tags (ESTs). Array hybridization, staining and scanning were performed
according to the manufacturer’s protocol and exactly as described previously (Thibault
et al., 2000, Kerns et al., 2005) using 10 µg of fragmented cRNA (in 200 µl master mix)
for hybridization to arrays.
Microarray data was initially processed using Microarray Suite Software version
5.0 (MAS, Affymetrix). Arrays were normalized to a median total hybridization intensity
(TGT = 190). All arrays had scaling factors <2.3, 3’-5’-actin ratio below 2, and linear
intensity values. Arrays were further analyzed in three steps to identify genes with
altered expression patterns. First, genes with consistently low expression values were
filtered to eliminate genes with MAS 5 intensity values below 50 in all samples.
Secondly, the S-Score algorithm, developed in this laboratory for the analysis of
Affymetrix oligonucleotide arrays (Zhang et al., 2002, Kerns et al., 2005, Kennedy et al.,
2006a, Kennedy et al., 2006b), was applied to compare hybridization signals between
two randomly selected arrays from different treatment samples. S-score results have a
normal distribution with mean 0 and SD of 1, and are correlated with the fold change. An
S-score of |2| corresponds to a p=0.0455, uncorrected for biological variability or
multiple comparisons. S-scores were calculated within each experiment replicate for
basal Lore5-specific changes across strains (S.5L-saline vs. ISS-saline; L.5S-saline vs.
ILS-saline; and ISS-saline vs. ILS-saline) or within-strain responses to ethanol (S.5Lethanol vs. S.5L-saline; L.5S-ethanol vs. L.5S-saline; ISS-ethanol vs. ISS-saline; and
ILS-ethanol vs. ILS-saline). These comparisons generated a total of 21 different Sscores, 7 for each experimental replicate. Finally, S-scores from the intensity trimmed
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gene list were loaded into The Institute for Genomics Research MultiExperiment Viewer
(TMEV) (Saeed et al., 2003, Saeed et al., 2006) for further statistical and multivariate
analyses. Statistical Analysis of Microarrays (SAM), a rank-based permutation method,
was used to identify genes with S-scores significantly different from zero (Tusher et al.,
2001) using a multi-class analysis. A false discovery rate of 10% or lower was used to
avoid eliminating genes that may be biologically important and could assist in
interpretation of expression patterns in multivariate studies. This gene list was used for
subsequent multivariate or bioinformatic analyses.
Statistically filtered genes were further analyzed for correlated gene expression
patterns by application of k-means clustering after estimating the number of nodes by
principle component analysis as described previously (Kerns et al., 2005). We also used
post-hoc template matching (PTM) (Pavlidis and Noble, 2001) to detect genes with
basal expression or ethanol regulation correlating with the Lore5 region. A cutoff of pvalue < 0.001 was used to detect genes with statistically similar basal or ethanol
responses for strains having either a ISS Lore5 interval (L.5S and ISS) or a ILS Lore5
interval (S.5L and ILS).

Bioinformatic Analysis of Microarray Data. Expression Analysis Systematic Explorer
(EASE v 1.21) (Hosack et al., 2003) was used to identify biological themes among gene
expression profiles and group genes into functional classifications developed by several
public databases. The following annotation groupings were analyzed for overrepresentation in gene lists: chromosome, SwissProt keyword, GenMAPP pathway,
Gene Ontology Consortium Biological Process, Molecular Function, and Cellular
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Component. EASE results were filtered to remove categories with EASE score > 0.05.
Gene Ontology Consortium (2001) categories with over 250 members on the U74Av2
array were considered too broad and removed. Redundant categories with the same
gene members were removed to yield a single representative category. Additional
bioinformatics analysis of genes showing altered basal expression or regulation by
ethanol was done by identifying the chromosomal location of all such genes and
superimposing this on the Lore support intervals. Chromosome locations for genes
probed by the Affymetrix U74Av2, U74Bv2, and U74Cv2 arrays were obtained through
the UCSC Mouse Genome database (http://genome.ucsc.edu/).Genes were also
probed for linkage of basal expression to published ethanol behavioral data and to
defined chromosome locations through the WebQTL database (http://genenetwork.org/
webqtl/main.py). The WebQTL database contains expression data on whole brain or
brain regions from recombinant inbred lines and can be used to correlate gene
expression, genetic marker information and behavioral QTL data (Chesler et al., 2005).

Northern Blot Analysis. Total RNA (5 µg/sample) was analyzed by denaturing gel
electrophoresis and transferred to nylon membranes for Northern blot analysis as
described previously (Thibault et al., 2000). Probes for Ndrg1 and C430014K11Rik were
prepared by reverse transcriptase PCR (rtPCR) amplification from total RNA isolated
from prefrontal cortex of ILS mice. Primer pairs were as follows: Ndrg1 -- forward
primer: 5’- CCAAAGGCAAGAAGTTCAG, reverse primer: 5’GGAAACAGGAAGTAGGCAGGTTG; C430014K11Rik (AW049397) -- forward primer:
5’-CACTCCCACGGAAACCATTG, reverse primer: 5’-

214

GCTTACAAAGTCTGCCCCTTCTC; GAPDH -- forward primer: 5’ACCACAGTCCATGCCATCAC, backward primer: 5’-TCCACCACCCTGTTGCTGTA.
Probe sequences were generated using PCR, a T7 promoter was ligated onto the 3'
end using the LigN'Scribe kit (Ambion). Labeled antisense probe sequences were
generated by in vitro transcription with 32P-CTP using the StripEz Kit (Ambion).

Genetical Genomics Analysis of Ndrg1 in LXS recombinant inbred lines. Male mice (6-8
per strain) from 42 recombinant inbred (RI) lines of the LXS RI battery (Williams et al.,
2004) were injected with saline IP and brain regions harvested by microdissection four
hours later. RNA isolation and microarray analysis were as described above except that
all strains were randomized at each step of the procedure so as to minimize potential
batch effects. Microarray analysis utilized Affymetrix 430A type 2 arrays. Genetic
analysis of Ndrg1 expression across the LXS lines was done using RMA intensity
scores (Irizarry et al., 2003) and the batch analysis feature of GeneNetwork to generate
an interval map analysis of Ndrg1 with significance levels determined by permutation
analysis.

Administration of acute alcohol, animal micro-dissection and RNA Isolation (Cuprizone
Study). All animals were treated according to protocols for animal care established by
Virginia Commonwealth University and the National Institute of Health. Adult male
C57BL/6J mice (6 to 7 week-old, The Jackson Laboratory, Bar Harbor, ME) were singly
housed with ad libitum access to water and standard rodent chow (catalog #7912;
Harlan Teklad, Madison, WI) or 0.2% cuprizone (w/w) rodent chow and a 12 hour light/
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dark cycle. Cuprizone chow was made by grinding standard rodent chow weighing 100
grams with 0.2% cuprizone (Bis(cyclohexanone)oxaldihydrazone; Sigma-Aldrich
#14690). All mice were fed cuprizone for a period of five weeks to induce demyelination.
Animals were weighed once weekly during cage changes to assess any potential
differences and body mass between controls and cuprizone fed mice. The Institutional
Animal Care and Use Committee (IACUC) of Virginia Commonwealth University
approved all experimental procedures (#AM10332 to Dr. Michael F. Miles).
Mice were given an intraperitoneal saline injection once daily for three days in
order to habituate to the injection and animal handling processes. On day four mice
received either an injection of saline or 20% ethanol in saline for the appropriate testing
procedure described the below. After four hours animals were killed by cervical
dislocation. Brain tissue was harvested as tree recently described in Kerns et al., 2005.
Brain regions were placed in individual tubes, frozen immediately with liquid nitrogen,
and stored at -80°C until isolation of total RNA was performed on individual brain
sections. Brain tissue from medial prefrontal cortex was homogenized with STAT-60
reagent (Tel-Test, Firendswood, TX) using a Tekmar homogenizer. Total RNA was
isolated per Qiagen protocols using RNeasy Midi Kit (#75144). RNA quantifican and
quality was determined by agarose gel electrophoresis using Bio-Rad Experion RNA
analysis kits (#700-7104).

Quantitative real-time reverse transcription – PCR. Total RNA (1 µg) passing quality
control was reverse transcribed into double-stranded cDNA using iScript cDNA
synthesis kit (Bio-Rad # 170-8891) according to the protocol from the manufacturer.
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Briefly, total RNA was incubated with oligo-dT, random hexamer primers, and reverse
transcriptase at the 55°C for 5 min., 42°C for 30 min., and 85°C for 5 min. Following
synthesis cDNA was immediately used or stored at -20°C. Quantitative real-time PCR
performed using the iCycler iQ system (Bio-Rad) according to the instructions of the
manufacturer for iQ SYBER Green Supermix (Bio-Rad #170-8880). Three technical
replicates for performed for each cDNA preparation and average prior to statistical
analysis. All primers were designed to minimize secondary structure formation and
cross intron-exon boundaries to reduce amplification of possible genomic DNA
contamination. Relative abundance of target transcripts was normalized to the
housekeeping gene GAPDH.

Locomotor and Anxiety -Like Behavior. Animals were placed into the behavioral room
and allowed to habituate for a period of one hour prior to testing. All locomotor / anxietylike experiments were conducted between 8 AM and 12 PM eastern standard time.
Following habituation animals were given an intraperitoneal injection of saline or 2 g/kg
ethanol and placed immediately in the light-dark box chamber facing the dark
compartment to start on entry. Two equally sized compartments (30 cm x 30 cm x 15
cm) or separated by a black plastic partition with an opening in the middle to allow for
light – dark transitions (Med Associates Inc., St. Albans VT). The boxes were enclosed
in a sound attenuating chamber equipped with overhead lighting in and ventilation
system was interfaced with Men Associates software enabling automatic measurement
of activity using a set of 16 infrared beam sensors along the X – why plane. All animals
were tested for a total of 10 minutes in the chamber using 5 minute bins and then
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returned to their home cage. Between sessions all chambers were cleaned with
ammonia and paper towels given 2 to 5 minutes to air dry. At completion of the
experiment animals are returned to their home cage monitored for period 24 hours.

Loss of righting reflex (LORR) due to ethanol. Animals were placed into the behavior
room and allowed to habituate for a period of one hour prior to testing. All LORR
experiments were conducted between 8 AM and 12 PM eastern standard time.
Following habituation animals were given an intraperitoneal injection of saline or 4 g/kg
ethanol and placed in a clean cage with bedding labeled with appropriate information.
Each animal was timed for the onset of the LORR from the moment of injection until
acquiring the LORR using a laboratory timer. Any animals not acquiring LORR within 5
minutes were deemed an outlier and removed from the study. Animals were deemed to
have acquired the LORR when placed on their back V-shaped cage-top and remained
in that position for no less than 20 seconds. Following acquiring the LORR animals were
scored for the duration of the LORR, defined as the amount of time it takes an animal to
right itself onto all four paws 2 to 3 times within 60 seconds. At completion of the
experiment animals are returned to their home cage monitored for period 24 hours.

Gait analysis of mouse locomotor behavior. Animals were placed into the behavior
room and allowed to habituate for a period of one hour prior to testing. All gait analysis
experiments were conducted between 8 AM and 12 PM Eastern Standard Time using
two groups of animals of equal group sizes on alternating days. Following habituation
animal’s paws were painted with Crayola non-toxic paint. Front paws were painted with
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blue and rear paws were painted in red. On day one each animal was immediately
placed the gait analysis box and allowed to run to the end of the chamber. Following this
initial run animals were each given a second opportunity to run through the chamber,
returned to their home cage, then given a intraperitoneal saline injection and run the
third time representing time zero. Each animal was run again at 5 minutes, 15 minutes,
30 minutes, and 60 minutes under saline conditions to complete day one. On day two
for each group each animal was given an intraperitoneal 2 g/kg ethanol injection and
immediately placed in the chamber for time zero then run again at 5 minutes, 15
minutes, 30 minutes, and 60 minutes. On day three for each group each animal was
given an intraperitoneal 2.75 g/kg ethanol injection and immediately placed in the
chamber for time zero then run again at 5 minutes, 15 minutes, 30 minutes, and 60
minutes. Animal groups were rotated to give each group at least one day off prior to
repeated testing. Paper strips for each animal were hung to dry and measured using a
standard ruler for stride length, stance length, and sway length. Measurements were
sampled using the average of six repetitive steps from the midsection of the paper.

Acute Alcohol Handling-Induced Convulsion Behavior. Adult male C57BL/6J mice preexposed to +/- cuprizone treatment were tested for acute alcohol (4 g/kg) withdrawal
seizures using handling-induced convulsions (HIC) (Metten and Crabbe, 2005). HIC is a
powerful behavioral model for assessing shared genetic/genomic influences across
different pharmacological agents, including alcohol (Belknap et al., 1988, Crabbe et al.,
2002). Individual-animals were tested immediately pre- and post-injection of alcohol,
then every hour between 2-8 hours. Video was recorded for individual subjects were
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lifted by their tail, gently spun at a 180-360° arc, and scored by a blinded observer on a
rating scale from 0 to 7. Scoring was determined as 0 (no convulsions), 1 (no
convulsions when lifted by tail, only presence of a facial grimace after spinning), 2 (no
convulsions when lifted by tail, but tonic convulsion elicited by spinning), 3 (no
convulsion when lifted by tail, but tonic-clonic convulsion after spinning), 4 (tonic
convulsion when lifted by tail), 5 (tonic-clonic convulsion when lifted by the tail, often
with onset delayed by 1-2 seconds), 6 (severe, tonic-clonic convulsion when lifted by
the tail, with quick onset and long duration, often continuing for several seconds after
the mice are released, and 7 (severe, tonic-clonic convulsion, with quick onset and long
duration: spontaneous, or elicited by mild environmental stimulus, such as lifting of the
cage-top). Overall withdrawal scores were computed as the area under the curve (AUC)
between 2 and 8 hours after alcohol administration. The average baseline HIC Score
fore each animal was then subtracted from its AUC score to calculate a total alcohol
withdrawal score, corrected for individual differences in baseline HIC.

Statistical Analysis. All data are reported as mean ± standard error of the mean and
analyzed using the appropriate statistical tests for each independent behavioral
assessment as discussed in the text. All the behavioral measures were collected
independently of one another, with no repeated behavioral testing of any subject to
prevent any possible carryover effects. Statistical analyses were performed in SPSS
and Prism, data was considered significant at the p-value less or equal to 0.05
confidence level. Graphs were rendered using Prism (GraphPad).
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Results
LORR behavioral differences between ISS, S.5L, ILS, and L.5S mice. The LORR
reflex behavior following acute alcohol administration was verified for Inbred ShortSleep (ISS) and Inbred Long-Sleep mice (ILS). Reciprocal introgression of the Lore5
QTL region onto the ILS background, ILS.ISS-Lore5 (L.5S), and the ISS background,
ISS.ILS-Lore5 (S.5L), led to a statistically significant reversal in duration of LORR
(Figure 51A). Behavioral differences were relatively small in magnitude, but only one
truncated chromosomal region (Lore5) was under investigation. Pairing differences in
gene expression profiles for saline and acute alcohol administration (Figure 51B with
mean behavioral differences in the LORR between strains we sought to define gene
networks associated with acute behavioral sensitivity to alcohol. As described above
and in previous chapters, we hypothesized from our earlier microarray analyses that
basal variation myelin-associated gene expression within PFC is an underlying factor of
acute behavioral sensitivity (i.e. LORR). Leveraging variation in gene expression within
a defined QTL for LORR further prioritized candidate genes, which helped explain the
genetic architecture for this specific alcohol behavioral response.

Refining the Lore5 QTL interval by single nucleotide polymorphism (SNP) and dinucleotide marker analysis. Advances in large-scale sequencing methodologies and
SNP genotyping for hundreds of mouse strains, in addition to interrogating microsatellite markers within the L.5S and S.5L congenics, allows for a more in-depth
analysis of sequence diversity within the Lore5 QTL interval. According to previous
analysis by Johnson and colleagues, the Lore5 QTL region extends from D15Mit278
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Figure 51. Behavioral genomics of ILS, ISS, L.5S, S.5L. (A) duration in the loss of
righting reflex behavior for ILS, ISS, L.5S, and S.5L mice following 4.1 g/kg (i.p.) alcohol
administration, * p-value < 0.01; (B) Hierarchical clustering of basal and alcoholresponsive gene expression within PFC for ILS, ISS, L.5S, and S.5L mice 4-hours post
i.p. injection; Red= increased expression. Green= decreased expression. Black = no
change in expression.
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(56.99 Mb) to D15Mit43 (97.82 Mb). Using publicly available data from a genome-wide
mapping study, analyzing SNPs data across 36 wild caught mice, 62 wild-derived
laboratory strains, and 100 classical mouse strains (including ILS and ISS mice),
identified a large portion of the Lore5 QTL candidate region (72.64-94.71 Mb) is
identical by descent (IBD) between ILS and ISS strains (Figure 52A). This suggests the
remaining non-IBD regions likely harbors the causal variant predisposing ILS and ISS
(as well as reciprocal congenics) for phenotypic differences to the LORR. Within the 22
Mb IBD region (from marker D15Mit169 to SNP rs13482721), there are a total of 121
SNPs and 44 di-nucleotide markers exhibiting no polymorphic differences between ILS
and ISS mice. However, within the non-IBD region D15Mit107 (84.21 Mb) and
D15Mit171 (89.88 Mb) are two polymorphic elements between ILS and ISS. Variation in
D15Mit107 and D15Mit171 may be a result of the relatively high mutation rate existing
among micro-satellite markers (Li et al., 2002b). Pseudo-colored images for haplotype
blocks between ILS and ISS mice (Figure 52B) illustrated allelic differences within a
small region of the Lore5 QTL interval. The IBD region haplotype block structure was
nearly identical across ILS, ISS, and C57BL6/J, further illustrating a lack of sequence
divergence for a large portion of the Lore5 QTL region. Overall, the Lore5 interval
contains 407 genes or predicted genes but after eliminating the IBD region, 78 genes
(Lore5-NonIBD) remained as probable candidates for the alcohol behavioral phenotype
LORR.

Differential gene expression between Lore5 congenics, ILS and ISS. Affymetrix
genechip arrays (U74Av2, Bv2 and Cv2) were used to investigate both basal and
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Figure 52. Genetic analysis of Lore5 genotype. (A) identification of regions identical
by descent (IBD) between ILS and ISS mice for the Lore5 interval; pink indicates
regions IBD, (B) Haplotype block analysis of ILS and ISS for the Lore5 interval using
pseudocolored blocks, (C) cis-eQTL for Ndrg1 basal gene expression in hippocampus
of the LXS RI panel (n = 79), (D) cis-eQTL for Ndrg1 basal gene expression in prefrontal
cortex of the LXS RI panel (n = 42). (http://msub.csbio.unc.edu/ & http://
www.genenetwork.org/webqtl/main.py)
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alcohol-responsive gene expression within the medial prefrontal cortex (PFC) of ILS,
ISS, L.5S, and S.5L mice. The PFC was selected based off our previous expression
profiling studies concerning a suspected role for myelin-associated gene expression,
and associated gene networks, influencing differences in acute and long-term alcohol
behavioral phenotypes. Additionally, despite disputes of evolutionary differences in the
neuroanatomical profile of the PFC, rodent PFC has a diverse role in a number of
behavioral processes, including motor execution and reward-associated behavior
(Dalley et al., 2004). Therefore, a functional genomics evaluation of this brain region in
mice may be important for pinpointing genetical-genomic factors relevant to the LORR
and the Lore5 behavioral QTL.
Similar to some of our previous studies, gene expression analysis was conducted
using the S-score algorithm (Zhang et al., 2002, Kennedy et al., 2006) for baseline
differences or differences following 4.1 g/kg of acute (i.p.) alcohol at a 4-hour time point.
Previous studies from our laboratory have utilized this time point to evaluate brainregion specific variation in alcohol elicited gene expression alongside baseline
dissimilarities (Kerns et al., 2005). Following a statistical filtering with permutation
analysis at a 10% FDR (Tusher et al., 2001) in the current analysis of ILS, ISS, L.5S
and S.5L animals, probesets were further filtered for an average S-score ≥ 1.5 or ≤ -1.5
across three biological replicates within each treatment group. Selecting gene
expression differences represented by an average S-score ≥ 1.5 or ≤ -1.5 eliminates
subtle variations in gene expression influenced by biological or technical noise.
Changes in gene expression due to acute alcohol exposure were inferred as surrogate
events for signaling mechanisms contributing to the acute behavioral response.
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Evaluating coordinate differences in baseline and alcohol-evoked gene expression led
to an overall assessment of the system(s) between mice specifically bred for divergence
in the LORR and a specific chromosomal interval (i.e. Lore5).
A total of 573 differentially expressed genes were determined due to background
strain or alcohol treatment. Congruent with behavioral observations ILS mice were more
sensitive to the sedative-hypnotic dose of alcohol than ISS mice. Congenic animals
followed a similar patterns as their respective progenitors with L.5S having more
alcohol-induced differences in gene expression compared to S.5L mice. Genotype
based differences in expression depended upon background strain, which is expected
because ILS and ISS mice were selectively mated for phenotypic differences related to
the LORR and congenic mice only differed from progenitors at a limited chromosomal
region. Thus, L.5S congenics were more similar to ILS mice and S.5L congenics were
more similar to ISS mice in terms of their gene expression profile within PFC. All SAM
positive S-scores filtered for values ≥ 1.5 or ≤ -1.5 were subsequently combined to
visualize global patterns of gene expression using multi-variant hierarchical clustering
(Figure 51B). Overt differences among the interaction of background genotype and
alcohol exposure, as also previously evident from Fyn kinase knockout mice, were
difficult to discern because most genes showing basal heterogeneity were also robust
regulated by an acute dose of alcohol. In order to narrow potential differences of the
Lore5 QTL interval our analysis was then restricted to comparing ILS > ISS or ILS <
ISS, L.5S > ILS or L.5S < ILS, and S.5L > ISS or S.5L < ISS. Thus, only genes
consistently altered either by alcohol or genetic background, falling within the Lore5
locus, remained as candidate regulators for the behavior.
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The Lore5 interval, including both the IBD and non-IBD region, contained
approximately 407 genes. The amalgamation of microarrays accounted for ~391
representative genes within the Lore5 region; however, the arrays accounted for all of
the genes within the non-IBD region. Variation in the entire Lore5 genotype coincided
with 13 differentially expressed probesets, representing 11 distinct gene products. Of
the 11 genes consistently altered with the Lore5 genotype, only N-myc downstreamregulated gene 1 (Ndrg1) and solute carrier family 38 member 2 (Slc38a2) were located
in the non-IBD region. The two suspected factors are located at two disparate sites of
the QTL interval with Ndrg1 being located at ~ 66.76 Mb and Slc38a2 located at ~ 96.52
Mb of chromosome 15. Comparing genotypic differences in gene expression using
other analytical techniques for microarray data, such as robust multi-array analysis
(RMA), further demonstrated co-variation in Lore5 genotype and expression of Ndrg1,
but not Slc38a2. Consistency in expression of basal expression for Ndrg1 and the Lore5
genotype strongly suggests Ndrg1 as a prominent factor related to the sedativehypnotic behavioral effect of acute alcohol. Correspondent changes in Lore5 genotype
and Ndrg1 were only witnessed for basal differences, whereas alcohol-responsiveness
of Ndrg1 expression appeared to be controlled by the background genotype outside of
the Lore5 interval.

Ndrg1 expression as a quantitative trait for the LORR behavior. Northern blot
analysis confirmed the expression patterns seen on microarrays for Ndrg1 (Figure 53A).
Differential expression of Ndrg1 within a defined QTL for the LORR suggests Ndrg1
may be a quantitative trait gene (QTG) for the LORR. Adult male C57BL/6J, DBA/2J,
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Figure 53. PFC basal Ndrg1 expression and LORR behavior. (A) Northern blot
analysis of Ndrg1 mRNA within ISS, S.5L, ILS, and L.5S PFC, showing inverse
relationship between Ndrg1 expression and duration in LORR, (B) confirmation of
LORR phenotype in differing laboratories for C57BL/6J, DBA/2J, C3H/HeJ, BALB/cByJ,
129S1/SvImJ, A/J, and FVB/NJ mice using data from Crabbe et al., 2006, (C) significant
correlation of basal PFC expression of Ndrg1 to the LORR duration across C57BL/6J,
DBA/2J, C3H/HeJ, BALB/cByJ, 129S1/SvImJ, A/J, and FVB/NJ mice.
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C3H/HeJ, BALB/cByJ, 129S1/SvImJ, A/J, and FVB/NJ mice were assessed for covariation of LORR and Ndrg1 gene expression within the PFC to test the relevance of
Ndrg1 as a QTG for the LORR behavior. Environmental variables may change the
outcomes of alcohol-related behavioral traits conducted in different laboratories (Crabbe
et al., 1999, Wahlsten et al., 2003). Therefore, durations in the LORR across the seven
strains mentioned above were correlated to previously reported outcome measures for
the LORR from a different laboratory, within the same strains of mice (Crabbe et al.,
2006a). Duration in the LORR from the seven genetically divergent strains of mice was
significantly correlated across laboratory environments (Figure 53B; R2 = 0.8226, pvalue = 0.0048), suggesting the behavioral phenotype is reproducible across
laboratories. Basal expression of Ndrg1 significantly correlated to duration in the LORR
(Figure 53C; R2 = 0.5775, p-value = 0.0474). The significant association of basal
abundance for Ndrg1 within PFC and alcohol-induced LORR behavior across a
heterogeneous stock of mice further suggests variation in the expression of Ndrg1 is
prominent factor for this specific behavioral measure.

Linkage of Ndrg1 gene region to expression divergence in ILS/ISS-Lore5
genotype. Variation in the expression of the candidate gene Ndrg1 reproducibly
associates with susceptibility to the duration of the LORR. Haplotype analysis of ILS
and ISS animals further suggested polymorphic differences in Ndrg1 between these two
strains. As part of our ongoing collaboration, Johnson and colleagues genotyped microsatellite markers spanning the location of Ndrg1, confirming the locus was non-IBD and
each respective congenic (L.5S and S.5L) possessed an identical form of Ndrg1 from
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the appropriate parental strain (S.5L = ILS, L.5 = ISS). Six genetic markers were
detected within Ndrg1, four of the markers verified genotypic differences aligned with
the Lore5 interval corresponding to sequence divergence of Ndrg1.
Using WebQTL online resource (www.genenetwork.org) basal variation in gene
expression from two available datasets (including prefrontal cortex) was analyzed
alongside selective recombination events in 42 LXS recombinant inbred strains of mice,
derived from ILS and ISS progenitor strains. Individually probing for Ndrg1 identified the
presence of an expression quantitative trait loci occurring exactly at the location of
Ndrg1 within the hippocampus (Figure 52C) and the prefrontal cortex (Figure 52D).
Calculating genetic linkage for the expression of Ndrg1 at it’s own genomic location
firmly demonstrates a cis-eQTL, suggesting differences in the assembly of nucleotides
between ILS and ISS influences expression of Ndrg1 under baseline conditions. The
presence of a cis-eQTL for Ndrg1 at the location of the phenotypic Lore5 QTL further
suggests that Ndrg1 is a candidate gene regulating the sedative-like behavioral
response to acute alcohol exposure.
Ndrg1 expression correlates with a cluster of myelin genes across microarray
studies in ISS, ILS, C57BL/6J, and DBA/2J mouse strains. Although our genetical
genomic analysis singled out variation of Ndrg1 as a causal factor for acute alcohol
sensitivity, we hypothesized that Ndrg1 participated within the framework of a gene
network to drive downstream behavioral responses to alcohol. Data from previous
chapters herein, as well as previous data from our laboratory, has demonstrated a
reoccurring association between Ndrg1 and large cohort of myelin-associated genes in
terms of coordinate gene expression. Thus, Ndrg1 may function within the context of a
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Figure 54. Ndrg1 and associated gene expression. (A) Hierarchical clustering of
gene expression for basal and alcohol-responsive gene expression six strains showing
Ndrg1 association with myelin genes and inverse relationship to acute alcohol
sensitivity, (B) Cytoscape network of 13 strongly basally correlated myelin genes,
including Ndrg1, across the LXS RI PFC, (C) Correlation of Ndrg1 expression with Clic4
expression across the LXS RI PFC, another gene known to influence the LORR
behavior in mice.
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myelin-related network across species to gauge an initial level of response and
susceptibility to long-term drinking behavior. Interpreting the association between a
Ndrg1 / myelin gene network and alcohol behavioral response is important because
together with Dr. Adron Harris and colleagues, our previous microarray studies have
shown myelin is significantly down regulated in the PFC of human alcoholics (Lewohl et
al., 2000); implying a myelin network containing Ndrg1 has immediate clinical
significance.
Array data from saline and alcohol-treated B6 and D2 mice was combined with that
reported in the current study on ISS, ILS and the Lore5 congenic strains to show
genetically convergent expression patterns across the PFC. Hierarchical clustering of
the six distinct strains revealed coordinate expression patterns for Ndrg1 alongside
multiple myelin-associated genes, including Mbp and Plp1, the two most abundant
myelin genes within the CNS. Relative expression of this myelin-associated cluster was
prominently correlated to the Lore5 genotype and alcohol sensitivity (Figure 54A). Thus,
the more alcohol behavioral sensitive strains (D2, ILS, and L.5S) exhibit lower basal
myelin-associated expression, while the less behaviorally sensitive mice (B6, ISS, and
S.5L) had higher relative expression of Ndrg1 and other myelin genes.
Analyzing basal gene expression across the PFC of the LXS RI panel (n = 42)
further identified a network of myelin-associated genes associated with Ndrg1 (Figure
54B). The same 13 genes also strongly connected across the PFC of BXD RI mice (n =
29), and significantly correlated to acute alcohol behavioral sensitivity and alcohol
drinking behavior (Table 6). Identification of differential Ndrg1 expression, as well as a
network of myelin-associated genes linked to Ndrg1, in mice selectively bred for the loss
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of righting reflex behavior may implicate basal differences in a myelin gene network for
this specific alcohol behavioral response (i.e. LORR behavior). Ndrg1 baseline
expression in the PFC significantly correlated to other genes determined in our previous
studies in mice and across species. The expression of the myelin gene claudin-11
(Cldn11) correlated to Ndrg1 (Pearson’s r = 0.657, p-value = 8.96 e-07) in LXS PFC.
Additionally, as shown in Figure 54C, expression of the myelin-associated gene network
and Ndrg1 is correlated to PFC expression of the chloride intracellular ion channel 4
(Clic4) (Pearson’s r = 0.736, p-value = 4.21 e-09). Differential expression of Clic4 is
associated with alcohol drinking behavior across the PFC of cynomolgus macaques and
mice (Figure 15). Our laboratory has also demonstrated that over-expression of Clic4
neuronal expression, using the adeno-associated virus type 2 (Srivastava et al., 1983),
in mouse PFC decreases duration of alcohol-induced LORR (Bhandari et al., 2012).
Coordinate expression of myelin-related genes with Clic4 further suggests that
differential basal expression of a myelin-associated gene network in PFC is a
determinant of acute behavioral effects of alcohol as measured by duration in the loss of
righting reflex behavior.

Acute Behavioral Sensitivity in a Demyelinated Mouse Model.
A network of myelin-associated genes in the PFC is coordinately regulated across
species. Continued investigation within PFC across the BXD RI panel and progenitors,
Fyn kinase knockout mice, and mice selectively bred for acute sensitivity to alcohol
provided strong corroborating evidence for basal variation of a myelin-associated gene
network as an underlying factor in acute behavioral sensitivity to alcohol. Among the
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differing acute behavioral measures may be influenced by variation in myelin gene
expression our data suggests basal variation in myelin contributes to acute functional
tolerance to the sedative-hypnotic effects of acute alcohol (i.e. LORR). In order to
extend these previous observations we used a demyelination mouse model to test the
hypothesis that the baseline abundance of a myelin gene expression network is a
crucial determinant in specifically mediating the sedative-hypnotic effects of acute
alcohol exposure as determined by the LORR. Cuprizone is a copper chelating agent
that selectively targets mature oligodendrocytes, causing demyelination, in adult C57BL/
6 mice (Matsushima and Morell, 2001). Using the neurotoxicant cuprizone allows for the
investigation of myelin in an adult animal model on a single genetic background, which
are devoid of potential developmental compensation (Torkildsen et al., 2008).
C57BL/6J mice were chronically fed 0.2% (w/w) of cuprizone or normal rodent
chow for a period of 5 weeks. A 5-week duration of cuprizone exposure is sufficient to
facilitate regional differences for a reduction in myelin-associated gene expression
(Hiremath et al., 1998, Gudi et al., 2009). Using quantitative real-time polymerase chain
reaction (Q-rtPCR) (Wong and Medrano, 2005), the mRNA abundance of seven myelin
genes were confirmed for decreased cuprizone-induced expression in PFC (Figure 55).
This included decreased expression of the LORR quantitative trait gene Ndrg1 in
response to cuprizone treatment. Exposure to 0.2% cuprizone did not alter expression
of Clic4, which if over-expressed in PFC neurons lessens the duration for LORR.
Immunostaining of coronal sections (30 µm) with the myelin stain fluoromyelin (Wu et
al., 2006) demonstrated a 20-30% decrease in width of the corpus callosum, and
qualitative thinning of myelinated fibers in the corpus callosum (Figure 56). Coordinate
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Figure 55. Validation of cuprizone model for myelin-associated gene expression.
Quantitative real-time PCR analysis of Ndrg1, Mobp, Mbp, Plp1, Mag, Mog, Mal, and
Clic4, demonstrating a selective decrease for basal expression of the myelin gene
network in mouse PFC.
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Figure 56. Validation of cuprizone model for decreased CNS white matter.
Immunostaining using Invitrogen BrainStain imaging kit for DAPI (blue), NeuN (red), and
fluoromyelin (green) showing decreased myelin content in the corpus callosum of mice
fed a cuprizone containing diet.
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decreases in myelin within the corpus callosum, and decreases in myelin mRNA
abundance for seven different genes in the PFC suggests cuprizone is causing reduced
expression of the entire myelin-associated gene network. Importantly, cuprizone
induced down-regulation of myelin genes occurs in the PFC of rodents, but not other
brain regions such as the hippocampus and striatum (Gregg et al., 2009). Decreased
expression of myelin-related transcripts, resulting from a cuprizone containing diet, is
associated with impairments in PFC-mediated behaviors (Gregg et al., 2009).

Assessment of Anxiety-Like Behavior. The light-dark box test, based on the natural
preference of rodents for the dark compartment, was used to assess anxiety-like or
anxiogenic-like behavior of cuprizone fed mice (Bourin and Hascoet, 2003). Alcohol is a
powerful anxiolytic agent in mice and humans, associated with dysfunction of the PFC
(Costall et al., 1988, Koob, 2006). There was no effect of acute alcohol [F (1, 28) =
0.007, p-value = 0.933], cuprizone exposure [F (1,28) = 0.065, p-value = 0.358], or
interaction of acute alcohol and cuprizone [F (1,28) = 0.873, p-value = 0.801] (Figure
57A). Mice treated with acute alcohol showed an increase in percent distance traveled
in the light [F (1,28) = 55.40, p-value < 0.0001] (Figure 57B) and percent time spent in
the light [F (1,28) = 49.33, p-value <0.0001] (Figure 57C). Saline treated mice spent
~15-20% of their time in the light-compartment, compared to alcohol treated animals
spending ~50-60% of their time in the light-compartment, suggesting a general
anxiolytic effect of acute alcohol administration. Cuprizone had no effect on percent
distance traveled [F (1,28) = 0.0765, p-value = 0.784] or percent time in the lightcompartment [F (1,28) = 0.333, p-value = 0.569]. Additionally, cuprizone showed not
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Figure 57. Cuprizone effect on anxiety-like behavior. Light dark box analysis for (A)
entries into the light zone, (B) percent distance traveled in the light (PDT), and (C)
percent time spent in the light (PTS) for saline and alcohol in cuprizone mice and
controls. Main effect of alcohol treatment on PDT [F (1,28) = 55.40, p-value < 0.0001]
and PTS [F (1,28) = 49.33, p-value <0.0001]. Data Mean ± SE.
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interaction with alcohol for percent distance traveled in the light [F (1,28) = 0.194, pvalue = 0.663] or percent time in the light-compartment [F (1,28) = 0.0374, p-value
0.848]. Thus, decreased myelin gene expression due to cuprizone exposure has no
effect on basal anxiety or alcohol-induced anxiolytic behavior.

Assessment of Locomotor Behavior. Acute 2 g/kg of alcohol may enable altered
locomotor behavior depending on the genetic background of mice; however, 2 g/kg (i.p)
of acute alcohol has no effect on locomotor activation in C57BL/6J mice (Phillips et al.,
1995). Non-specific effects on initial exploratory or locomotor behavior may confound
may confound interpretation of anxiety-like responses and other behavioral measures.
Reducing the basal amount of myelin-associated gene expression with cuprizone did
not change baseline locomotor behavior [F (1,28) = 2.22, p-value = 0.148] or interact
with alcohol for distance traveled [F (1,28) = 1.49, p-value = 0.233] (Figure 58A). Lack
of differences in total distance traveled suggests a cuprizone-induced demyelination
phenotype had no competing effects on locomotor behavior. Acute alcohol also did not
alter acute locomotor activity [F (1,28) = 1.80, p-value = 0.191], reconfirming previous
results from our laboratory and others for C57BL/6J mice. Average velocity, however,
was diminished for cuprizone mice and controls [F (1,28) = 97.1, p-value < 0.0001]
following acute alcohol (Figure 58B). Cuprizone did not alter mean velocity [F (1,28) =
0.347, p-value = 0.560] or interact with alcohol to change the average velocity [F (1,28)
= 0.397, p-value = 0.534], suggesting a main effect of alcohol for this behavioral
measure. The number of ambulatory episodes did not change due to cuprizone
exposure [F (1,28) = 0.559, p-value = 0.461], acute alcohol treatment [F [1,28) = 1.13,
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Figure 58. Cuprizone effect on locomotor behavior. (A) Distance traveled, (B)
average velocity, and (C) ambulatory episodes following 2 g/kg (i.p.) alcohol
administration for controls and cuprizone exposure. Main effect of alcohol administration
on average velocity [F (1,28) = 97.1, p-value < 0.0001], but no effect on general
locomotor function. Data Mean ± SE.
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p-value = 0.297], or interaction of the two factors [F (1,28) = 0.820, p-value = 0.373]
(Figure 58C).
Mice were also monitored for jumping behavior, number of vertical counts, and
number of abnormal repetitive behaviors or stereotypy. Acute 2g/kg of alcohol markedly
decreased jumping behavior [F (1,28) = 19.05, p-value = 0.0002] (Figure 59A) and the
total number of vertical movements [F (1,28) = 97.13, p-value < 0.0001] (Figure 59B).
Cuprizone did not alter the number of jumps [F (1,28) = 0.027, p-value = 0.870], vertical
counts [F (1,28) = 0.347, p-value = 0.560], or interact with acute alcohol actions on the
number of jumps [F (1,28) = 0.003, p-value = 0.957] and vertical movements [F (1,28) =
0.397, p-value = 0.534]. Abnormal brain function associated with psychiatric disorders
may be apparent by divergent stereotypy behavior (Garner, 2005). Stereotypy counts
were reduced in response to acute alcohol administration [F (1,28) = 24.55, p-value <
0.0001] (Figure 59C). Decreasing myelin gene expression, using the neurotoxicant
cuprizone, did not alter the number of repetitive movements [F (1,28) = 3.33, p-value =
0.079], or modify alcohol-induced stereotypy counts [F (1,28) = 0.850, p-value = 0.364].
Although acute alcohol lowered the average velocity, number of jumps, vertical counts,
and stereotypy counts, there were no differences or interaction effect due to a cuprizone
containing diet on general locomotor-related behavioral measures. The absence of
altered locomotor responses may suggest that reduced myelin-associated gene
expression does not confound the results witnessed for anxiety-like behavior or other
quantitative traits associated with overt locomotor behavior.
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Figure 59. Cuprizone effect on additional motor-oriented behaviors. Cuprizone was
insensitive to behavioral effects on (A) jumping activity, (B) number of vertical
movements, or (C) stereotypy counts; demonstrating a main effect of alcohol
administration on jumping [F (1,28) = 19.05, p-value < 0.0002], vertical counts [F (1,28)
= 97.13, p-value < 0.0001], and stereotypy [F (1,28) = 24.55, p-value < 0.0001]. Data
Mean ± SE.
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Assessment of Gaiting Behavior. Ataxia and fine-motor coordination were
determined using the footprint test, also referred to as gait analysis, (Crawley, 1999) for
mice on normal rodent chow and food supplemented with cuprizone. Pronounced loss
of CNS myelin can impair fine-motor control in mice (Jensen et al., 1993, Emery et al.,
2009). Stride length, sway length, and stance length were recorded from paw tracings
for individual mice (Figure 60A). Cuprizone did not alter stride length [t (10) = 0.323, pvalue = 0.753] (Figure 60B), stance length [t (10) = 0.097, p-value = 0.924] (Figure
60C), or sway length [t (10) = 0.164, p-value = 0.873] (Figure 60D). The near equivalent
gait analysis measurements indicates decreased CNS myelin, resulting from 5 weeks of
cuprizone exposure does not interfere with coordinated fine-motor control.

Handling-Induced Convulsion Behavior. A state of CNS hyper-excitability follows
acute high-dose and chronic exposure to alcohol, causing convulsions in withdrawn
mice (Mc and Fingl, 1958). Damage to the myelin sheath can facilitate CNS mediated
convulsing activity (You et al., 2011). A blinded observer scored handling-induced
convulsions (HIC) in cuprizone fed mice and controls for baseline HIC activity, and
subsequent a single exposure of 4-g/kg intraperitoneal alcohol. Cuprizone did not
change baseline susceptibility to HIC [t (30) = 0.361, 0.533] (Figure 61A). Video
recording of HIC every hour from 2-8 hours post alcohol exposure lead to a timedependent an increase in HIC behavior [F (6, 84) = 7.29, p-value < 0.0001] (Figure
61B), but showed no interactions with cuprizone diet [F (6, 84) = 0.938, p-value =
0.472]. HiC scores typically reach a maximum threshold approximately 7-hours post
alcohol exposure (Belknap et al., 1993, Roberts et al., 1995). Collapsing the data for

243

Figure 60. Cuprizone effect on gaiting behavior. (A) Gait analysis was conducted to
determine potential effects on fine-motor coordination, demonstrating no effect on (B)
stride length t (10) = 0.323, p-value = 0.753, (C) stance length t (10) = 0.097, p-value =
0.924, or (D) sway length t (10) = 0.164, p-value = 0.873, suggesting no adverse effects
of cuprizone on mouse gaiting behavior. Data Mean ± SE.
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area under the curve (Buck et al., 1997) from 2-8 hours revealed no differences
between cuprizone and controls for alcohol-induced withdrawal behavior [t(14) = 0.476,
p-value = 0.641] (Figure 61C). Genetic variation and divergent expression of the
quantitative trait gene multiple PDZ domain protein (Mpdz) is a major determinant of
withdrawal episodes from alcohol and other drugs of abuse (Fehr et al., 2002, Fehr et
al., 2004, Shirley et al., 2004). Expression of Mpdz is associated with myelin gene
expression in PFC (Kerns et al., 2005). Q-rtPCR demonstrated Mpdz expression was
not altered by acute 4 g/kg of alcohol or a cuprizone containing diet [Interaction effect: F
(1,28) = 0.006, p-value = 0.940] (Figure 61D). Thus, cuprizone does not cause altered
HIC behavior following an acute high-dose alcohol exposure or alter the expression of a
QTG for HIC activity. Animals also did not differ for HIC behavior following 24 hours of
alcohol withdrawal (data not shown).

Loss of Righting Reflex Behavior. Microarray analysis of the PFC from C57BL/6J,
DBA/2J, Fyn kinase knockout mice, Inbred Long-Sleep, Inbred Short-Sleep, and Lore5
congenic mice suggested an inverse relationship between myelin-associated gene
expression and alcohol-induced loss of righting reflex behavior. Cuprizone exposure led
to a significant decrease of expression in a myelin-associated gene network within PFC
(Figure 55). The reduction in myelin gene expression did not affect the onset for the
LORR following a sedative-hypnotic dose of acute alcohol administration [t (18) = 0.600,
p-value = 0.556] (Figure 62A). Both cuprizone fed animals and controls acquired the
LORR behavior with a mean onset time approximately equal to 85 seconds. Animals
treated with saline did not acquire the LORR behavior at any time-point. Cuprizone mice
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Figure 61. Cuprizone effect on handling induced convulsion (HiC) behavior.
Blinded observation of HIC activity revealed cuprizone had no effect on (A) baseline
HIC t (30) = 0.361, 0.533, (B) alcohol-withdrawal HIC time-course [F (6, 84) = 7.29, pvalue < 0.0001], or (C) area under the curved (AUC) for alcohol-induced withdrawal
scores t(14) = 0.476, p-value = 0.641, suggesting no adverse effects of cuprizone on
CNS hyperexcitability. Cuprizone also did not effect expression of the HIC quantitative
trait gene Mpdz in PFC [F (1,28) = 0.006, p-value = 0.940]. Data Mean ± SE.
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had longer sleep time following 4 g/kg of alcohol exposure, with greater duration in their
LORR behavior compared to controls [t (18) = 3.44, p-value = 0.0029] (Figure 62B).
Control mice had a mean duration of LORR equal to 42.4 minutes, compared to a mean
duration for the LORR of 60.7 minutes in cuprizone-exposed mice. Altered LORR
behavior was not explained by non-specific effects on alcohol metabolism, with a maineffect of time between cuprizone and controls [F (4,35) = 24.69, p-value < 0.0001].
Differences in the LORR behavior are also not explained by confounding effects of
cuprizone on motor function due to the lack of significant effects of cuprizone on
locomotor-related behavior or gaiting behavior. The increased duration of the LORR
suggests reduced myelin gene expression is associated with reduced acute-functional
tolerance to the sedative-hypnotic effects of acute alcohol administration.

Discussion
Using whole-genome oligonucleotide microarrays, expression profiling was applied
to aid in the identification of candidate QTGs underlying the Lore5 QTL spanning a
portion mouse chromosome 15. The Lore5 QTL influences the duration in the loss of
righting reflex (LORR) behavior, a measure of acute neurosensitivity and development
of acute tolerance to a sedative-hypnotic dose of alcohol (Tabakoff and Ritzmann,
1979). Localizing the causal genetic variant or variants underneath the plethora of
complex trait QTLs for alcohol and other drugs of abuse has been frustratingly elusive,
with only a limited number of QTGs having been conclusively identified (Phillips et al.,
2008, Spence et al., 2009). High-throughput methods of measuring differential
expression and sequence variation have accelerated the identification of genetics
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Figure 62. Cuprizone effect on LORR behavior and alcohol metabolism. Cuprizone
treatment did not effect alcohol-induced (4 g/kg i.p.) (A) time of onset for LORR t (18) =
0.600, p-value = 0.556, but greater mean duration in LORR behavior compared to
controls * t (18) = 3.44, p-value = 0.0029, confirming effects related to expression of
Ndrg1. Cuprizone also did not have off-target effects with a main effect of time (C)
alcohol metabolism [F (4,35) = 24.69, p-value < 0.0001], suggesting a neurobiological
effect of cuprizone on LORR. Data Mean ± SE.
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factors shaping the manifestation of complex traits. Although the precise brain-region or
physiological system underlying the LORR is unknown, the PFC is an important point of
convergence in neural processing and motor execution. Comparing an unbiased
genomic profile for mice selectively bred for differentially sensitivity to the LORR,
including interval specific congenics for a known behavioral QTL, our analysis has
uncovered a restricted amount of gene expression patterns related to the Lore5 QTL.
Pairing together genetics, genomics, and network- based bioinformatics approaches
demonstrated the LORR is driven through a network of myelin-associated genes
anchored by a genetic variant in N-myc downstream-regulated gene 1 (Ndrg1) beneath
the Lore5 interval.
Genomic evaluation of reciprocal congenics and inbred mice used in this study
combined with recent high-density genotyping of the ISS and ILS strains, limited the
Lore5 interval to two regions of Chr 15 (56.99-72.64 and 94.71-94.71 Mb). Dissection of
this Chr 15 region assumes genes located within the IBD region are not genetically
divergent between selected strains. A recent SNP analysis of 198 genetically distinct
strains of mice, including ILS and ISS mice, further demonstrated a large portion of the
Lore5 QTL is IBD. C57BL/6 mice, having a very dense database of publicly available
genetic markers, also possessed a very similar haplotype block structure compared to
ILS and ISS mice across the IBD interval. Although undetected mutations may still exist
within the IBD region of the Lore5 QTL, our in silico analysis by and large suggests
causal genetic variants rest within 56.99-72.64 or 94.71-94.71 Mb on Chr 15.
Additionally, no genes within the IBD region of the Lore5 QTL, or the more distal region
94.71-94.71 Mb, revealed any cis-eQTLs across the LXS RI population. Expression of
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Ndrg1 within both the prefrontal cortex and hippocampus demonstrated a cis-eQTL,
suggesting the expression of Ndrg1 is linked to recombination events occurring between
genetic offspring of ILS and ISS progenitors. The existence of a cis-eQTL aligned with a
phenotypic QTL advocates regulatory variation corresponding to the presence of
disease or intermediate phenotypes linked to disease (Gilad et al., 2008, Hansen et al.,
2008, Williams et al., 2009).
Several investigations of ILS and ISS mice, and their descendents, have
delineated several genetic loci contributing to the LORR and other alcohol-related
behavioral traits. Similar to other genetic inquires of substance abuse and other
complex traits; progress has been slow towards uncovering the genetic components
underlying the LORR (Crabbe, 2002, Flint and Mackay, 2009). Our genetical-genomics
analysis of the Lore5 QTL for both basal and alcohol-response gene expression strongly
supports a role for Ndrg1 in mediating acute sensitivity to the LORR. Differences in
baseline expression for Ndrg1 were initially confirmed through Northern blot analysis of
ILS, ISS, L.5S, and S.5L mouse PFC. PFC expression of Ndrg1 under baseline
conditions also correlates to the duration in LORR across a heterogeneous stock of
mice, further implicating Ndrg1 as a probable QTG for the sedative-hypnotic properties
of alcohol. Combined with the cis-eQTL inquiry of LXS RI mice, these data suggest that
Ndrg1 gene regulatory sequence variation between genotypes may cause differential
expression of the gene and contributes to the observed behavioral differences in
response to high-dose alcohol administration.
The precise function of Ndrg1 is uncertain, but Ndrg1 has been implicated in
multiple biological processes. Variation in the expression of Ndrg1 may serve as an
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early indicator in different cancerous growths (Chua et al., 2007, Inagaki et al., 2009,
Strzelczyk et al., 2009). Cell growth and differentiation related transcription factors
myelocytomatosis oncogene (Myc), p53 gene product (p53), and hypoxia inducible
factor-1 alpha (Hif1a) serve as upstream regulators of Ndrg1 (Ellen et al., 2008).
Functioning within the CNS, Ndrg1 has an uncharacterized role in neuronal-glial cell
differentiation and myelination (Kalaydjieva et al., 2000, Berger et al., 2004). Over
stimulation of the proto-oncogene Myc inhibits the expression of Ndrg1, leading to
escalating hypomyelination (Jensen et al., 1998). Deficiencies or mutations in Ndrg1 are
known to produce a progressive demyelination phenotype (Kalaydjieva et al., 2000,
Okuda et al., 2004), suggesting that Ndrg1 expression is an important regulator for a
subgroup of myelin genes. The expression pattern for Ndrg1 clusters with a group of
myelin genes that also have basal expression patterns associated with the Lore5
genotype and behavioral sensitivity. Basal expression for a network of myelin-related
genes strongly correlates to Ndrg1 expression within PFC across two different
recombinant inbred panels of mice. The myelin gene network, including Ndrg1,
significantly correlates to acute sensitivity and alcohol consumption within the PFC of
BXD mice. Furthermore, decreasing the expression of Ndrg1 and the myelin gene
network with the neurotoxicant cuprizone reliably altered the predicted phenotype (i.e.
LORR), without significantly impairing gross motor function.
Cross-species network analysis of gene expression determined alcohol-drinking
behavior is significantly associated with myelin-related gene expression across mice,
monkeys, and humans within the PFC. CNS myelin integrity is severely compromised in
the frontal systems of alcoholics (Pfefferbaum et al., 2009), and is down-regulated in
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prefrontal cortex of alcoholics (Lewohl et al., 2000). In addition to alcoholism, myelin
dysfunction occurs in a myriad of substance abuse and neuropsychiatric disorders (Lim
and Helpern, 2002). Myelin-related transcripts are also down regulated in schizophrenia
and bipolar disorder (Davis and Haroutunian, 2003, Tkachev et al., 2003).
Commonalities between alcoholism and other psychiatric conditions for abnormal
myelin gene expression and structure may suggest comorbid pathophysiology related to
oligodendrocytes dysfunction underlying CNS mediated diseases. Although aberrant
myelin expression clearly occurs in alcohol dependence from chronic heavy alcohol
drinking behavior, our results point towards a novel role of basal myelin abundance in
neurobehavioral functions related to acute alcohol exposure.
Myelin gene discrepancies within the CNS during critical developmental periods
may confer vulnerability to neuropsychiatric conditions (Harris et al., 2009). Subtle
variations in myelin are associated with subtle differences in cognitive and behavioral
performance (Perrin et al., 2008, Paus, 2010). Oligodendrocytes, the myelin forming
cells of the CNS, express growth factors that support neuronal function and survival (Du
and Dreyfus, 2002). Myelination influences structural and functional plasticity within
neuronal populations (Woodhoo et al., 2009, Raiker et al., 2010), which may suggest
dynamic interactions among CNS cell types and consequential behavioral processes.
The precise function of some myelin-related genes is still uncertain (Montague et al.,
2006); however, NDRG1 is proposed to regulate cholesterol transport and associated
intracellular trafficking mechanisms (Hinds et al., 2004, Hunter et al., 2005). The
composition of myelin is fundamentally different from the cell membrane, enriched with
myelin structural proteins, glycosphingolipids, and cholesterol (Gielen et al., 2006).
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Thus, NDRG1 may play a central role in the variation of myelination through regulating
protein-lipid interactions and trafficking to site of neuronal ensheathment.
Our work suggests that Ndrg1 and a myelin-related gene network may play a
fundamental role in alcohol-induced loss of righting reflex. Additional evidence from our
previous microarray studies further suggests that variation in a myelin-associated gene
network within the PFC is an underlying aspect of acute alcohol sensitivity and longterm drinking behavior. Continued investigation of Ndrg1 is necessary to understand the
role of Ndrg1 in the regulation of myelination and alcohol behavioral phenotypes;
however, Ndrg1 may function as a QTG for the sedative-hypnotics effects of alcohol.
Acting within the framework of a genetical-genomics network, we propose Ndrg1 is an
important molecular endophenotype for long-term risk of developing an alcohol use
disorder.

253

CHAPTER 7:
GENERAL DISCUSSION AND FUTURE PERSPECTIVES

Myelin is a major constituent of the vertebrate nervous system, accounting for
nearly half of the total volume within the human brain (Filley, 2010). Insulating neuronal
axons, myelin facilitates the saltatory conduction of action potentials along nodes of
Ranvier to permit efficient communication throughout different brain regions (Zoupi et
al., 2011). The vast neuronal architecture of the human brain relies on up to 176,000 km
of myelinated fibers to properly function (Marner et al., 2003). Although the multilamellar structure of myelin sheaths are comprised largely of lipids, CNS myelin is
associated with approximately 342 proteins (Jahn et al., 2009). Major, as well as minor,
alterations in the amount of CNS myelin can impair cognitive behavior (Bartzokis et al.,
2007, Johansen-Berg, 2010).
Chronic alcohol abuse leads to myelin deficits, particularly in frontal regions,
associated with cognitive and motor function impairments (Pfefferbaum et al., 2009).
The maximum amount of daily alcohol consumed negatively correlates to the degree of
myelin deficiency (Kril et al., 1997), with pronounced loss occurring in the prefrontal
cortex white matter (Harper and Matsumoto, 2005). Myelin gene expression is
significantly down regulated in the prefrontal cortex of alcoholics (Lewohl et al., 2000,
Mayfield et al., 2002). Interestingly, deficits of myelin are also observed in the frontallimbic systems, including the prefrontal cortex, for major depressive disorder (Ouyang et
al., 2011, Tham et al., 2011), substance abusers without comorbid alcohol problems
(Schlaepfer et al., 2006), schizophrenia (Katsel et al., 2005, Regenold et al., 2007), as
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well as other psychiatric and neurological disorders such as autism spectrum disorder
(Fields, 2008, Zikopoulos and Barbas, 2010).
Convergent evidence in myelin abnormalities from multiple CNS-related disorders
may suggest a common underlying mechanism in disease; however, the extent to which
myelin affects differing behavioral systems is unclear. Additionally, aberrant myelin
expression may be a common secondary factor caused by different primary
mechanisms for separate neuropsychiatric or neurological diseases. Characterizing
intermediate phenotypes for both behavioral and molecular processes may assist in
defining key aspects of disease (Meyer-Lindenberg and Weinberger, 2006). Divergence
in the coordinate regulation of gene expression is one potential molecular
endophenotype leading to behavioral perturbations (Gould and Gottesman, 2006). The
advent of microarray technologies has led to a high-throughput methodology for an
unbiased, parallel assessment of gene expression within complex systems (Sobek et
al., 2006). A previous microarray study from our laboratory determined basal and
alcohol-responsive brain-region specific gene expression patterns in mesocorticolimbic
system of C57BL/6J and DBA/2J mice (Kerns et al., 2005); two strains of mice that differ
in acute alcohol sensitivity and long-term drinking behavior. Variation in acute behavioral
responses to alcohol is an indicator of the long-term risk of heavy-drinking behavior in
humans and animal models (Schuckit, 1994, Metten et al., 1998b). Myelin-associated
gene expression was differentially regulated by acute alcohol exposure and under
baseline conditions in the PFC between C57BL/6J and DBA/2J mice (Figure 6).
Contrasting gene expression profiles in myelin-related genes pointed towards a possible
role of myelin within PFC for acute alcohol sensitivity and self-administration. Based on
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these observations in mice and previous findings from postmortem alcoholic brain tissue
we hypothesized that the expression of a myelin-associated gene network is an
important determinant of alcohol behavioral phenotypes.
Gene expression data was obtained for chronic alcohol drinking female and male
cynomolgus macaques, rhesus macaques, humans, and a panel of BXD recombinant
inbred mice. Applying weighted gene co-expression network analysis (WGCNA) to each
of these five datasets revealed a statistically conserved co-expression pattern for
myelin-associated gene expression with the PFC across species (Figure 35). The
myelin gene network significantly correlated to alcohol drinking behavior in mice and
rhesus macaques, which sufficiently varied in alcohol intake. The amount of alcohol
consumed for human samples was unavailable. Focusing on rhesus macaques as a
surrogate for the neurobiology of chronic alcohol exposure in human brain revealed a
set of ten gene expression networks associated with average daily alcohol intake
spanning one year of self-administration behavior (Figure 23). This core group of ten
alcohol drinking-related gene networks may be important for future targeted inquiries of
genetic or genomic aspects of chronic alcohol exposure. Combined, the networks were
over-represented in binding sites for several key microRNAs, including miR-9, miR-212,
and miR-219. Alcohol up-regulates miR-9 and contributes to mechanisms in alcohol
tolerance (Pietrzykowski et al., 2008). Signaling events regulated by miR-212 confer
vulnerability to cocaine addiction (Hollander et al., 2010, Im et al., 2010), but has yet to
be directly studied in relation alcohol abuse. Inhibition of miR-219 impairs NMDA
receptor transmission and associated behaviors (Kocerha et al., 2009).
Oligodendrocytes rely on miR-219 for developmental control of myelination (Dugas et
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al., 2010), suggesting microRNAs may mediate different actions in differing CNS cell
types. The role of miR-219 in alcohol drinking behavior and acute behavioral responses
has also yet to be investigated.
MicroRNAs play key roles in CNS plasticity and behavior (Dreyer, 2010, Bredy et
al., 2011). Directly profiling expression of microRNAs in the PFC of controls and alcoholexposed subjects will provide another layer of experimental data to supplement the
gene expression results obtained across species. Coordinate regulation of microRNAs
and mRNA with shared functional roles may help define transcriptional networks
operating in response to acute and chronic alcohol. Profiling the expression pattern of
microRNAs from intact brain tissue, rather than isolated cell-types, may be essential
given the diverse expression of microRNAs among different brain regions and CNS cell
types (Cao et al., 2006, Kapsimali et al., 2007). Comparing microRNA networks across
species may further help narrow large inventories of microRNA to a limited conserved
set of microRNAs. Elucidating specific microRNA focal points sharing expression
patterns and sequence homology will be important given the diversity of microRNAs
across differing species (Berezikov et al., 2006, Bak et al., 2008). Variation in
microRNAs and microRNA networks may serve as modifiers of gene expression
networks acting on complex traits (Bandiera et al., 2010, Su et al., 2011). Our analysis
suggests differential expression of miR-219 may be a critical point of intersection for
alcohol behavioral traits through downstream effects on NMDA receptor function and
coordinate expression of myelin-associated gene expression.
The myelin-associated gene network within the rhesus macaque and BXD RI
mouse PFC datasets significantly correlated to alcohol intake; however, coordinate
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expression was positively, and not negatively, associated with drinking behavior.
Multiple studies conducted on alcoholic brain tissue have ascertained an inverse
association between alcohol consumption and myelin brain volume (Harper and Kril,
1990, Harper, 2007). The discrepancies between our preclinical models and the effects
on myelin gene expression in humans may be due to the timeline of alcohol intake and
patterns of alcohol self-administration. In view of our previous analysis of C57BL/6J and
DBA/2J mouse PFC (Kerns et al., 2005), a positive correlation to alcohol drinking
behavior in mice and non-human primates also put forth the possibility that higher basal
myelin gene expression was related to increased alcohol intake patterns and decreased
sensitivity to acute alcohol-related behaviors. The conservation of a myelin gene
network across species and a compilation of previous alcohol behavioral genetic studies
conducted on BXD RI strains allowed us to test the hypothesis that basal variation of
myelin-related gene expression in PFC was an underlying factor in alcohol behavioral
phenotypes. Myelin was strongly conserved across 71 different strains of mice within
PFC (Figure 40&41). The expression and connectivity of the PFC myelin network was
unlike available data from nucleus accumbens and ventral tegmental area across the
BXD RI panel (Figure 42). Most importantly, the PFC myelin network, as well as
individual myelin genes, was positively correlated to alcohol drinking behavior and
inversely associated with acute sensitivity. Future studies on BXD RI mice selected for
extreme differences in myelin gene expression could be used to verify the behavioral
results from our in silico analysis. In addition to behavioral phenotypes, the myelin gene
network may be regulated through correlated transcripts. For example, the
progesterone receptor (Pgr) is significantly correlated to the first principal component of
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the myelin gene expression network. Progesterone is neurosteroid known to promote
myelination and myelin repair (Schumacher et al., 2012). The progesterone metabolite
allopregnanolone, and other endogenous neurosteroids, may exert differences in the
positive (i.e. reward) and negative (i.e. withdrawal) effects of alcohol (Finn et al., 2010).
Thus, further investigation into interaction of the progesterone receptor and the myelin
gene network may reveal novel insights into neurobiology of short and long-term alcohol
behavioral phenotypes.
The alcohol drinking model employed for the BXD RI mice used for our chronic
alcohol exposure studies were performed using an alcohol vapor intermittent access
model originally developed for C57BL/6J mice (Becker and Lopez, 2004, Lopez and
Becker, 2005). Differences in genetic background may impart differential sensitivity to
the effects of alcohol on myelin-associated gene expression. C57BL/6J mice are
insensitive to acute alcohol regulation of myelin gene expression in PFC, as was
evident for DBA/2J mice. Additionally, due to the robust metabolism of alcohol in mice
the alcohol vapor model uses the alcohol dehydrogenase inhibitor pyrazole (Blomstrand
et al., 1979) to establish consistent blood and brain alcohol concentrations during vapor
exposure. Pyrazole has off target effects, acting as a non-competitive antagonist for
NMDA receptors (Pereira et al., 1992). Antagonists of NMDA receptors possess
neuroprotective effects within the CNS (Choi et al., 1988, Choi and Rothman, 1990).
Brain damaged caused by chronic alcohol exposure and withdrawal partially the result
of excitotoxicity related to increased NMDA receptor function (Lovinger, 1993).
Excitoxocity as result of glutamate receptor malfunction also causes damage to
oligodendrocytes and myelin (Matute et al., 2007). Although air controls also receive
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pyrazole injections, in the absence of adverse side effects pyrazole may be masking the
neurotoxic effects of chronic alcohol exposure in mice. Using alternative drinking
models, such as two-bottle choice intermittent access (Wise, 1973, Simms et al., 2008)
or the liquid diet technique (Lieber and DeCarli, 1989), on a variety of genetic
backgrounds may help refine an animal model for reductions in CNS myelin gene
expression. Selection of the proper genetic background may be essential due to
differential regulation of alcohol between strains (Kerns et al., 2005), and some strains
of mice have pre-existent missing or incomplete major white matter fiber tracts (Livy and
Wahlsten, 1991).
Although our analyses of chronic alcohol exposure across species did not
recapitulate an overall down-regulation of myelin gene expression as seen with
postmortem brain tissue of alcoholics, the network approach did demonstrate a
conserved myelin gene expression network associated with drinking behavior. The
myelin network was further conserved in alcohol naïve mice, but suggested a novel
hypothesis for the role of myelin variation as a predisposing element in acute alcohol
sensitivity. Literature association analysis identified the non-receptor tyrosine kinase
Fyn as a potential signaling mechanism regulating differences in myelin gene
expression (Figure 44). Previous work has shown Fyn kinase knockout mice lack acute
tolerance to a sedative hypnotic dose as determined by the loss of righting reflex
(LORR) behavior (Miyakawa et al., 1997, Boehm et al., 2003). Our microarray analysis
of Fyn kinase knockout mice revealed a significant decrease in multiple myelinassociated transcripts with the NAC and PFC (Figure 46), suggesting a developmental
defect in myelin expression for Fyn knockout animals. Extending the Fyn knockout
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profiling results to BXD and LXS PFC gene expression discovered a set of 50 genes
sharing robust correlated expression and protein-protein interactions (Figure 48& 50)
also correlated to the LORR behavior (Figure 49). Probing the Fyn-dependent networks
through knockout mice or viral-vector approaches, may identify new molecular factors
regulating the sedative-hypnotic properties of acute alcohol and myelin-associated gene
expression. Although the basal Fyn-dependent network was over-represented for genes
regulating myelin expression, no myelin structural proteins were consistently correlated
to Fyn expression across all of the microarray studies. The lack in reproducible
correlation may be due to the developmental deficits occurring in the Fyn kinase
knockout mouse. All of the PFC samples for BXD, LXS and Fyn knockout mice were
harvested from adult animals. Myelin mRNA levels peak within the first three weeks of
development (Campagnoni and Macklin, 1988), consistent with the time-course of Fyn
kinase on myelinogenesis (Lu et al., 2005). If our studies had focused on earlier
developmental time-points corresponding with the regulation of myelinogenesis a
correlation between Fyn and myelin genes may have been detected. Regardless, the
decrease in basal abundance for myelin-associated gene expression within the PFC of
Fyn knockout mice is consistent with an inverse relationship to acute alcohol sensitivity.
The reproducible LORR behavioral phenotype in Fyn knockout animals further
narrowed our attention to the potential of myelin-related gene expression as a
determinant for a specific alcohol behavioral response, the LORR.
Derived from a multi-generational cross of eight founder strains, genetically inbred
long sleep (ILS) and inbred short sleep mice (ISS) were established for divergent
sensitivity to alcohol-induced LORR (McClearn, 1970), a measure of acute tolerance in
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mice (Ponomarev and Crabbe, 2004). LXS mice, using ILS and ISS mice as
progenitors, are one of the larges panels of recombinant inbred mice created to
determine the genetic influences underlying susceptibility to the LORR behavior
(Bennett et al., 2006). Mapping phenotypic variation for LORR provisionally determined
seven quantitative trait loci (QTL) for this specific behavioral trait within the LXS
reference population (Markel et al., 1996). Four of the seven QTL (chromosomes 1, 2,
11, and 15) were later confirmed and capture within interval-specific congenic strains,
allowing for fine-mapping the LORR genetic loci (Bennett et al., 2008). Through
collaboration with these investigators we conducted a genetical-genomic inquiry
(Jansen and Nap, 2001) of ILS, ISS, L.5S, and S.5L mice to determine potential
quantitative trait genes (QTGs) residing within the chromosome 15 interval (Lore5) for
the LORR. Genetic variation paired with differential expression identified the myelinrelated gene Ndrg1 as a high priority candidate for the LORR. Expression of Ndrg1 was
confirmed for the Lore5 genotype, and showed a significant correlation to the duration of
LORR across a heterogeneous stock of mice (Figure 53). The function of Ndrg1 is
largely uncertain, but is suggested to be involved in cholesterol transport and
intracellular trafficking. Polymorphisms and genetic null mutations for Ndrg1 lead to a
demyelination phenotype (Okuda et al., 2004, Echaniz-Laguna et al., 2007). Expression
of Ndrg1 was correlated to other myelin-associated genes in every genomic profiling
experiment conducted herein, and ranked as one of the top five genes associated with
alcohol drinking across species (Figure 35). Further investigation of Ndrg1 will be
invaluable in determining the role of Ndrg1 in the LORR and alcohol drinking behavior.
Our laboratory is currently in the process of generating an Ndrg1 conditional knockout
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mouse that will be used for directly testing alcohol behavioral phenotypes and the
underlying neurobiology linked with Ndrg1.
Alternative splicing could be an essential component of downstream functional
consequences for Ndrg1. A mutation in NDRG1 resulting in skipping of exon 9 is
associated with demyelination in humans (Hunter et al., 2003). The role of alternative
splicing for Ndrg1 in animal models has yet to be explored. Reintroduction of the short
form of Mbp into shiverer mice, which normally lack all forms of Mbp, largely recovers
myelin structural and behavioral abnormalities (Kimura et al., 1989). Expression of Fyn
was associated with the RNA binding protein quaking (Qk), which regulates alternative
splicing of myelin-associated genes (Wu et al., 2002, Zhao et al., 2010a). Determining
uniquely spliced forms of Ndrg1 and other myelin-associated genes using nextgeneration sequencing technologies (Metzker, 2010), tiling or exon arrays (Johnson et
al., 2003, Soreq et al., 2011), or other methodologies may assist in pinpointing distinct
myelin gene products associated with the development of complex traits.
Studying the mechanisms specifically regulated by Ndrg1 could delineate how
differential expression of Ndrg1 affects myelin gene expression and structural variation
of the myelin sheath. Cell culture systems permit the dissection of specific processes
not easily attainable in vivo (Gibbons and Dragunow, 2010). Although traditional culture
methods are typically inadequate for discerning the final stages of myelinogenesis in
vitro, newer specialized coculture systems can clarify substrates required for adhesion,
ensheathment, wrapping, and compaction (Watkins et al., 2008, Emery et al., 2009).
Expression of Ndrg1 could be silenced in culture using available siRNA constructs and
then determine potential dysregulation of coordinately regulated myelin transcripts and
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formation of the myelin sheath. Suppressing Ndrg1 in culture could also be used to test
the consequences of alcohol exposure. A previous proteomics analysis has shown
NDRG1 is predominantly phosphorylated by PKA and interacts with molecular
chaperone proteins such as GPR94 (Tu et al., 2007). Alcohol acutely regulates the
expression of GPR94 and other molecular chaperones (Miles et al., 1994, Wilke et al.,
2000). Increased expression of molecular chaperones is a suggested protective
mechanism against glutamate excitotoxicity (Lowenstein et al., 1991), which may be
related to the maladaptive effects of chronic alcohol within the CNS. Depletion of
cholesterol, a major constituent of the myelin sheath, is another protective mechanism
against glutamate receptor induced excitotoxicity (Ponce et al., 2010). Cholesterol
depletion also causes a reduction in NDRG1 (Ponce et al., 2010). The relationship of
NDRG1 with cholesterol and molecular chaperones may suggest a functional
association to NMDA receptor mediated excitotoxicity due to chronic alcohol exposure.
Specialized CNS coculture systems for myelination could unravel a mechanistic role of
NDRG1 and myelin gene expression related to NMDA receptor signaling processes in
development and response to alcohol exposure.
Decreasing myelin-associated gene expression using the neurotoxicant cuprizone
complemented our previous studies, showing myelin deficits increased sensitivity to the
sedative-hypnotic effects of acute alcohol. Increased duration of the LORR was not due
to adverse effects on motor function or altered alcohol metabolism. Notwithstanding the
potential for cuprizone to exert global reductions in CNS myelin beyond just the PFC,
cuprizone treatment showed down-regulation of the myelin gene network in an adult
animal altered the predicted alcohol behavioral phenotype. Further behavioral
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phenotypes could certainly be investigated using the cuprizone model of demyelination.
Two-bottle choice drinking behavior and the stationary dowel test are two behavioral
models that may be of immediate interest due to their relation to our studies on myelinassociated gene expression. Alcohol consumption is generally inversely correlated to
sensitivity to the loss of righting reflex behavior. Studies on the Fyn kinase knockout
mice demonstrate an increased sensitivity to the LORR is associated with decreased
alcohol drinking behavior (Boehm et al., 2003). Fyn kinase knockout mice also
demonstrate similar behavioral responses to the LORR and stationary dowel test
(Boehm et al., 2003). The stationary dowel test is commonly used to test acute
functional tolerance to sedative-hypnotic effects of acute alcohol administration (Erwin
and Deitrich, 1996, Kirstein et al., 2002). Thus, assessing vulnerability to alcohol
drinking behavior and sensitivity for the stationary towel, due to cuprizone exposure,
may extend our observations for the behavioral pharmacology of alcohol exposure
related to variation in myelin-associated gene expression. However, different behavioral
phenotypes may capture different aspects of complex behavioral domains (Crabbe et
al., 2005) and be caused by multiple genetic factors not captured in a single animal
model (Crabbe et al., 1994b).
The cuprizone model of demyelination also has the added advantage of
undergoing remyelination following the removal of cuprizone and re-administration of
normal rodent chow (Morell et al., 1998, Jurevics et al., 2002). Although cuprizone could
have unforeseen neurobiological effects, future work could evaluate alcohol behavioral
phenotypes during different stages of demyelination and remyelination. Operating on a
C57BL/6J background the cuprizone model also permits the usage of genetic knockout
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animals, which are traditionally established on a C57BL/6J background, to determine
potential interactions of a selected gene(s) and myelin on alcohol behavioral
phenotypes. Soluble drugs may be added to an animal’s drinking water to probe other
mechanisms related to myelin gene expression in cuprizone exposed mice. For
example, addition of the atypical antipsychotic quetiapine to an animal’s drinking water
alleviates myelin abnormalities due to a concomitant cuprizone containing diet (Zhang
et al., 2008). The versatility of the cuprizone model could thus allow a variety of genetic
and pharmacological approaches to investigate the neurobiology of myelin in relation to
alcoholism and associated behavioral phenotypes in a preclinical animal model.
Human brain imaging, or imaging genetics, is an available platform for probing
intermediate phenotypes related to the function of PFC networks and neuropsychiatric
disease (Tan et al., 2009). Several techniques (i.e. magnetic resonance imaging,
diffusion tensor imaging, fractional anisotropy) are available for measuring myelin
content/structure in the human brain. Although substantial heterogeneity exists among
the brains of differing individuals, large-scale three-dimensional mapping strategies can
be combined with behavioral and genetic profiling to determine maladaptive brain
structure underlying disease (Thompson et al., 2002, Van Essen et al., 2012). Overall
brain and white matter volume is highly heritable in humans (Hulshoff Pol et al., 2006,
Schmitt et al., 2007). A single nucleotide polymorphism in Fyn kinase is associated with
alcohol dependence and related endophenotypes (Schumann et al., 2003, Pastor et al.,
2009); however, it is unknown whether this polymorphism in Fyn kinase is also
associated with myelin variation in alcohol dependent individuals. Additionally, it is
uncertain whether polymorphisms directly within NDRG1, or other myelin-related genes,
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are associated with structural variation and alcoholism. Identifying the intersection of
genetic components involving myelinogenesis and acute behavioral responses to
alcohol may be important for distinguishing genetic risk factors for the development of
an alcohol use disorder.
Through a system-based approach, using gene expression networks as an
intermediate phenotype, the work presented herein suggests myelin-associated gene
expression is a quantitative trait gene network linked to alcohol behaviors. Acute and
chronic alcohol exposure causes changes in myelin-related gene expression associated
with CNS plasticity; however, our analyses suggest a novel relationship of basal
variation in myelin gene expression within prefrontal cortex as a determinant for alcohol
behavioral phenotypes across species (Figure 63). Combining genetical-genomics
inquiries on myelin gene expression with future studies on structural variation of myelin
can facilitate a translational approach for understanding the neurobiology of alcohol
abuse and dependence (Badea et al., 2009, Poot et al., 2011). Although additional
experimental evidence will further refine the relationship between myelin gene
expression and alcohol-related phenotypes, our work may warrant a longitudinal
analysis of myelin in human populations as an underlying component in the risk of
developing an alcohol use disorder. Continuing investigation of the myelin gene network
may provide unique insights into the susceptibility for neuropsychiatric disease, and be
an avenue to therapeutic interventions.
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Figure 63. Myelin and Alcoholism. Prior works suggests acute and chronic alcohol
exposure alters myelin-associated gene expression in PFC, which may be related to
short- and long-term CNS plasticity. However, our analyses suggest basal variation in
myelin-associated gene expression may be a quantitative trait gene network (QTGN) for
alcohol behavioral phenotypes, especially as it relates to the loss of righting reflex
behavior.
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